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ABSTRACT 
 
Acute respiratory distress syndrome remains a significant cause of mortality among 
intensive care patients.  Mechanical ventilation is a crucial component of therapy but 
can exacerbate injury through overstretch of lung units, known as ventilator-induced 
lung injury (VILI).  The mechanisms by which ventilation triggers the characteristic 
inflammatory cascade and how this pulmonary inflammation progresses to 
extrapulmonary organs have not been clearly elucidated.  In this work I explored the 
role of mononuclear phagocytes in the initiation (alveolar macrophages) and 
subsequent progression (monocytes) of VILI, using in vivo mouse models.   
Initially, the importance of alveolar macrophages in VILI was clarified by 
pharmacologically depleting these cells, which substantially attenuated injury.  The 
observation that injurious ventilation led to a decrease in macrophage recoverability 
led us to hypothesise that adhesive interactions between epithelial cells and 
macrophages may be important in their activation. 
To address this, I developed a novel flow cytometric methodology to assess 
intracellular mitogen activated protein (MAP) kinase phosphorylation in discrete 
pulmonary cell populations.  I was able to demonstrate rapid alveolar macrophage 
activation, but little epithelial activation, during high stretch ventilation. This 
potentially indicated that alveolar macrophages directly sense stretch through their 
adhesive contacts with epithelial cells.  I attempted to study this using antibodies to 
block integrin-mediated interactions, although results were inconclusive.  
In addition to these experiments, I carried out a preliminary study showing, 
for the first time, that activated leukocytes marginate to extrapulmonary organs 
during VILI.  This supports the possibility that monocytes and neutrophils play a role 
in the development of extra-pulmonary organ injury, although this remains 
undefined. 
This data shows that mononuclear phagocytic cells are likely to play crucial 
roles in the pathogenesis of VILI.  The findings and methodologies developed provide 
many possibilities for future research that will enhance our understanding of this 
iatrogenic injury, ultimately in view of potential therapeutic targets.  
3 
 
TABLE OF CONTENTS 
 
ABSTRACT 2 
TABLE OF CONTENTS 3 
TABLES AND FIGURES 6 
ACKNOWLEDGEMENTS 9 
DECLARATION 10 
Introduction 11 
1.1 Acute Lung Injury & Acute Respiratory Distress Syndrome 12 
Interventional and therapeutic treatment of ARDS 16 
1.2  Ventilator-induced lung injury 18 
'Baby lung' phenomenon 19 
The Five Factors of VILI 20 
Multiple system organ failure 26 
1.3  The Alveolar Unit 29 
Neutrophils 30 
Monocytes 32 
Pulmonary Endothelium 33 
Alveolar macrophages 37 
Alveolar epithelium 44 
1.4  Other Factors 46 
Surfactant 46 
Glycocalyx 49 
Extracellular matrix 50 
1.5  Adhesion molecule-mediated mechanisms of cell communication and activation 52 
Beta-2 integrins 53 
ICAMs 55 
VCAM-1 60 
Selectins 62 
1.6  Intracellular signalling pathways 66 
Nuclear factor-kappa B 67 
Akt/PI3 kinase pathway 68 
MAP kinase signalling 70 
1.7  Hypothesis and Aims 79 
 
4 
 
Materials and Methods 80 
2.1  Animals 81 
2.2 In vivo mouse model of VILI 81 
Ventilation apparatus 81 
Animal preparation 82 
Measurement of respiratory mechanics and physiological changes 83 
2.3 Intratracheal instillation 84 
2.4 In vivo sampling 85 
2.5 Flow cytometry 86 
2.6 Protein assay 96 
2.7 KC/MIP-2 ELISAs 96 
2.8  Model validation 97 
Ventilation strategy parameter validation 97 
Model Justification and Relevance 101 
2.9 Statistics 104 
Alveolar macrophages play an important role in ventilator-induced lung injury 105 
3.1  Background 107 
3.2  Aim 110 
3.3 Protocols 110 
3.4  Results 111 
Alveolar macrophage depletion is protective 111 
Macrophage recoverability 116 
CD11b expression on alveolar macrophages 118 
ICAM-1 expression on EpCAM
+
 cells 120 
Macrophage aggregation 120 
ICAM-1 expression on alveolar macrophages 123 
3.5 Discussion 125 
Starfish hypothesis 131 
Development of markers of alveolar macrophage and alveolar epithelial cell activation 134 
4.1  Background 136 
4.2   Aims 138 
4.3  Protocols 138 
4.4  Results 141 
mTNF was not a useful marker of alveolar macrophage activation during VILI 141 
MAP kinase development 144 
Epithelial cell identification validation 145 
5 
 
The best control? Isoflurane vs ketamine/xylazine 150 
Phosphorylated MAP kinase levels following LPS instillation 153 
MAP kinase levels following TNF instillation 156 
MAP kinase levels following high stretch ventilation 158 
4.5  Discussion 160 
Blockade of intra-alveolar integrin-mediated cellular interactions 167 
5.1  Background 169 
5.2  Aims 170 
5.3  Protocols 171 
5.4  Results 173 
Group 1: 5 mins high stretch, 1 hour after antibody instillation 173 
Group 2: overnight antibody incubation + 5 mins high stretch 175 
Physiological changes with CD18 blockade 177 
5.4  Discussion 181 
The recruitment of activated leukocytes to extra-pulmonary organs with high stretch ventilation 185 
6.1  Background 187 
6.2  Aims 188 
6.3  Protocols 189 
6.4  Results 190 
Monocytes in extrapulmonary organ dysfunction during VILI 190 
Leukocyte activation status 192 
Liver and kidney wet/dry weight ratios 195 
6.5  Discussion 197 
Final Discussion 200 
7.1  Summary of Findings 202 
7.2  Nervous control of MAP kinase activation 204 
7.3  Negative regulation of the lung, in practice 206 
7.4  Triggering the inflammatory cascade and the starfish hypothesis 207 
7.5  Monocyte-endothelial interactions: a mirror of the alveolar macrophage-epithelial 
relationship? 210 
7.6  Concluding remarks 211 
References 214 
 
 
6 
 
TABLES AND FIGURES 
 
TABLES 
Table 2.1:  Fluorochromes associated with fluorescence channels on FACSCalibur
TM
 and Cyan
TM
 flow 
cytometers 
Table 2.2:  Antibodies used for cell identification by flow cytometry 
Table 2.3:  Antibodies used to measure activation markers expressed by cells using flow cytometry 
Table 5.1:  Physiological changes during high stretch ventilation in animals treated with anti-CD18 
 
FIGURES 
Figure 1.1: Diagram of an ICAM-1 molecule 
Figure 1.2: MAP kinase signalling pathway overview.   
Figure 1.3: A simplified outline of the NFκB, JNK, p38 and ERK1/2 pathways 
Figure 2.1: Identification of alveolar macrophages in bronchoalveolar lavage and lung single cell suspensions 
by flow cytometry.   
Figure 2.2: Physiological changes within the lung with due to high stretch ventilation 
Figure 2.3: Chemokines in bronchoalveolar lavage are upregulated by high stretch ventilation.   
Figure 2.4: Leukocyte recruitment to the lung with high stretch ventilation 
Figure 3.1: Alveolar macrophage depletion 48 hours after intratracheal clodronate lipsome instillation 
Figure 3.2: Alveolar macrophage depletion attenuated ventilator-induced lung injury 
Figure 3.3: KC and MIP-2 levels in BAL after high stretch ventilation are lower with clodronate depletion. 
Figure 3.4: Macrophages recovered by bronchoalveolar lavage after ventilation 
Figure 3.5: CD11b expression on alveolar macrophages from bronchoalveolar lavage 
Figure 3.6: ICAM-1 expression on EpCAM
+
 cells increases with high stretch ventilation 
Figure 3.7: Macrophage aggregation in bronchoalveolar lavage 
Figure 3.8: ICAM-1 expression on alveolar macrophages increases with high stretch ventilation 
7 
 
Figure 3.9: The starfish hypothesis.   
Figure 4.1: Membrane-bound TNF expression on alveolar macrophages 
Figure 4.2: Alveolar epithelial cell identification by flow cytometry 
Figure 4.3: Four pulmonary epithelial sub-populations identified by flow cytometry 
Figure 4.4: EpCAM
high
 cells are not present in alveoli 
Figure 4.5: Ketamine/xylazine lowers MAP kinase levels in alveolar macrophages and type II and type I 
epithelial cells of untreated animals 
Figure 4.6: Representative histograms showing alveolar macrophage activation in response to intratracheal 
LPS 
Figure 4.7: Time course of alveolar macrophage and epithelial MAP kinase responses to intratracheal LPS.   
Figure 4.8: Time course of MAP kinase response to intratracheal TNF in alveolar macrophages and epithelial 
cells 
Figure 4.9: MAP kinase levels in alveolar macrophages, type II and type I alveolar epithelial cells after 
ventilation 
Figure 5.1: Alveolar macrophage MAP kinase levels following 5 mins high stretch ventilation following CD18 
blockade and 60 mins low stretch 
Figure 5.2: MAP kinase levels following overnight CD18 blockade and 5 mins high stretch ventilation 
Figure 5.3: Lung wet/dry ratio  and bronchoalveolar lavage protein concentration following high stretch 
ventilation in anti-CD18 treated animals 
Figure 5.4: MIP-2 and KC levels in bronchoalveolar lavage from ventilated animals following anti-CD18 
antibody pre-treatment 
Figure 5.5: Differential cell cytology from lavage of isotype and anti-CD18 treated animals subjected to 180 
mins of high stretch ventilation 
Figure 6.1: Leukocyte numbers in the liver, spleen kidney, heart and blood 
Figure 6.2: CD11b expression on neutrophils in the liver, kidney, spleen and blood 
Figure 6.3: L-selectin expression on neutrophils and Gr-1
high
 monocytes in the liver, kidney, spleen and blood 
Figure 6.4: Wet/dry ratios of kidney and liver following high stretch ventilation do not show signs of 
extrapulmonary organ injury 
Figure 7.1: The inflammatory reflex 
 
8 
 
 
 
  
9 
 
ACKNOWLEDGEMENTS 
 
 
I would like to thank a number of people who made my time in the lab a truly 
rewarding experience.   
 
Firstly, I am deeply grateful to my supervisors Dr Mike Wilson and Prof Masao 
Takata.  Mike has been an incredibly patient supervisor and has offered continual 
support in the transition from the BSc project to my taste of science as a PhD 
student.  I’m indebted to you for reaching this far.  I’m very thankful for the guidance 
and encouragement from Masao who, over the past years, has continually urged me 
to push myself further and from whom I have learnt a great deal.   
 
My thanks goes to other members of the Critical Care group for providing such an 
enjoyable environment throughout the course of my PhD. Particular thanks goes to 
Kieran for his invaluable advice as flow cytometry guru and his continual willingness 
to share ideas.  I have learnt a great deal from the experience of Szabi, Kenji and Ant, 
whose help has been much appreciated.  And Marianne’s never-ending positivity has 
made coming into the lab a joy.  
 
Lastly, I would like to voice my heartfelt appreciation of the unwavering support of 
my parents and friends.  Thank you.  
 
 
10 
 
DECLARATION 
 
This thesis is the result of my own work. Any assistance provided has been 
acknowledged in the Acknowledgements.  
 
This thesis does not exceed the word length stipulated by the College Regulations.  
 
  
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER ONE 
 
 
Introduction  
 
12 
 
1.1 Acute Lung Injury & Acute Respiratory Distress Syndrome 
Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury 
(ALI), a term which itself encompasses a wide spectrum of illness.  The clinical 
hallmarks of ALI/ARDS are severe refractory hypoxaemia, bilateral pulmonary 
infiltrates on radiological images of the lung (representing pulmonary oedema and 
atelectasis), and normal intracardiac filling pressures (which rule out cardiogenic 
causes of pulmonary oedema) (Bernard, Artigas et al. 1994; Puneet, Moochhala et al. 
2005; Wheeler and Bernard 2007).  A consensus on the most recent definition of 
ALI/ARDS was reached in 1994 at the American-European Consensus Conference on 
ARDS in order to facilitate standardisation of the study and treatment of ARDS 
patients (Bernard, Artigas et al. 1994).  The criterion that differentiates between a 
diagnosis of ALI or ARDS is the efficiency of alveolar oxygenation as represented by a 
ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen 
(PaO2:FiO2); ALI has a PaO2:FiO2 of ≤300mHg, whilst for ARDS the PaO2:FiO2 is 
≤200mHg.  If the PaO2:FiO2 falls between 200-300mmHg, this is referred to as 'mild 
ALI', which has half the mortality rate of ARDS (Brun-Buisson, Meshaka et al. 2004).   
Although there is some contention over whether mortality rates of ARDS have fallen 
since 1994 (Zambon and Vincent 2008; Brochard and Rouby 2009; Phua, Badia et al. 
2009), there is a general consensus that the number of patients dying as a result of 
ARDS is still too high and needs to be reduced, with mortality rates usually reported 
around 40-60% (Phua, Badia et al. 2009; Vincent, Sakr et al.) ARDS is one of the five 
most common diagnoses for patients entering the ICU (Khan, Palepu et al. 2008), 
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with an incidence amongst intensive care unit (ICU) patients of ~2-7% (Goss, Brower 
et al. 2003; Brun-Buisson, Minelli et al. 2004; Vincent, Sakr et al.).  
 ARDS is a syndrome, rather than being a disease, which means that although 
the symptoms patients present with are similar, the underlying cause of injury can 
vary from patient to patient.  The causes of lung injury can be direct (e.g. pneumonia 
or aspiration of gastric contents) or indirect (e.g. sepsis) (Ware and Matthay 2000), 
and although it is likely that the inflammatory pathways triggered may differ 
depending on the mode of injury, the consequential pathophysiological processes 
characteristic to ARDS are common and irrespective of the initial injury.  The major 
causes of ARDS are infection-related, whether as a result of pulmonary (e.g. 
pneumonia) or extra-pulmonary (sepsis) infection (Matthay and Zemans 2011).  
There is a suggestion within the literature that indirect, sepsis-related lung injury is 
more severe than non-sepsis-related ARDS (Sheu, Gong et al. 2010), although the 
mechanisms underlying this difference have yet to be explored.  
 
The pathology underlying ARDS can be roughly divided into three phases: an initial 
inflammatory or exudative phase, followed by a proliferative and finally a fibrotic 
phase (Bellingan 2002). 
 
Inflammatory phase 
One of the cardinal signs of inflammation in any part of the body is swelling, due to 
the influx of excess fluid. The lung is no exception.  The primary function of the lung 
is gas exchange and its delicate structure is highly suited to this role.  The thin walls 
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of the alveolar epithelium and capillary boundaries provide a short distance for 
gaseous exchange between the gaseous and vascular compartments.  The 
inflammatory phase of ARDS is however characterised by the influx of protein-rich 
oedema fluid which widens the interstitial space between the two compartments 
due to increased permeability of the endothelial and alveolar epithelial barriers.  A 
number of structural and functional changes can be observed. Type I epithelial cells 
undergo necrosis and/or apoptosis (Lee, Fang et al. 2007) and slough, exposing the 
denuded basement membrane beneath and facilitate the formation of hyaline 
membranes (Ware and Matthay 2000; Matthay and Zemans 2011). Damage to the 
epithelium results in impaired surfactant production by type II pneumocytes and 
inefficient fluid transport, both of which contribute to the impaired capacity for 
effective ventilation.  A number of fluid transport mechanisms exist with the ability 
to clear fluid from the alveoli if pulmonary oedema were to develop.  These 
transporters (including aquaporin channels, Na+K+-ATPase, epithelial sodium 
channels (ENaC), cystic fibrosis transmembrane conductance regulator (CFTR) 
(Matthay, Folkesson et al. 2002) work inefficiently during ARDS due to their down 
regulation / inhibition (Berger, Guetta et al. 2011).  The deficiency of surfactant and 
excess of fluid within the alveoli results in the lungs becoming less compliant and 
increases the tendency for alveolar collapse (atelectasis).  A ventilation-perfusion 
mismatch therefore transpires, with shunting of blood through 
atelectatic/consolidated regions of lung (Townsend and Webster 2000).  Normally, 
hypoxic pulmonary vasoconstriction occurs in order to distribute blood away from 
non-ventilated areas, however in ARDS this mechanism appears to be dysfunctional 
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or lost.  In this fashion the efficiency of alveolar oxygenation is reduced, ultimately 
resulting in severe hypoxaemia. In addition, neutrophils and monocytes marginate 
into the lungs and the alveolar spaces and in conjunction with macrophages, which 
are major producers of cytokines (Dunn and Pugin 1999), endothelial and epithelial 
cells are activated and release various inflammatory mediators which contribute to 
the inflammatory cascade network (Burke-Gaffney and Hellewell 1996; Weinacker 
and Vaszar 2001).  Furthermore, research has demonstrated that these inflammatory 
sequelae correlate with the severity of injury (Meduri, Headley et al. 1995).    
 
Proliferative phase  
The breakdown of the endothelial-epithelial barrier permits red cells and fibrin to 
enter the alveolar space in addition to the continued influx of inflammatory cells.  
The coagulation pathway is known to be activated during VILI, and the tissue factor-
dependent extrinsic pathway has been implicated (Chambers 2008).  Fibrin 
deposition (hyaline membranes) is a product of this pathway and is an attempt to 
plug gaps in the epithelial wall where the barrier is damaged (Wang, Bastarache et 
al. 2007).  But soon macrophages begin to phagocytose neutrophils, the hyaline 
membranes and other debris (Weinacker and Vaszar 2001; Bellingan 2002) and type 
II pneumocytes proliferate and differentiate into their type I counterpart in order to 
replace the damaged epithelium.  This phase marks the tipping of the immune 
balance from pro- to anti-inflammatory and the beginning of repair (Bellingan 2002).   
 
 
16 
 
Fibrotic phase 
As the epithelium repairs, fluid is returned to the correct compartment (transported 
to the interstitium and removed by the lymphatic system), and resolution of 
inflammation can occur.  Fluid clearance is understood to be largely facilitated by 
active ion transport through epithelial sodium channels and Na+-K+-ATPase, and via 
aquaporin receptors (Borok and Verkman 2002; Matthay, Folkesson et al. 2002; 
Sartori, Fang et al. 2002).  The proliferation of type II epithelial cells is thought to 
have a particularly great influence on the restoration of fluid balance (Folkesson, 
Nitenberg et al. 1998).  This ability to clear fluid is crucial for restoration of normal 
gas exchange and has been shown to correlate with increased mortality (Matthay 
and Wiener-Kronish 1990).  This final stage is also characterised by fibrosis, scarring 
and cyst formation, although some patients do not go through this phase and can 
regain normal pulmonary architecture (Weinacker and Vaszar 2001).  Although the 
resolution and repair phase may be more amenable to therapy, most research has 
been conducted to enhance understanding of the acute phases of this syndrome.  
 
Interventional and therapeutic treatment of ARDS 
Despite improvement in mortality rates demonstrated by some studies, ARDS 
mortality in general has proven difficult to improve (Erickson, Martin et al. 2009).  A 
number of different treatment strategies have been tested in patients but were 
unsuccessful (Esper and Martin 2005; Diaz, Brower et al. 2010)  including fluid 
restriction (Thrane, Schwarze et al.), prone positioning (Gattinoni, Tognoni et al. 
2001; Wiedemann, Wheeler et al. 2006; Taccone, Pesenti et al. 2009), use of nitric 
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oxide (Lundin, Mang et al. 1999; Adhikari, Burns et al. 2007) administration of beta-2 
agonists (salbutamol) (Perkins, McAuley et al. 2006),  exogenous surfactant 
administration (which was successful in infant respiratory distress syndrome but not 
in adults) (Spragg, Lewis et al. 2003; Kesecioglu and Haitsma 2006; Kesecioglu, Beale 
et al. 2009), general anti-inflammatory (e.g. steroids (Thompson 2003; Steinberg, 
Hudson et al. 2006)) and specific anti-cytokine therapy (www.clinicaltrials.gov; 
Network 2002; Kadoi, Hinohara et al. 2004).  
 Inflammation is considered the best target of future therapeutic strategies.  
The lack of success to date in this field may be partly due to an underestimation of 
the complexity of the pulmonary inflammatory network.  For example, despite the 
wealth of experimental and clinical evidence indicating that TNF is upregulated 
within the lung by high stretch ventilation (Meduri, Headley et al. 1995; Takata, Abe 
et al. 1997; von Bethmann, Brasch et al. 1998; Haitsma, Uhlig et al. 2000; Park, 
Goodman et al. 2001; Tremblay, Miatto et al. 2002), anti-TNF therapy has proven 
unsuccessful to date in the treatment of patients with sepsis (Cohen and Carlet 1996; 
Reinhart, Menges et al. 2001; Panacek, Marshall et al. 2004).  Under normal 
circumstances an inflammatory response within the lung is self-regulated with a 
natural switch from a pro-inflammatory response to anti-inflammatory (Wissinger, 
Goulding et al. 2009).  There is some evidence to suggest that anti-inflammatory 
signalling is in fact integral to a pro-inflammatory response.  Serhan and Savill 
suggest that the neutrophils infiltrating into the alveolar space provide an early 
signal to promote progress to the resolution phase and a halt to further recruitment 
of neutrophils through initiation of their apoptosis (Serhan and Savill 2005).  
18 
 
Additionally, there is mounting evidence that neutrophil apoptosis also promotes 
resolution (Savill 1997).  Ultimately, the effectiveness of an anti-inflammatory 
therapy may come down to the timing of its application (Meduri, Marik et al. 2008) 
and it may not be possible to block an inflammatory response if treatment is started 
too late.   
 
 
1.2  Ventilator-induced lung injury 
There is no specific nor curative treatment for ARDS, which is at least in part due to 
its different aetiologies.  Supportive therapy is therefore employed, of which 
mechanical ventilation is an essential component.  However, mechanical ventilation 
can induce non-physiological stresses on the lung and cause ventilator-induced lung 
injury (VILI), exacerbating existing injury.  In some of the literature, VILI in humans is 
referred to as ventilator-associated lung injury (VALI), as within the clinical setting 
patients normally have some degree of injury before the commencement of 
ventilation.  There is however some evidence to indicate that ventilation can induce 
injury and inflammation in humans in the absence of pre-existing injury (Tsangaris, 
Lekka et al. 2003; Gajic, Dara et al. 2004; Gajic, Frutos-Vivar et al. 2005).  The 
concept of VILI actually derived from experimental studies with animals.  In a seminal 
study in 1974, Webb & Tierney demonstrated that there was no histological 
difference between ARDS and VILI (Webb and Tierney 1974).  Although previous 
studies had suggested that mechanical ventilation could injure the lungs, this was 
the first study to clearly demonstrate that in vivo mechanical ventilation could cause 
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pulmonary oedema.  The similarities between the inflammatory and 
pathophysiological sequelae following ARDS and VILI are such that the incidence of 
VALI is difficult to ascertain.  However, in light of large-scale trials such as ARDSNet 
(ARDSNet 2000) and the widespread use of mechanical ventilation of ARDS patients, 
the evidence to date suggests that VALI is a common problem.   
  
'Baby lung' phenomenon 
Finding the optimum tidal volume that provides an ARDS patient with sufficient 
oxygenation without overstretching any lung regions is essentially infeasible due to 
the heterogenous nature of ARDS.  This heterogeneity was lucidly described by 
Gattinoni and colleagues, who carried out and reviewed a series of CT scans to 
observe the distribution of oedema and atelectasis in the lungs of ARDS patients 
(Gattinoni, Tognoni et al. 2001; Gattinoni, Mascheroni et al. 1986).  As a result of 
their work the term 'baby lung syndrome' was coined, referring to the small volume 
of lung available for effective ventilation (Gattinoni and Pesenti 2005).  Because 
these areas of functional lung are sporadically located, if the tidal volume was 
lowered to match the functional lung volume, the ventilation/oxygenation of patent 
alveoli would be insufficient. Thus regional overstretching is inevitable and this 
iatrogenic insult can exacerbate lung injury, resulting in ventilator-induced lung 
injury.   
 There is a school of thought in which extracorporeal membrane oxygenation 
(ECMO) is considered a viable alternative to conventional treatment of ARDS, which 
would circumvent the issue of baby lung entirely.  ECMO, essentially the respiratory 
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equivalent of cardiac bypass, facilitates the oxygenation of circulating blood 
extracorporally.  Following historical development of the technique, Morris and 
colleagues conducted a randomised control trial which compared ECMO to 
conventional therapy and found no significant difference between the treatment 
groups (Morris, Wallace et al. 1994).  However a number of criticisms of their study 
lead to continued investigation of the benefits of ECMO (Lewandowski 2000).  More 
recently the CESAR trial, again comparing conventional ventilator support with 
ECMO, demonstrated a significant improvement in survival to 6 months with ECMO 
(Peek, Mugford et al. 2009).   However, complications with ECMO are common, with 
mortality rates reported between 30-48% (Peek, Moore et al. 1997; Hemmila, Rowe 
et al. 2004; Linden, Lidegran et al. 2009) and one study reporting haemorrhagic 
complications in 54% of patients with influenza-associated ARDS (9% patients with 
intracranial haemorrhage) (Davies, Jones et al. 2009).  Due to ECMO’s bad press, 
with a historical lack of success in clinical trials and a high complication rate, more 
evidence of the benefit of ECMO will need to be demonstrated in clinical trials 
before a widespread change in clinical practice can be instigated. 
 
The five factors of VILI  
There are five factors that are considered important elements of VILI, namely 
volutrauma (high tidal volumes causing overstretch), barotrauma (high pressures), 
hyperoxia (toxic effects of high concentration of inspired oxygen), atelectotrauma 
(repeated collapse and reopening of alveoli), and biotrauma (pulmonary and system-
wide inflammation due to soluble mediator production following ventilation).  
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Volutrauma vs barotrauma 
Dreyfuss and colleagues carried out a series of experiments using an in vivo rat 
model of VILI to explore the importance of high tidal volume (volutrauma) in 
comparison to high airway pressure (barotrauma) in the development of pulmonary 
oedema and injury (Dreyfuss, Soler et al. 1988).  They found that use of high tidal 
volume produced severe lung injury, irrespective of airway pressure.  In 2000 the 
ARDS Network undertook a large, multi-centre trial to compare ventilation strategies 
with one cohort of patients being ventilated with 12ml/kg and the second cohort 
with a lower tidal volume of 6ml/kg (ARDSNet 2000).  The trial was stopped early 
due to the significant survival improvement of 22% in patients ventilated with the 
lower tidal volume strategy. To date, use of lower tidal volumes is the only 
intervention shown to improve mortality rates and no other significant leaps have 
been made in the treatment of ARDS patients. As such volutrauma is considered the 
primary determinant of lung injury related to ventilation.  
 
Hyperoxia 
Hypoxia is well known to be harmful, but at the opposite end of the scale hyperoxia 
can also have detrimental effects (Altemeier and Sinclair 2007) and is widely used as 
an insult to induce ALI in experimental models (where it may even be lethal) (e.g. 
Otterbein, Mantell et al. 1999; Clayton, Carraway et al. 2001; Bellmeyer, Martino et 
al. 2007; and more specifically in respect to VILI Bailey, Cavanagh et al. 2002; Quinn, 
Moufarrej et al. 2002; Makena, Luellen et al. 2010).  As such, patients in the ICU are 
commonly ventilated with the lowest amount of oxygen necessary, with oxygen 
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toxicity thought to occur at a FiO2 of 40% or more (Branson and Robinson).  A 
retrospective study by De Jonge and colleagues observed that high FiO2 was 
associated with an increased mortality of mechanically ventilated ICU patients, 
although they were unable to say whether this was merely a reflection of the 
severity of illness (de Jonge, Peelen et al. 2008).  However, a large-scale formal 
assessment of the conservative approach to administration of oxygen (or 
“permissive hypoxemia”) has not been conducted to date.  There is some evidence 
to suggest that hyperoxia-induced injury does not in fact occur in humans (Matute-
Bello, Frevert et al. 2008) and furthermore that hyperoxia may in fact be beneficial 
(Barth, Bassi et al. 2008; Hou, Xie et al. 2009; Hou, Xie et al.).  A porcine model of 
faecal peritonitis where animals were ventilated with either FiO2 of 21% or 100% 
showed that hyperoxia had no effect on lung function nor oxidative stress and 
actually attenuated apoptosis within the lung and liver (Barth, Bassi et al. 2008).  
Despite a substantial body of experimental data demonstrating the noxious effect of 
hyperoxia and anecdotal evidence of low FiO2 being non-toxic within the clinical 
setting, safe levels for supplemental oxygenation of ICU patients and specifically 
ARDS patients have yet to be clearly defined.  In addition, the majority of 
experimental studies have exposed animals to hyperoxia over extended periods of 
time (e.g. up to 84 hours (Bellmeyer, Martino et al. 2007)) and thus these changes 
are not directly comparable to ventilated animals in our model which were exposed 
to oxygen for up to 3 hours.   
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Atelectrauma 
Atelectrauma was first described by Robertson and colleagues who observed it in 
infants with respiratory distress syndrome (Robertson 1984).  The layer of surfactant 
that normally lines the alveoli decreases surface tension and helps to maintain 
patency of the air spaces during expiration and prevent collapse of lung units.  In 
ARDS the presence of plasma proteins within the alveolar space and the disruption 
to surfactant production and clearance renders surfactant inactive and ineffective, 
and as a result alveolar collapse is inevitable.  The repeated opening and closure of 
lung units with the respiratory cycle stresses and strains the epithelial surface, and 
this insult is termed atelectrauma.  Atelectrauma can occur at both high (Otto, 
Markstaller et al. 2008) and low tidal volumes (Duggan and Kavanagh 2005; 
Wakabayashi, Wilson et al. 2011) but can be reduced/avoided through application of 
positive end-expiratory pressure (PEEP) or continuous positive airway pressure 
(CPAP) and by performing recruitment manoeuvres, which have been shown to be 
beneficial in patient outcome (ARDSNet 2000; Kacmarek and Schwartz 2000; Meade, 
Cook et al. 2008; Mercat, Richard et al. 2008)  
 In animal models the application of positive end-expiratory pressure maintains 
the patency of the air spaces and thus prevents their collapse at end-expiration 
(Duggan, McCaul et al. 2003; Halter, Steinberg et al. 2003; Valenza, Guglielmi et al. 
2003; Hauber, Karp et al. 2010).  But higher PEEP is thought to have adverse effects, 
by decreasing cardiac output and increasing pulmonary oedema (Nieman, 
Bredenberg et al. 1990).  Clinical trials testing increased PEEP have not been able to 
show such a clear and consistent benefit as seen in animal models (Meade, Cook et 
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al. 2008; Mercat, Richard et al. 2008; Briel, Meade et al. 2010).  A clinical trial 
conducted by Brower and colleagues (Brower, Lanken et al. 2004) compared the 
application of a lower PEEP of 8.3(±3.2)cmH2O to a higher PEEP of 13.2(±3.5)cmH2O 
in ARDS patients being ventilated with a low tidal volume.  They found no difference 
in outcome between the two groups.  Villar and Kacmarek (Villar and Kacmarek 
2008; Villar and Kacmarek 2010) point out that this lack of evidence is due to the 
patient selection for these trials, as a large proportion of patients included in these 
trials had only modest lung injury.  In contrast, studies by Amato et al (Amato, Barbas 
et al. 1998) and Villar et al (Villar, Kacmarek et al. 2006) only enrolled patients with 
more severe ARDS and were both able to demonstrate an improved outcome with 
the application of higher levels of PEEP.   
 
Biotrauma 
Biotrauma is the biochemical injury and inflammation that occurs as a consequence 
of soluble mediator release.  There is a wealth of in vitro (Pugin, Dunn et al. 1998; 
Grembowicz, Sprague et al. 1999; Mourgeon, Isowa et al. 2000; Vlahakis and 
Hubmayr 2003; Marsh, Cakarova et al. 2009), ex vivo (Held, Boettcher et al. 2001; 
Tremblay, Miatto et al. 2002; Whitehead, Zhang et al. 2004) and in vivo studies 
(Takata, Abe et al. 1997; Tremblay, Valenza et al. 1997; von Bethmann, Brasch et al. 
1998; Chiumello, Pristine et al. 1999; Verbrugge, Uhlig et al. 1999; Imanaka, 
Shimaoka et al. 2001; Wilson, Choudhury et al. 2005; Belperio, Keane et al. 2006; 
Vaneker, Joosten et al. 2008) demonstrating that mechanical stretch per se can 
stimulate the release of soluble mediators.  In vitro studies of macrophages, lung 
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epithelial and endothelial cells have highlighted the capacity of most alveolar cells to 
produce both pro-inflammatory (e.g. TNF, MIP-2, KC) and anti-inflammatory (e.g. IL-
10) cytokines in response to stretch (Pugin, Dunn et al. 1998; von Bethmann, Brasch 
et al. 1998; Grembowicz, Sprague et al. 1999; Vlahakis, Schroeder et al. 1999; 
Mourgeon, Isowa et al. 2000).  The exact mechanism by which cells detect stretch 
(mechanosensing) and subsequently transduce an intracellular signal has not yet 
been clearly identified.  There are at least three mechanisms by which ventilation 
could trigger mediator release: i) mechanotransduction, ii) necrosis and iii) 
decompartmentalisation (Uhlig 2002).  
 Mechanotransduction is the conversion of an extracellular mechanical force 
into an intracellular biochemical signal which activates gene transcription.  
Mechanical forces and the signals produced can be physiological and are important 
for cell migration, survival and cell cycle progression (Pugin 2003; Vlahakis and 
Hubmayr 2003; dos Santos and Slutsky 2006).  They can also be pathological, as is 
the case in VILI where stretch triggers the activation of intracellular signalling 
pathways to contribute to an exaggerated inflammatory response.  The mitogen-
activated protein (MAP) kinases are thought to mediate stretch-induced intracellular 
signalling (Pugin 2003).  Mechanosensors that have been identified and are thought 
to participate in the response to lung overstretch are stretch-sensitive ion channels 
(Hamill and Martinac 2001), growth factor receptors (Jalali, del Pozo et al. 2001), cell 
adhesion molecules (e.g. beta2 integrins) (Radel and Rizzo 2005) and the 
extracellular matrix-integrin-cytoskeleton syndicate (Ingber 2000; Schwartz).  Coste 
and colleagues have recently discovered two proteins, Piezo1 and Piezo2, which they 
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propose are components of stretch-activated cation channels, as they were able to 
detect these proteins within the lung and demonstrate their importance in the 
triggering of stretch-induced activation cation ion channels using knockdown 
techniques (Coste, Mathur et al.).  Conformational changes in membrane-associated 
molecules are currently the most investigated mechanism and are likely to have the 
greatest importance.  This will be discussed in greater detail later.   
 Stress failure of the plasma membrane can result in necrosis, which in turn 
causes a decompartmentalisation of cellular contents.  Apoptotic cells undergo a 
quiet and controlled death, while in contrast cells undergoing necrosis lose their 
membrane integrity and intracellular molecules (referred to as damage-associated 
molecular patterns, DAMPs) are exposed to the immune system and act as danger 
signals in a pro-inflammatory manner (Matzinger 1998; Kono and Rock 2008). 
   
Multiple system organ failure 
A larger-scale decompartmentalisation occurs following failure of the alveolar 
barrier, resulting in the leakage of soluble mediators into the vascular compartment.  
Evidence of cytokines within the systemic circulation has been observed clinically 
(von Bethmann, Brasch et al. 1998; Held, Boettcher et al. 2001), with detection of an 
upregulation of various cytokines both within the alveolar and vascular 
compartments following ventilation (Ranieri, Suter et al. 1999; Stuber, Wrigge et al. 
2002; Parsons, Matthay et al. 2005).  The observation that inflammation in VILI is not 
constrained to the lungs is the main reason given in explanation for the high 
occurrence of extra-pulmonary organ injury in ARDS patients (Slutsky and Tremblay 
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1998).  Multiple system organ failure (MSOF) is a major cause of death amongst 
ARDS patients accounting for 30-50% of deaths, whilst in comparison less than 20% 
are due to respiratory failure (Stapleton, Wang et al. 2005).  VILI, and more 
specifically biotrauma, is thought to be a key component in the mechanism by which 
pulmonary injury can propagate to the systemic scale.  The biotrauma theory, as 
outlined by Slutsky in 1998, is the most widely accepted hypothesis for the 
phenomenon of extrapulmonary injury following acute lung injury (Slutsky and 
Tremblay 1998).  This theory proposes that ventilation overstretches the lungs 
causing an increase in permeability of the alveolar-capillary barrier and increased 
production of inflammatory mediators, which spill over into the systemic circulation 
(decompartmentalisation) thus expanding the inflammation and ultimately causing 
extrapulmonary organ injury.  This theory is supported by an interesting study by 
Haitsma and colleagues who demonstrated the ability of high stretch ventilation to 
disrupt the alveolar-capillary barrier.  They reported an increase in TNF within BAL 
after animals were challenged with intratracheal LPS.  However, only after 
subsequent ventilation did decompartmentalisation  occur, with TNF then detectable 
upon analysis of plasma samples (Haitsma, Uhlig et al. 2000).  
 The most prominent study to date that has investigated the link between 
mechanical ventilation and MSOF, by looking at direct injury to extra-pulmonary 
organs, suggested that a soluble factor released by the lungs led directly to injury 
(Imai, Parodo et al. 2003).  This study used a two-hit in vivo rabbit model of acid-
aspiration lung injury with injurious and non-injurious ventilation strategies and 
looked at cell apoptosis in the lungs, liver, kidney and small intestine in addition to 
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biochemical markers of hepatic and renal dysfunction.  They found that acid plus 
high stretch ventilation caused epithelial cell apoptosis in the kidney and the small 
intestine, and they demonstrated a correlation between renal damage and increased 
soluble Fas Ligand, a pro-apoptotic soluble factor.  Dhanireddy and colleagues more 
recently confirmed that MSOF frequently involves the kidney and liver in clinical 
practice and demonstrated damage to these organs in a two-hit bacterial-aspiration 
plus mechanical ventilation in vivo murine model of ALI (Dhanireddy, Altemeier et al. 
2006).  However, there is no way of directly proving the role of soluble factors within 
this theory, as the labelling of in vivo lung-derived inflammatory products is not 
possible in practice (Bhatia and Moochhala 2004).  Additionally, it may be unlikely 
that cytokines ‘leaking’ from the lung could have such a substantial role on the 
systemic scale and the feasibility of this explanation has been called into question, 
particularly in light of papers by Jaecklin and colleagues (Jaecklin, Otulakowski et al. 
2010; Jaecklin, Engelberts et al. 2011) and is also questionable when the capacity for 
erythrocytes to act as a ‘sink’ for cytokines is taken into consideration (Darbonne, 
Rice et al. 1991).    
 A different version of the biotrauma theory is the concept that an 
inflammatory ‘signal’ is carried to extrapulmonary organs by leukocytes rather than 
soluble factors, infiltration of leukocytes into organs being a characteristic sign of 
inflammation and tissue damage.  Along this line of thought, a small number of 
studies have postulated that leukocytes can cause extrapulmonary damage in 
models of ALI.  For example, Goldman and colleagues used a rat model of acid 
aspiration to demonstrate that induction of lung injury led to oedema formation in 
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the kidney and heart, which was attenuated by leukocyte depletion (Goldman, 
Welbourn et al. 1990).  But such a role for leukocytes in mediating extrapulmonary 
organ dysfunction has not previously been considered in VILI.  In addition, the 
involvement of different leukocyte subsets in this type of extrapulmonary injury has 
not yet been thoroughly investigated in any type of ALI, with studies focusing, again, 
on neutrophils.   
 
 
1.3  The Alveolar Unit 
The functional units of the lung are composed of the alveolar and vascular 
compartments. The alveolar sac is lined by type I and type II alveolar epithelial cells, 
and covered by a layer of surfactant fluid within which alveolar macrophages are 
found closely associated with the epithelium (Wright and Youmans 1993). Separating 
the basement membrane of the epithelium and the capillary endothelium, which are 
both only one cell thick, is the interstitium.  One side of the capillary is thin, 
facilitating efficient gas exchange, and this is where the alveolar unit is particularly 
fragile and most prone to damage.  In this region the interstitial space is negligible, 
with a distance between the two compartments of 0.3-0.5μm during homeostasis 
(West 2001).  Fusion of the epithelial and endothelial layers at this point is often 
evident on electron microscopic images of the lung (Weibel 1973).  The thicker side 
of the capillary is responsible for fluid exchange and the interstitium here is more 
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substantial.  Within the vasculature are leukocytes, particularly neutrophils and 
monocytes, which are known to play an important role during inflammation.   
 Structural cells (epithelium, endothelium, fibroblasts) and molecules 
(surfactant, extracellular matrix) were originally believed to only play a biophysical 
role, but there is increasing evidence to suggest that they are important in 
maintaining homeostasis within the lung and furthermore that each component of 
the lung unit may play a crucial and active role in the pathogenesis of ARDS.  In this 
section I will describe the main cells and structures that comprise the alveolar unit in 
more detail and will outline their possible involvement within the context of ALI/VILI, 
before going on to focus on some of the molecules expressed by the alveolar cells 
which are thought to be involved in the inflammatory processes underlying VILI.    
 
Neutrophils  
Neutrophils are multi-lobed granulocytes originating in the bone marrow and 
residing mainly within the circulation.  The name ‘neutrophil’ was coined by Paul 
Ehrlich in the late 19th century due to their appearance when stained with a dye he 
had developed called the neutralen Farbkörper or neutral stain.  This stain was 
composed of two components, an acidic fuchsin solution and the basic methylene 
blue, which were mixed to form a clear neutral solution.  Using this neutral stain, red 
blood cells and eosinophils appeared bright red, lymphocytes and basophils 
appeared blue or dark blue respectively, and neutrophils stained with both 
components of the dye and therefore appeared a neutral colour (Krafts, 
Hempelmann et al.).   
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 Neutrophils play an important role as part of the innate immune system and 
virtually all forms of inflammation trigger an increase in neutrophils (Segel, 
Halterman et al.).  In addition to their ability to opsonise and phagocytose 
pathogens, various cytokines have been reported to be produced by neutrophils, 
including TNF, IL-1, IL-6 and TGF-β (Kasama et al, 2005).  Recruitment of both 
neutrophils and monocytes to the lungs is mediated by membrane-bound cell 
adhesion molecules (ICAM-1, L-selectin, CD11/CD18) and soluble chemotactic agents 
(IL-8 or MIP-2/KC, its murine equivalents) and importantly, neutrophils also release 
mediators that increase endothelial permeability (Gautam, Herwald et al. 2000; Ley 
2001; DiStasi and Ley 2009). Amongst the alveolar cells, the importance of 
neutrophils in the development of ARDS has arguably been the most thoroughly 
investigated cell to date.   
 It appears that similar processes are involved in neutrophil recruitment in VILI 
as other types of lung injury (Belperio, Keane et al. 2002).  Our group has previously 
demonstrated that neutrophil infiltration is dependent on intra-alveolar TNF (as 
opposed to systemic TNF), which we already know to be important in VILI.  In the 
absence of TNF signaling, neutrophil infiltration was significantly diminished, despite 
the presence of MIP-2/KC (IL-8 homologues) (Wilson, Choudhury et al. 2005).  We 
have additionally shown that early neutrophil sequestration appears to be 
independent of CD18 but is mediated by L-selectin and neutrophil stiffening 
(Choudhury, Wilson et al. 2004).  Furthermore, neutrophil depletion has been shown 
to reduce IL-8 production and result in the development of a less severe VILI 
(Kawano, Mori et al. 1987; Belperio, Keane et al. 2002).   
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Monocytes 
Monocytes are a heterogenous population that can be divided into functional 
subsets based on their phenotype.  In murine blood, Gr-1high monocytes are called 
the ‘inflammatory’ subset due to their behaviour of actively migrating to sites of 
inflammation, whereas Gr-1low monocytes are thought to be a mature or ‘resident’ 
subset from which tissue macrophages differentiate (Geissmann, Jung et al. 2003; 
Sunderkotter, Nikolic et al. 2004).  Similar populations have been identified in human 
blood and are defined by their CD14/CD16 expression.  Three clear human subsets 
exist, CD14+CD16–CCR2+, CD14+CD16+CCR2+ and CD14lowCD16+CCR2– (Shantsila, 
Wrigley et al. 2011), although precisely how these relate to the mouse subsets 
remains somewhat uncertain.   Additionally, the ‘inflammatory’ monocyte subset has 
been described as being ‘neutrophil-like’ in its phenotype.  And thus, with the 
identification of these monocyte functional subsets, it has become apparent that the 
assumed critical role of neutrophils may have been somewhat overestimated.  We 
now know that previously used methods of neutrophil depletion were not 
necessarily neutrophil-specific.  For example, Kantrow and colleagues used a Gr-1 
antibody to deplete neutrophils, whilst Abraham and colleagues used 
cyclophosphamide, both of which are now known to affect the monocyte population 
(Abraham, Carmody et al. 2000; Kantrow, Shen et al. 2009).  IL-8 is also a monocyte 
chemoattractant (Gerszten, Garcia-Zepeda et al. 1999) and therefore the effects 
seen would not have been specific to neutrophils.  Despite the characteristic role 
that is attributed to neutrophils within the context of ALI, there is evidence that 
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neutrophil-independent lung injury can occur (Steinberg et al, 2004; Mulligan et al, 
1994) and within the clinical environment ARDS can occur in neutropenic patients 
(Ognibene, Martin et al. 1986), although the underlying pathological mechanisms 
have yet to be clearly defined (Djamel, Julien et al. 2002).  
 Our group has recently demonstrated that Gr-1high monocytes are recruited 
to the lung and are activated during high stretch ventilation, and that Gr-1high 
monocytes play an important role in the development of pulmonary oedema during 
VILI and sepsis-related ALI.  However, the mechanisms responsible for recruiting 
monocytes to the lung, and the processes by which monocytes exacerbate 
pulmonary oedema during VILI, have yet to be elucidated.   
Previous work by our group has shown that during endotoxaemia, lung-
marginated monocytes activate the pulmonary endothelium in a contact-dependent, 
TNFα-mediated manner (O'Dea, Young et al. 2005).  There is also preliminary 
evidence that platelet-activating factor (PAF) may be involved in some way in this 
process (Miotla, Williams et al. 1996), although whether similar mechanisms may be 
at work in a model of VILI has not yet been investigated.  
 
Pulmonary Endothelium 
Endothelial permeability increases during inflammation and is a central component 
of the development of lung oedema.  Within the extensive research into leukocyte 
behaviour in inflammation, their interactions with the endothelium have been 
widely documented.  Various cell adhesion molecules have been identified as crucial 
in mediating the processes of rolling, adhesion and transmigration of leukocytes into 
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the pulmonary tissue.  This well-coordinated mechanism of extravasation which has 
been referred to as the ‘leukocyte-endothelial cell adhesion cascade’ (Albelda, Smith 
et al. 1994; Carlos and Harlan 1994; Springer 1995; Dunon, Piali et al. 1996; DeLisser 
and Albelda 1998) and has been vividly demonstrated using intravital microscopy, 
permitting real-time visualization of leukocyte behaviour (Pinho, Coelho et al. 2011).   
Most leukocyte emigration within the lung is thought to occur in the capillaries, in 
contrast to the rest of the circulation where most transmembrane leukocyte 
movement occurs in the post-capillary venules (Hogg and Doerschuk 1995).  
Additionally, the majority of the literature about margination/extravasation of 
leukocytes is focused on neutrophils, although monocytes are probably similar, 
though not identical due to their slightly different phenotype. 
The process of extravasation has distinct phases which are regulated by 
different cell adhesion molecules, the role of which will be described briefly here and 
detailed later on.  Selectins are responsible for the rolling phase, during which 
leukocytes are slowed down but can still move over the endothelial surface.  Cell 
adhesion molecules belonging to the immunoglobulin superfamily (ICAM-1 and -2, 
VCAM-1, and PECAM-1) then mediate firm adhesion which arrest leukocyte 
movement and facilitate subsequent extravasation.  However, leukocyte adhesion 
does not automatically equate to transmigration for which a chemotactic gradient 
must be present, with IL-8 being arguably the most well known leukocyte 
chemotactic agent (Rosengren, Olofsson et al. 1991).  It is also worthy of note that 
movement of leukocytes through the lung capillaries is accepted within the literature 
to be slow due to the small size of the vessels, and rolling, which takes place in larger 
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vessels, is not necessary.  This concept of leukocyte trapping within the vasculature 
network upon recruitment to the lung is well accepted in the literature but has 
recently been challenged by Summers and colleagues, who suggest that de-priming 
is an important aspect of such margination (Summers, Rankin et al. 2010). 
 These adhesive interactions between leukocytes and the endothelium occur 
within homeostasis, but the scale of interaction is magnified many-fold in the 
inflammatory state.  A number of stimuli have been shown to increase the 
expression of endothelial cell adhesion molecules, including endotoxin (Xing and 
Birukova 2010), hyperoxia (Brueckl, Kaestle et al. 2006) and pro-inflammatory 
cytokines such as TNF (Shen, Ham et al. 1995; Carlos and Harlan 1994).  Stretch has 
been shown to activate endothelial cells in a similar fashion.  Miyao and colleagues 
performed an eloquent study using intravital microscopy to examine the constitutive 
expression of ICAM-1, VCAM-1 and P-selectin on the endothelial cells lining 
pulmonary arterioles, venules and capillaries and how this expression changed upon 
ventilation of the lungs (Miyao, Suzuki et al. 2006).  Their findings suggest that 
ventilation per se may activate the pulmonary endothelium in a more aggressive 
manner than found in response to endotoxin or hyperoxia (Nishio, Suzuki et al. 
1998).  In addition to an increase in expression on capillary and venular walls, they 
also observed an increased expression of cell adhesion molecules on artierolar walls, 
which had not been observed in other models of lung injury.  Miyao and colleagues 
were however unable to show a significant difference between their control (VT: 
7.5ml/kg) and high tidal volume (VT: 15ml/kg) ventilation groups (Miyao, Suzuki et al. 
2006).   
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Studies have shown however that neutrophil emigration can occur 
independent of ICAM-1, selectins or CD11/CD18 (DeLisser and Albelda 1998), 
although L-selectin and CD11/CD18 have been shown in other studies to play an 
important role in keeping the neutrophils within the capillaries for long enough to 
permit extravasation (Doerschuk 1992; Kubo, Doyle et al. 1999).  Gao and colleagues 
carried out an interesting study comparing the involvement of CD18 and ICAM-1 in 
the migration of neutrophils using anti-CD18 and anti-ICAM-1 monoclonal antibodies 
in a model of Escherichia coli-induced ALI.  They found that whilst anti-cd18 and anti-
ICAM-1 did attenuate neutrophil margination to the lung, the peak responses seen at 
3 and 6 hours were only inhibited by 40% suggesting that, other mechanisms were 
involved in neutrophil margination (Gao, Xu et al. 2001).  
The precise mechanism by which endothelial cells are activated by 
mechanical ventilation in vivo has yet to be elucidated.  Endothelial detection of 
alveolar overstretch in vivo seems wholly possible due to the close proximity of the 
capillaries to the epithelium of the alveolar sacs which they surround.  The enhanced 
endothelial cell adhesion molecule expression with ventilation as compared to other 
stimuli reported by Miyao and colleagues (Miyao, Suzuki et al. 2006) provides further 
evidence to support mechanotransduction, but this remains to be proved.  However, 
cytokines are widely considered crucial to endothelial activation and alveolar 
production of chemokines such as IL-8 (MIP-2/KC) and monocyte chemoattractant 
protein-1 (MCP-1) are thought to play an important role in leukocyte recruitment 
and margination to the lung.  Decompartmentalisation of alveolar cytokines and/or 
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production/release of TNF for instance from monoytes/leukocytes also has the 
capacity to further activate the endothelium.   
 Hegeman and colleagues demonstrated that the stimulatory capacity of 
mechanical ventilation on endothelial cells is not limited to the pulmonary 
vasculature.  In addition to an increase in E-selectin and VCAM-1 mRNA expression 
within the lung they showed an increase in E-selectin, VCAM-1, and ICAM-1 mRNA 
expression in the liver and kidney in rats ventilated with 20ml/kg  for 1, 2 and 4 
hours (Hegeman, Hennus et al. 2009).  The mechanism for extrapulmonary 
endothelial activation again has not yet been investigated, although it seems 
probable that already activated leukocytes and/or systemic cytokines may play a 
role. 
  
Alveolar macrophages 
Alveolar macrophages are part of the mononuclear phagocyte family. They are an 
essential component of the innate immune system and are often referred to as the 
sentinel of the alveolar space, due to their position in the front line of defence 
encountering the plethora of pathogenic material entering the lung during normal 
respiration.  In their contribution to the adaptive immune response, they also play a 
critical role as the most abundant pulmonary antigen presenting cells and typically 
internalise foreign microbes before degrading them (Guth, Janssen et al. 2009).  In 
addition to their well-established phagocytic role (participating in surfactant 
catabolysis and removal of innocuous pathogens during homeostasis, and clearing 
cell debris and infiltrated neutrophil during inflammation) it now is widely accepted 
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that alveolar macrophages are a major source of cytokines within the alveolar space 
and they are thought to be key to the pathogenesis of ARDS. 
Alveolar macrophages derive from circulating Gr-1low monocytes (Maus, 
Janzen et al. 2006; Landsman, Varol et al. 2007) and/or from local proliferation of 
progenitor cells within the lung (Sawyer, Strausbauch et al. 1982; Bitterman, 
Saltzman et al. 1984; Tarling, Lin et al. 1987).  As monocytes leave the circulation and 
enter organs to become tissue resident macrophages, their phenotype transforms 
and matures from a monocyte-like appearance to being more characteristically 
macrophage-like (Rosseau, Hammerl et al. 2000).  However, alveolar macrophages 
are phenotypically and functionally different from their counterparts elsewhere in 
the lung (interstitial and pleural macrophages (Lohmann-Matthes, Steinmuller et al. 
1994; Ferrari-Lacraz, Nicod et al. 2001)), peritoneal macrophages (Gjomarkaj, Pace et 
al. 1999; Salez, Singer et al. 2000; Dorger, Munzing et al. 2001) and those 
macrophages in other organs within the body (Laskin, Weinberger et al. 2001).  
Dorger et al examined macrophages recovered from bronchoalveolar and peritoneal 
lavage and pleural fluid (Dorger, Munzing et al. 2001). They observed that alveolar 
macrophages produced more TNF and reactive oxygen species (superoxide anion) 
upon stimulation in vitro, were present in higher numbers and expressed lower 
levels of surface markers (e.g. CD11b (Guth, Janssen et al. 2009)) than peritoneal and 
pleural macrophages.  The location of alveolar macrophages within the alveolar 
space is ideal for exposure to inhaled pathogens and makes them unique, in 
comparison to their counterparts elsewhere in the lung and body, as being the only 
macrophages located outside the epithelial barrier. Their differences to other 
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macrophages, including increased phagocytic capability and TNF production, adapts 
alveolar macrophages for their specialised environment (Garn et al, 2006).   
 
 Depletion of alveolar macrophages, using intratracheal instillation of 
clodronate lipsosomes, has been shown to attenuate acid-induced lung injury (Beck-
Schimmer, Rosenberger et al. 2005) and stretch-induced pulmonary oedema (Frank, 
Wray et al. 2006; Eyal, Hamm et al. 2007).  However, a study by Elder and colleagues 
(Elder, Johnston et al. 2005) demonstrated that animals treated with intratracheal 
clodronate liposomes and subsequently given intratracheal LPS were more injured 
than animals treated with LPS alone.  Additionally, a study by Bem and colleagues 
(Bem, Farnand et al. 2008) showed a similar outcome where alveolar macrophage -
depleted animals showed more injury upon histological analysis than control animals 
in a model of Fas-induced pulmonary inflammation.  These latter studies seem to 
suggest that alveolar macrophages may in fact exert an anti-inflammatory effect, but 
this potential role remains unclear.  The discrepancies between these studies may be 
due to toxic effects of the instillation in some of the models, but it leaves the precise 
role of alveolar macrophages during ALI/VILI quite unclear.   
  Alveolar macrophages are most well known for their production of TNF, 
which they secrete, amongst other inflammatory cytokines, when stimulated in 
various in vitro models (Brown and Donaldson 1996; Thorley, Ford et al. 2007), and in 
a ‘2-hit’ model of VILI, with saline lavage followed by ventilation, TNF mRNA was 
upregulated within alveolar macrophages after only 1 hour of mechanical ventilation 
(Takata, Abe et al. 1997).  Soluble TNF is increased within the alveolar space early in 
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the course of VILI (Wilson, Choudhury et al. 2003), and blockade of intra-alveolar TNF 
reduces neutrophil recruitment to the lung (Wilson, Choudhury et al. 2005; Imai, 
Kawano et al. 1999).  These data are consistent with macrophage activation 
occurring early during VILI, leading to TNF production and the subsequent 
downstream consequences of this.  However, the specific mechanism by which AM 
are activated in VILI is unclear and a source of some scientific controversy regarding 
the nature of stretch-induced lung injury.  With ALI of bacterial or chemical origin it 
is not difficult to explain how a soluble mediator (eg. LPS) may directly activate 
macrophages (through Toll-like 4, TLR4, receptors on the surface of the cells 
(Henning, Azad et al. 2008)).  A series of in vitro studies (Gordon and Taylor 2005) 
have identified three different mechanisms of macrophage activation, namely innate 
activation, whereby bacteria (Neisseria meningitides) activate macrophages directly; 
classical activation, where IFN-γ (or TNF/LPS (Mosser and Edwards 2008)) triggers 
activation; and alternative activation, which requires IL-4 and IL-13 (Taylor, Martinez-
Pomares et al. 2005).  Innate detection of bacterial pathogens would trigger 
inflammatory sequelae through TLR4 signalling (Fitzgerald, Rowe et al. 2004), a 
pathway that has been well explored.  The IFN-γ that has been identified as the 
trigger for classical activation is understood to be produced by activated CD4+ T 
helper 1 cells (Th1), CD8+ T cytotoxic 1 cells and natural killer (NK) cells and activates 
alveolar macrophages, priming them for their role in the adaptive immune response 
to bacterial presence within the alveolar space (Martinez, Helming et al. 2009), 
increasing their production of pro-inflammatory molecules and augmenting their 
phagocytic and antigen presenting capacities.  Inflammatory sequelae of this method 
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of activation include pro-inflammatory cytokine production, nitric oxide synthesis, 
respiratory burst (rapid release of reactive oxygen species, ROS) and tissue damage 
(Gordon 2003).  Classical activation is an antigen-non-specific response to 
pathogenic material or a sterile inflammatory agent, whilst alternative activation is 
an antigen-specific immune response (Gordon 2003).  Interleukins 4 and 13 are both 
produced by CD4+ T helper 2 cells (Th2) and essentially act as the counterpart to IFN-
γ exerting an anti-inflammatory signal on alveolar macrophages and Th1 cells.  This 
type of activation would result in an immune response mediated by eosinophils, 
basophils, monocytes and B cells (Martinez, Helming et al. 2009).  
  
Negative regulation of alveolar macrophages 
Amongst the multitude of antigenic stimuli that enter the respiratory tract only a 
small percentage pose a real threat to the immune system. Thus, in order to prevent 
an excessive inflammatory response to innocuous pathogenic stimuli, alveolar 
macrophages must be negatively regulated during homeostasis and in the resolution 
of inflammation, whilst a homeostatic environment is restored. 
 Negative regulation of alveolar macrophages relies on secreted factors (e.g. 
IL-10, nitric oxide (Bingisser and Holt 2001; Rubovitch, Gershnabel et al. 2007), MUC1 
(Ueno, Koga et al. 2008) and localised control (e.g. CD200, SIRPα, TGF-β) which 
facilitates a more specific control than soluble factors can infer and involves direct 
communication between cells. These in conjunction are thought to alter the 
threshold at which AM are activated and respond to antigenic stimuli (Barclay, 
Wright et al. 2002; Wissinger, Goulding et al. 2009).  
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 CD200.  CD200, previously known as OX2, was first discovered in 1984 by 
Webb and Barclay (Webb and Barclay 1984), but until recently little was known of its 
role within the lung. It is a relatively ubiquitous molecule found on a diverse range of 
cell types including type 2 alveolar epithelial cells, endothelial cells, B cells, activated 
T cells, thymocytes and neurons (Snelgrove, Goulding et al. 2008).  In contrast, the 
CD200 receptor (CD200R) is found on a limited range of cells, including monocytes, 
macrophages, dendritic cells and some T cell subsets (Barclay, Wright et al. 2002; 
Wright, Cherwinski et al. 2003).  Interactions between CD200 and CD200R result in a 
uni-directional signalling to the cells expressing CD200R (e.g. alveolar macrophages). 
Thus, lung epithelial cells, which express CD200, exert control over alveolar 
macrophages (Barclay, Wright et al. 2002). Alveolar macrophages have a much 
higher basal expression of CD200R than macrophages in other compartments 
(Snelgrove, Goulding et al. 2008). Splenic macrophages, for example, have low basal 
levels of CD200R, but these levels are increased when the cells are incubated with 
TGF-β and IL-10 (Wissinger, Goulding et al. 2009).  Alveolar macrophages in CD200 
KO mice are more easily activated / have a more activated phenotype upon 
stimulation in vivo, suggesting that CD200R is functionally important (Hoek, Ruuls et 
al. 2000).  
 SIRP-alpha (CD47-CD172a).  The CD47-CD172α interaction is similar to the 
CD200-CD200R interaction in that CD47, which has a broad distribution, interacts 
with CD172α (also known as signal inhibitory regulator protein alpha, SIRPα), which 
is mainly restricted to myeloid cells.  SIRPα is involved in the down regulation of 
macrophages, but the exact mechanism by which negative regulation is achieved is 
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unclear (Kharitonenkov, Chen et al. 1997). In addition, surfactant proteins A and D 
reduce the phagocytic activity of alveolar macrophages by binding to and activating 
SIRPα (Janssen, McPhillips et al. 2008).   
 TGF-β.  Transforming growth factor-beta (TGF-β) is secreted by almost all 
cells as an inactive pro-protein, latent TGF-β, and is activated by extracellular 
cleavage of the pro-domain.  This can occur via several mechanisms including being 
activated by reactive oxygen species or interaction with specific integrins such as 
αvβ6 (Annes, Chen et al. 2004).  In the alveolar space, TGF-β is secreted by both 
macrophages and epithelial cells.  On epithelial cells, TGF-β is tethered to and binds 
to the receptor on alveolar macrophages, thus exerting an inhibitory influence on 
the macrophages (Lambrecht 2006).  Morris and colleagues report that mice lacking 
integrin αvβ6
 had spontaneously activated alveolar macrophages, due to the lack of 
active TGF-β. This macrophage activation was reversed with re-expression of integrin 
αvβ6
 by epithelial cells (Morris, Huang et al. 2003).  In addition, Toll-like receptor 
signalling causes a down-regulation of the αvβ6 integrin and reduces epithelial CD200 
expression, thus removing inhibition of alveolar macrophages (Lambrecht 2006; 
Wissinger, Goulding et al. 2009). 
  
It remains difficult to explain how mechanical ventilation would activate 
macrophages and answering this question is one of the fundamental issues currently 
surrounding VILI.  In vitro studies have been performed in which macrophages are 
mechanically stretched, resulting in an upregulation of cytokines (Pugin, Dunn et al. 
1998; Fujishiro, Nishikawa et al. 2004).  Of note, Pugin and colleagues found that 
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when alveolar macrophages were stretched in the absence of LPS, they released IL-8 
but not TNF nor IL-6, which is somewhat surprising following previous evidence that 
these cells produce TNF during VILI in vivo.  It remains unclear as to whether in vitro 
stretch represents in vivo occurrence of the same. Furthermore, it is evident from 
the negative regulatory molecules that have been identified that epithelial cells may 
regulate macrophages in an inhibitory fashion.  However, exactly how activation 
occurs in the context of negative regulation also remains unclear.  
 
Alveolar epithelium 
The epithelium is composed of type I and type II cells; type I pneumocytes are thin 
cells that account for 40% of alveolar cells but cover 95% of the alveolar surface, 
while the remaining 5% is covered by type II pneumocytes, which are cuboidal cells 
that account for 60% of alveolar cells. Type II cells are responsible for the production 
of surfactant, and possess the capacity to differentiate into type I cells, thereby 
facilitating repair and renewal of the epithelial layer.  Epithelial cells are understood 
to form the main permeability barrier and are also responsible for fluid clearance.   
 When cultured in vitro, type II pneumocytes rapidly lose their phenotype, 
transdifferentiating into a type I phenotype (Foster, Varghese et al. 2007).  This 
phenomenon allows examination of phenotypic differences between these cells, but 
as type II pneumocytes are not stable in culture, cell lines (such as the type II-like 
A549 cell line) tend to be used to investigate the responses of this population.   
 Type I AEC are known to express high constitutive levels of ICAM-1 on their 
surface, whereas type II pneumocytes express very little ICAM-1 (Kang, Crapo et al. 
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1993). There may however be some species specific differences, as Guzman and 
colleagues found that 60-90% of freshly isolated human type II cells expressed ICAM-
1 (Guzman, Izumi et al. 1994).  Stimulation can induce an upregulation of ICAM-1 
expression on type II AEC, in vitro or in vivo, with hyperoxia (Kang, Crapo et al. 1993), 
pro-inflammatory cytokines (Wegner, Gundel et al. 1992; Roebuck and Finnegan 
1999), LPS (Beck-Schimmer, Madjdpour et al. 2002) and in vitro mechanical stretch 
(Pugin, Dunn et al. 1998; Vlahakis, Schroeder et al. 1999; Correa-Meyer, Pesce et al. 
2002; Hu, Zhang et al. 2008).  
Macrophage-epithelial interactions are likely to be mediated in part by cell 
adhesion molecules, ICAM-1 and VCAM-1.  Beck-Schimmer investigated the effect of 
blocking interactions between alveolar macrophages and epithelial cells in vitro using 
anti-VCAM-1 and anti-ICAM-1 antibodies. They found that 85% of adherence of 
macrophages to epithelial cells was blocked by anti-VCAM-1 and 100% blockade of 
adhesion was achieved by blocking both VCAM-1 and ICAM-1. Unfortunately they 
did not report the effect of anti-ICAM-1 by itself (Beck-Schimmer, Schimmer et al. 
2001).  To date there is little information about the expression of VCAM-1 on 
alveolar epithelial cells, with it being difficult to detect on human type II 
pneumocytes (Cunningham, Milne et al. 1994).  
  In vitro studies have demonstrated that lung epithelial cells produce 
chemotactic agents IL-8/MIP-2/KC, which contribute to the recruitment of 
leukocytes, as discussed earlier (Li, Ouyang et al. 2003).  However there is little in 
vivo data to offer a more physiological context for these findings.  Most studies 
looking at epithelial cells and mechanical stretch focus on inflammatory mediator 
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production and intracellular signalling pathways, which will be discussed in greater 
detail later.   
 
 
1.4  Other Factors 
There are a few alveolar components (surfactant, glycocalyx, extracellular matrix) 
which we were not in a position to investigate in this work, but are worth 
mentioning here in terms of their role within the physiological lung and within ALI.   
 
Surfactant 
Surfactant is a mixture of lipids (90%) and proteins (10%) secreted by type II alveolar 
epithelial cells (Forbes, Pickell et al. 2007).   As mentioned earlier, surfactant is 
catabolised by alveolar macrophages and either catabolised or recycled (SP-B and C 
only (Kazi, Tao et al. 2010)) by type II pneumocytes (Poelma, Zimmermann et al. 
2002; Gurel, Ikegami et al. 2001).  It serves two functions within the lung: 1) to 
facilitate normal respiration, by reducing surface tension at the fluid-air interface; 
and 2) as a component of the innate immune system. The surfactant monolayer 
allows the surface tension to change as the surface area changes, thus preventing 
collapse of alveolar units (atelectasis) during expiration (Possmayer, Nag et al. 2001).  
In experimental models where surfactant is removed/manipulated and in clinical 
surfactant-deficient states, such as infant respiratory distress syndrome, diffuse 
atelectasis is observed and as a consequence the lung is non-homogenously inflated, 
often with inefficient gas exchange (Jobe 1993).   
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 There are four surfactant-associated proteins, SP-A, -B, -C and -D, which play 
different roles in the function of surfactant.  A careful balance of the composition of 
surfactant is crucial as is the overall quantity, as an excess or deficit can greatly 
impair lung function (Kazi, Tao et al. 2010). Levels of both SP-A and -D are raised in 
the serum of ARDS patients and as such they have been identified as biomarkers of 
injury: SP-D for ARDS and SP-A as a more general marker of alveolar injury and 
respiratory disease.  
  SP-B and -C are small hydrophobic proteins that, together with the lipid 
component, are largely responsible for the biophysical properties of surfactant, 
reducing surface tension following expiration. They also mediate organisation of the 
phospholipid molecules and facilitate their adsorption into a monolayer.  In contrast, 
SP-A and D are large hydrophilic proteins and have important functions in host 
defence and maintaining surfactant homeostasis (Kesecioglu and Haitsma 2006). 
Guzman and colleagues report that SP-A can enhance the phagocytic activity of 
alveolar macrophages and their capacity to kill/clear bacteria  (Guzman, Izumi et al. 
1994). SP-A also has an important role in regulating secretion and endocytosis of 
surfactant by type II pneumocytes (Kesecioglu and Haitsma 2006).  Senft and 
colleagues observed that SP-D regulates beta-2 integrin expression on alveolar 
macrophages. By knocking out SP-D in mice they observed a loss of CD11b and 
CD11c, which were restored with replenishment of SP-D (Senft, Korfhagen et al. 
2007).  Both SP-A and -D infer some control over inflammation depending on their 
orientation and availability of their binding sites.  They exert an anti-inflammatory 
effect by inhibiting cytokine production when they interact with SIRPα (negative 
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regulatory molecule expressed on alveolar macrophages, described earlier), and 
healthy lungs this SP-A/D-SIRPα interaction is present.  However, an alternative site 
on SP-A and -D can bind to calreiculin (CD91) and cause the opposite effect, thus 
facilitating the production of pro-inflammatory mediators such as TNF (Gardai, Xiao 
et al. 2003).  Interestingly, production of SP-A and SP-D is not limited to the lung. 
These proteins can be found in other mucosal secretions (including in the gut, 
urinary tract and lacrima amongst others) supporting the plausibility of the role in 
host defence (Akiyama, Hoffman et al. 2002; Madsen, Kliem et al. 2000; Grubor, 
Meyerholz et al. 2006).  
 The careful balance of surfactant components is perturbed by high stretch 
ventilation.  Maruscak and colleagues examined the effect of injurious high stretch 
ventilation on the composition of surfactant compared to low stretch ventilation, 
and the effect of administering exogenous surfactant after a period of high stretch.  
They found that changes in surfactant composition occurred before the 
development of injury, and that exogenous surfactant alleviated ensuing lung 
dysfunction (Maruscak, Vockeroth et al. 2008).  The change in surfactant 
composition negatively impacts on its role in reducing surface tension, and contact 
with plasma proteins inactivates surfactant thus removing its anti-inflammatory 
effects on alveolar macrophages.  As such, altered surfactant during VILI could in fact 
promote inflammation. 
 The most well known mechanism of surfactant dysfunction is inhibition due 
to contact with plasma proteins (Seeger, Stohr et al. 1985; Holm, Enhorning et al. 
1988; Cockshutt, Weitz et al. 1990).  Elevated levels of cholesterol have recently 
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been shown to contribute to surfactant inhibition in VILI.  Vockeroth and colleagues 
used an in vivo model of VILI and analysed the biophysical properties of surfactant in 
mice ventilated with either high stretch (VT=30ml/kg) or low stretch (VT=8ml/kg).  
They found increased surfactant cholesterol levels with high stretch and 
demonstrated cholesterol-mediated inhibition of the surfactant (Vockeroth, 
Gunasekara et al. 2010).  Increased quantities of the lipid component of surfactant 
has also been observed previously in a model of VILI (Maruscak, Vockeroth et al. 
2008), and within the clinical setting (Markart, Ruppert et al. 2007).  There is also 
evidence to suggest that surfactant proteins can have a more direct impact on 
inflammation by acting as DAMPs (danger associated molecular pattern molecules) 
and activating pro-inflammatory pathways by signaling through toll-like receptors.  In 
vitro studies have shown that SP-A can activate the NFκB signaling pathway and 
upregulate TNF and that this response is mediated by TLR4 (Guillot, Balloy et al. 
2002; Koptides, Umstead et al. 1997).  Additionally, Henning and colleagues 
demonstrated that SP-A upregulates TLR2 expression on macrophages, despite 
decreasing the activation and translocation of NFκB to the nucleus in the presence of 
ligands for TLR2 or 4 (Henning, Azad et al. 2008).   
 
Glycocalyx 
Copley initially developed the idea of a thin molecular layer and a static zone of 
plasma over the endothelium (Copley 1974; Copley 1989), which subsequent studies 
have confirmed.  The thin molecular layer, consisting largely of membrane-bound 
proteoglycans and glycoproteins, forms the glycocalyx which is part of the thicker 
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endothelial surface layer (ESL, which includes the plasma sheet), and is thought to 
range in thickness from 0.5μm - 1μm (Pries, Secomb et al. 2000).  A number of 
studies suggest that shedding of the glycocalyx occurs in response to TNF (Chappell, 
Hofmann-Kiefer et al. 2009), isolation/reperfusion and other stimuli (Mulivor and 
Lipowsky 2004), as evidenced by increased levels of syndecan-1 and heparan 
sulphate within the circulation, and this has been witnessed following 
ischaemia/reperfusion within the clinical setting (Rehm, Bruegger et al. 2007).  
Schmidt and colleagues found in an ex vivo VILI model that degradation of heparan 
sulphate within the glycocalyx worsened VILI (Schmidt, Servinsky et al. 2009).  It 
therefore seems that the glycocalyx may act as an endothelial equivalent of the 
surfactant layer, and damage to the glycocalyx could potentially facilitate enhanced 
leukocyte-endothelial interactions. 
 
Extracellular matrix  
As we have discussed, VILI results from various mechanical forces causing stress and 
strain on the lung, and more recently the effect this has on the extracellular matrix 
(ECM) has been considered.  The ECM is a collection of fibrous proteins (e.g. 
collagen, elastin), adhesive proteins (e.g. fibronectin, laminin), proteoglycans, 
glycosaminoglycans (e.g. heparan sulphate, hyaluronan) and matrix 
metalloproteinases (Pelosi and Rocco 2008) and constitutes a supportive and 
interactive scaffold to which cells are attached.  In addition to maintaining the 
structure of the lung, the ECM is a dynamic mesh that can influence cell migration 
and proliferation (Raines 2000).  Integrins are the main point of connection between 
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pulmonary cells and the ECM, providing a link to the intracellular actin cytoskeleton 
through this association (Wang, Butler et al. 1993; Choquet, Felsenfeld et al. 1997).  
The architectural structure of alveolar cells with their respective connections to the 
ECM provides a unified structural system enabling cells to sense and respond to their 
extracellular milieu in a highly sensitive manner.  As such, it seems completely 
feasible that the ECM could play a role in mechanotransduction through its detection 
of mechanical stretch.  Ingber and colleagues postulated the leading hypothesis for 
how the ECM detects stretch, which proposes that mechanical forces distort the 
ECM, which is detected by cells via integrin receptors either directly or as a result of 
increased rigidity of the ECM.  The cytoskeleton then responds by rearranging itself, 
strengthening the cell against mechanical damage and mobilising various 
components of intracellular signalling pathways, thus facilitating their activation 
(Ingber 1991). 
 In addition to possible roles in mechanotransduction, a number of 
extracellular matrix components have been identified as being able to signal via Toll-
like receptors and trigger inflammation.  Mascarenhas and colleagues demonstrated 
that in vivo high stretch increased low molecular weight hyaluronan production, 
which triggered IL-8 production/secretion in epithelial cells in vitro (Mascarenhas, 
Day et al. 2004).   Jiang and colleagues showed that chemokine production (of MIP-2, 
MIP-1α and KC) in response to hyaluronan fragments was mediated through TLR2 
and TLR4 (Jiang, Liang et al. 2005).  Hyaluronan has also been implicated in NOS 
production in macrophages (McKee, Lowenstein et al. 1997) and signalling via NFκB 
(Noble, McKee et al. 1996).  A study by Bai and colleagues demonstrated that 
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neutrophil infiltration following high stretch in vivo ventilation is partly dependent 
on Has3 (hyaluronan synthase 3), a molecule which they showed is responsible for 
the synthesis of low molecular weight hyaluronan (Bai, Spicer et al. 2005).  Low 
molecular weight hyaluronan fragments meanwhile have been identified at sites of 
inflammation (McKee, Penno et al. 1996), in comparison to high molecular weight 
fragments which are physiological and have in fact been shown to inhibit TRL2 
signalling (Scheibner, Lutz et al. 2006).  Other ECM components that have been 
shown to change in response to ventilation are versican, heparan sulphate and 
bigylcan which were all increased by high stretch compared to controls (Al-Jamal and 
Ludwig 2001).  Babelova and colleagues showed that bigylcan signals via TLR2/4 and 
can trigger in vitro macrophage production of IL-1β (Babelova, Moreth et al. 2009).  
Additionally, both soluble heparan sulphate and fibrinogen have been shown to be 
able to signal via TLR4 (Okamura, Watari et al. 2001; Smiley, King et al. 2001; 
Johnson, Brunn et al. 2002). 
 
 
1.5  Adhesion molecule-mediated mechanisms of cell communication and 
activation 
As mentioned above, alveolar cells interact with their environment through a 
plethora of receptors, membrane-bound molecules and soluble mediators. 
Receptors and membrane-bound molecules facilitate transmission of signals, 
whether direct (via adhesion) or indirect (through soluble signals), from cells and the 
extracellular matrix.  Intracellular signalling pathway molecules, linked to the actin 
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cytoskeleton then provide a link between signals at the cell surface and the up or 
down regulation of genes expressed within the nucleus.  And thus, there is an 
intricate network that exists both internal and external to a cell which renders it 
sensitive in the detection of changes to the environment and able to respond.   
 A number of cell adhesion molecules mediate both homotypic and 
heterogenous interactions.  During homeostatic conditions both epithelial and 
endothelial cells respectively form a tight barrier, which is crucial to maintaining the 
optimum ventilation/perfusion balance.  This barrier stability is maintained by 
junctional adhesion molecules, including cadherins (Lorenowicz, Fernandez-Borja et 
al. 2007). However, interactions between leukocytes and the endothelium and 
macrophages and the epithelium are largely mediated through beta-2 integrins, 
intercellular cell adhesion molecules (ICAMs), vascular cell adhesion molecules 
(VCAMs) and selectins. 
 
Beta-2 integrins 
Integrins are a superfamily of heterodimeric membrane-bound adhesion molecules 
which play an important role in the interactions between cells and their extracellular 
milieu, mediating homotypic and heterotypic cell-cell interactions (Van der Vieren, 
Le Trong et al. 1995) and links between cells and the extracellular matrix (Guzman, 
Izumi et al. 1994).  Beta-2 integrins (or leukointegrins) are a sub-family of integrins 
whose expression is limited to bone marrow-derived cells (leukocytes, macrophages, 
dendritic cells, granulocytes, NK cells) (Danilenko, Rossitto et al. 1995).  Beta-2 
integrins consist of a constant beta chain, CD18, and a variable alpha chain, CD11a, 
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CD11b, CD11c or CD11d. Neutrophils and monocytes express CD11b>CD11a>CD11c 
whereas macrophages and dendritic cells express CD11c>CD11a>CD11b (Stent, 
Irving et al. 1995; Haugen, Skjonsberg et al. 1999).   
 The importance of leukointegrins was made quite evident by the discovery of 
a congenital syndrome called leukocyte adhesion deficiency, in which patients have 
an absence or deficiency of CD18, the beta chain.  Patients present with abnormal 
wound healing and are susceptible to infections (Diamond, Staunton et al. 1990; 
Harlan 1993).  Mulligan and colleagues pharmacologically blocked CD11a and CD11b 
in an IgG/IgA immune complex model of lung injury and showed that intravenously 
administered anti-CD11a reduced injury whereas anti-CD11b provided relatively little 
protection in comparison (Mulligan, Wilson et al. 1993).  In another study, they 
demonstrated that blockade of CD11b and CD18 via the intratracheal route was 
however protective (Mulligan, Vaporciyan et al. 1995).  Folkesson and colleagues 
also demonstrated that inhibition of CD18 (using a monoclonal anti-CD18 antibody) 
or CD11b (using neutrophil inhibitory factor, NIF, which inhibited both CD11b and 
CD18) attenuated the development of injury following intratracheal acid instillation 
in rabbits (Folkesson and Matthay 1997).  It is therefore evident that beta-2 integrins 
have compartment specific roles.   
  In addition to their role as cell adhesion molecules, within both the alveolar 
and vascular compartments, integrins are capable of bi-directional signalling, first 
described by Hynes in 1992  (Hynes 1992). Cells interact with their environment via a 
variety of cell adhesion molecules and integrins are largely responsible for 
interactions with the extracellular matrix, as discussed previously (Legate, Wickstrom 
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et al. 2009). The binding of an activated integrin with their ligand can induce a 
number of changes within the cell, conveying an 'outside-in' signal. Ligands for 
integrins may be soluble mediators, other membrane-bound molecules or 
components of the extracellular matrix (Thrane, Schwarze et al.; Sugimori, Griffith et 
al. 1997). The main ligand for beta-2 integrins is thought to be ICAM-1.  Inside-out 
signalling is also possible, an example of which is the activation of integrins.  
 Integrins are normally expressed on the cell surface in an inactivated form in 
which they are unable to bind to components of the ECM nor their ligands other 
than with a weak affinity.   Integrin activation is marked by an increase in the affinity 
for ECM interaction and it occurs as a result of integrin clustering on the cell 
membrane, whereby hundreds of weakly-interacting integrins accumulate their 
efforts into a tightly bound adhesive unit (Legate, Wickstrom et al. 2009); and/or 
through integrin cross-talk, which is thought to alter the activity of other integrins 
(Blystone, Slater et al. 1999; Porter and Hogg 1997).  Integrin clustering involves the 
initial grouping of integrins into nascent adhesions (Choi, Vicente-Manzanares et al. 
2008), which may then advance to dot-like focal complexes, which can evolve into 
focal adhesions and ultimately streak-like fibrillar adhesions (Geiger, Bershadsky et 
al. 2001).  
 
ICAMs  
Intercellular cell adhesion molecules (ICAMs) are transmembrane glycoproteins 
belonging to the immunoglobulin superfamily.  Five ICAM molecules have been 
identified, ICAM-1 to ICAM-5, all of which bind with beta-2 integrins (CD11/CD18).  
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ICAM-1 (CD54) is the most extensively investigated ICAM and, as mentioned 
previously, is constitutively expressed on type I epithelial cells, alveolar 
macrophages, leukocytes and endothelial cells and is upregulated by various 
inflammatory stimuli.  ICAM-2 (CD102) has been identified on endothelial cells, 
leukocytes and platelets, but unlike ICAM-1 its expression has been shown to 
decrease upon stimulation of endothelial cells with TNF (Kotovuori, Pessa-Morikawa 
et al. 1999).  The expression of ICAMs 3-5 is more limited and their roles have been 
less clearly defined. ICAM-3 is primarily expressed on leukocytes and is thought to be 
play an important role in T-cell mediated immune responses. (Fawcett, Holness et al. 
1992; Montoya, Sancho et al. 2002).  Whereas ICAM-4 is red blood cell specific 
(Toivanen, Ihanus et al. 2008) and ICAM-5 has only been located in the brain 
(Yoshihara, Oka et al. 1994).    
 The ICAM-1 molecule is 95kDa and consists of a short cytoplasmic tail and an 
extracellular portion composed of five immunoglobulin-like domains, to which the 
beta-2 integrins bind (See Figure 1.1) (Hubbard and Rothlein 2000).  ICAM-1 is 
expressed on a wide variety of cell types within the lung and participates in both 
homotypic and heterotypic interactions between pulmonary cells (Xu, Ye et al. 2010) 
(Simon, Chambers et al. 1992; Simon, Rochon et al. 1993; Sasaki, Namioka et al. 
2001).  ICAM-1 has important physiological and inflammatory roles.  Cell migration 
and differentiation are dependent on ICAM-1, as is the trafficking of leukocytes 
which occurs both during homeostasis and inflammation (Hubbard and Rothlein 
2000; Hauzenberger, Hultenby et al. 2000). The importance of ICAM-1 in the 
leukocyte-endothelial cell adhesion cascade was demonstrated in the study by 
57 
 
Mulligan described above (in the context of CD11b blockade) where they 
demonstrated that by using an anti-ICAM-1 antibody in rats, recruitment of 
neutrophils to the lungs was attenuated and the injury in response to intratracheal 
instillation of IgG/IgA immune complexes was reduced. 
 In addition to its well known role in cell adhesion/migration, a number of 
studies have indicated that ICAM-1 has the capacity to signal in an outside-in 
direction leading to activation of pro-inflammatory pathways (Holland and Owens 
1997; Lawson, Ainsworth et al. 1999; Wang, Pfeiffer et al. 2003). Cross-linking of 
ICAM-1 molecules has been shown to activate epithelial (Choi, Fleming et al. 2007) 
and endothelial cells (Wang and Doerschuk 2001).  Several cytokines, including IFN-γ, 
IL-1, and TNF (Krunkosky, Fischer et al. 2000; Lin, Lin et al. 2005; Ibrahim, Dominguez 
et al. 1993), and LPS (Madjdpour, Oertli et al. 2000) are able to upregulate the 
expression of ICAM-1 on leukocytes, endothelial and epithelial cells, which is thought 
to be dependent on NFκB and/or MAP kinase signalling pathways (Guzman, Izumi et 
al. 1994; Krunkosky and Jarrett 2006).   
 The upregulation of ICAM-1 is often used as a marker of activation on 
endothelial cells, and mechanical stretch has been shown to trigger such activation 
on epithelial cells.  Hu and colleagues stretched pulmonary epithelial cells (A549) in 
vitro and demonstrated an increase in ICAM-1 expression after 3 hours (Hu, Zhang et 
al. 2008).  Imanaka and colleagues used an in vivo model of VILI to demonstrate an 
increase in ICAM-1 expression on alveolar macrophages using flow cytometry, 
following 40 mins of high stretch ventilation (peak inspiratory pressure, PIP: 
45cmH2O) compared to low stretch (PIP: 7ml/kg) (Imanaka, Shimaoka et al. 2001). 
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 The importance of ICAM-1 may actually go beyond that of cell-mediated 
interactions, as increases in soluble ICAM-1 (sICAM-1) in BAL samples and plasma 
have been shown in clinical studies to correlate with morbidity of ARDS patients and 
as such sICAM-1 has been identified as a biomarker of injury (Calfee, Eisner et al. 
2009).  Experimental studies using animal models of ALI have demonstrated an 
increase in sICAM-1 associated with progressive injury comparable to the clinical 
findings (Schmal, Czermak et al. 1998; Mendez, Morris et al. 2006; Mendez, Morris et 
al. 2008).  The mechanism by which sICAM-1 is expressed has not been fully 
elucidated but there is evidence to suggest that sICAM-1 is either cleaved from its 
membrane-bound form by TACE (Champagne, Tremblay et al. 1998; Tsakadze, Sithu 
et al. 2006) or is alternatively spliced at a transcriptional level (Wakatsuki, Kimura et 
al. 1995).  Soluble ICAM-1 can be found in the plasma/BAL of untreated animals but 
increased shedding/production has been induced in vitro by administration of pro-
inflammatory cytokines (TNF, IL-1β, IFNγ) (Lawson, Ainsworth et al. 1999).  In 
contrast to its membrane-bound counterpart, the biological activity of soluble ICAM-
1 is still controversial. (Paine, Morris et al. 2002)  Administration of sICAM-1 in vitro 
has been shown to stimulate production of pro-inflammatory cytokines (TNF, IFNγ, 
IL-6, MIP-2, MIP1α) and activate intracellular pathways (NFκB, ERK) in various cell-
types (McCabe, Riddle et al. 1993; Schmal, Czermak et al. 1998; Otto, Heinzel-Pleines 
et al. 2000; Otto, Gloor et al. 2002) but Lawson and colleagues propose that it may 
be a competitive inhibitor acting to block interactions with membrane-bound ICAM-
1 and thus associations between leukocytes and the endothelium or macrophages 
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and the epithelium.  The relevance of these results in vivo has not yet been 
thoroughly explored.  
 It is clear that ICAM-1 plays an important role in inflammatory processes 
within the lung.  Its role within the vascular compartment has been clearly defined, 
but the role of ICAM-1 in the alveolar compartment in VILI, particularly in the 
initiation of inflammation, has yet to be clearly defined.  Nevertheless, it seems 
possible that ICAM-1 could have an important role to play in the initiation and/or 
subsequent development of injury during VILI, either by mediating cellular 
interactions or by acting as a soluble mediator.  
 
 
 
 
 
 
 
Figure 1.1: Diagram of an ICAM-1 molecule showing binding sites of the beta-2 
integrins CD11a, CD11b and CD11c. Adapted from (Bella, Kolatkar et al. 1998; Frick, 
Odermatt et al. 2005) 
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VCAM-1 
Vascular cell adhesion molecules (VCAMs) are also transmembrane glycoproteins 
and are part of the immunoglobulin superfamily.  They were first identified on the 
endothelial surface (Rice and Bevilacqua 1989) but since have also been identified on 
human epithelial cells (Pelletier, Lavastre et al. 2002; Albelda 1991).  Two VCAM 
molecules have been identified: VCAM-1, which is a 90kDa molecule consisting of 
seven immunoglobulin domains (and is structurally quite similar to ICAM-1/2) and is 
found on a number of cells within the body, including vascular endothelium (Kansas 
1996), human lung epithelial cells (Atsuta, Sterbinsky et al. 1997) and fibroblasts 
(Atsuta, Sterbinsky et al. 1997); and VCAM-2, which is an alternatively spliced version 
of VCAM-1 that lacks domain 4, is only found on epithelial cells and is seldom 
described in the literature (Lyall, Boswell et al. 1997).  Hession and colleagues 
showed that VCAM-1 was the major form produced by endothelial cells (human 
umbilical vein endothelial cells, HUVEC) stimulated with TNF in vitro and concluded 
that both VCAM-1 and VCAM-2 have a similar degree of leukocyte binding ability 
(Hession, Tizard et al. 1991) and that domain 4 is not essential for leukocyte 
adhesion, which was confirmed by Pepinksy and colleagues (Pepinsky, Hession et al. 
1992).  The main ligand of VCAM-1 is the integrin α4β1 (very late antigen-4, VLA-4), 
expression of which has been identified on monocytes but not neutrophils 
(Kalogeris, Kevil et al. 1999) and plays a role in their recruitment to sites of 
inflammation (Lobb and Hemler 1994).    
 Whilst the role of VCAM-1 in leukocyte adhesion to the endothelium is quite 
well defined, its role on the pulmonary epithelium is less clear.  Expression of VCAM-
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1 has been identified on human lung epithelial cells, which are frequently used in 
vitro studies, but there is a lack of evidence to suggest pulmonary epithelial 
expression of VCAM-1 in rodents.  Fries and colleagues analysed in vivo expression of 
VCAM-1 in rats but did not report its detection on pulmonary epithelial cells after 
immunohistochemical analysis of the lung, although they observed an increase in the 
oesophagus and the bladder after the animals were challenged with LPS (Fries, 
Williams et al. 1993).  Nevertheless, studies with human cells suggest that VCAM-1 
plays a role, in conjunction with ICAM-1, in cell adhesion on the epithelial side of the 
alveolar unit.  Neff and colleagues exposed primary rat tracheobronchial epithelial 
cells to LPS and then assessed the degree of neutrophil adherence.  They found that 
use of a VCAM-1 blocking antibody reduced neutrophil adherence by 55%, whilst 
ICAM-1 blockade reduced adherence by 69% (Neff, Z'Graggen B et al. 2006).  
Mulligan and colleagues blocked the VCAM-1 ligand VLA-4 and demonstrated a 
partial protection from immunoglobulin complex-induced lung injury in rats and a 
35-40% reduction of neutrophil accumulation in the lung (Mulligan, Wilson et al. 
1993).  They have assumed this VLA-4 blocking agent was acting within the alveolar 
compartment, but there is a lack of evidence to suggest that VLA-4 is expressed on 
rodent alveolar macrophages.  As such, whilst VCAM-1 is likely to play an important 
role in intra-alveolar cell adhesion with human lung epithelial cells, its apparent 
absence in the rodent alveolar compartment indicates that such a role cannot be 
investigated in an in vivo setting using mice.  
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Selectins 
The selectin family are transmembrane cell adhesion molecules comprised of three 
members, L-selectin, E-selectin and P-selectin, which all share a similar structure 
consisting of short cytoplasmic tail, a transmembrane domain, a variable number of 
repeated units (short consensus repeats), an epidermal growth factor-like domain, 
followed by a NH2-terminal lectin-like domain at the tip (Weller, Isenmann et al. 
1992).  As discussed earlier, the main role of selectins is in leukocyte trafficking, 
particularly the rolling phase of the adhesion cascade.  The role is quite 
demonstrated in mice that are genetically manipulated to be deficient in specific 
selectins; they develop normally but have abnormal leukocyte trafficking, with poor 
mobilisation and homing of leukocytes to organs (L-selectin and P-selectin deficient 
mice) and defects in leukocyte rolling (L-, P- and E-selectin deficient mice) (Arbones, 
Ord et al. 1994; Labow, Norton et al. 1994; Johnson, Mayadas et al. 1995; Ley, 
Bullard et al. 1995; Mayadas 1995; Subramaniam, Saffaripour et al. 1995).  
 L-selectin is found on most bone marrow-derived cells: on all monocytes and 
neutrophils, most lymphocytes and a subset of NK cells (Kansas 1996).  L-selectin is 
used a marker of leukocyte activation as it is rapidly lost from the cell surface 
(Kishimoto, Jutila et al. 1989) upon stimulation with a variety of challenges, including 
cytokines (Garcia-Vicuna, Diaz-Gonzalez et al. 1997) and high stretch ventilation 
(Wilson, O'Dea et al. 2009).  Cleavage is thought to be mediated by TACE (TNF alpha 
converting enzyme) (Smalley and Ley 2005).  However, L-selectin is also understood 
to be constitutively shed, at a much slower rate than during inflammation, and 
circulating L-selectin can be detected in healthy human subjects (Schleiffenbaum, 
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Spertini et al. 1992) and has been observed from circulating neutrophils and 
eosinophils (Van Eeden, Bicknell et al. 1997; Spoelstra, Berends et al. 1998).  The 
main ligand that has been identified for L-selectin on leukocytes is PSGL-1 (P-selectin 
glycoprotein ligand-1), which also is a primary ligand for P-selectin (Moore, Patel et 
al. 1995; Ramos, Smith et al. 1998; Sperandio, Smith et al. 2003; Rosen 2004), which 
is a transmembrane sialomucin molecule (Sako, Chang et al. 1993).  Blockade studies 
by Andre and colleagues indicate that PSGL-1 is not the sole ligand, as they only 
achieved 60% inhibition of neutrophil-neutrophil interactions by blocking L-selectin 
interactions with an anti-PSGL-1 antibody (Andre, Spertini et al. 2000).  In addition to 
other ligands that have been identified, including CD34, MAdCAM-1 (mucosal 
addressin CAM-1) and GlyCAM-1 (Elangbam, Qualls et al. 1997), Picker and 
colleagues demonstrated that L-selectin on neutrophils can also bind to both E-
selectin and P-selectin (Picker, Warnock et al. 1991).  
 P-selectin is found on endothelial cells and platelets and is stored in 
intracellular granules in both these cells, facilitating its rapid upregulation upon 
activation of the cell (McEver, Beckstead et al. 1989; Weller, Isenmann et al. 1992).  
However, the speed of its upregulation is matched by a relatively quick 
downregulation, as endothelial P-selectin expression tends to return to basal levels 
within 30 to 60 mins (Hattori, Hamilton et al. 1989).  Various inflammatory mediators 
can stimulate an increase in P-selectin expression and synthesis, including TNF, LPS, 
histamine and thrombin (Dore and Sirois 1996; Hattori, Hamilton et al. 1989). 
 E-selectin is solely located on the endothelium and its upregulation has been 
shown to be stimulated by TNF, IL-1 and LPS (Adamson, Tighe et al. 1996; Bevilacqua, 
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Stengelin et al. 1989) and inhibited by TGF-β (Gamble, Khew-Goodall et al. 1993).  In 
vitro culture of endothelial cells demonstrates that E-selectin expression increases 
more slowly than P-selectin, peaking between 3 to 6 hours after stimulation with 
TNF returning to baseline levels by 12 hours, but despite the more gentle dynamics 
of E-selectin, it can be rapidly endocytosed and degraded (Berman, Yeo et al. 1986; 
McEver 1994).  
 Ligands that are common to all three selectins are sialylated and fucosylated 
oligosaccharides, which are referred to communally as sialyl Lewisx (sLex), however 
the affinity/avidity of selectins to glycoprotein ligands (such as PSGL-1) is much 
greater, though the reason for this remains unclear.  Both L-selectin and PSGL-1 have 
been located on the microvilli present on neutrophils (Picker, Warnock et al. 1991;  
Kansas 1996).  These projections are thought to be a mechanism by which binding 
domains can extend above the glycocaylx, thus facilitating rapid interactions 
(McIntyre, Prescott et al. 2003; Moore, Patel et al. 1995).  Another mechanism 
thought to occur increasing the efficiency of interactions is the clustering of selectins 
or their ligands (Lasky, Singer et al. 1992), a phenomenon discussed earlier in 
relation to beta-2 integrins, and this clustering has been identified in terms of 
receptors present on neutrophil microvilli (McEver 1994).   
 There is also evidence to suggest that selectins interact with the actin 
cytoskeleton and can signal in an outside-in fashion, triggering intracellular influx of 
Ca2+, reactive oxygen species production and activation of MAP kinase pathways (L-
selectin),  or activation of the NFκB  pathway (E-selectin) (Kansas 1996).  
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1.6  Intracellular signalling pathways 
Among the earliest consequences of cellular stimulation is the activation of 
intracellular signalling pathways, which influence/regulate gene transcription and 
the production of soluble and membrane-bound inflammatory mediators.  Of these 
intracellular pathways, mitogen activated protein (MAP) kinases are the most 
commonly investigated.  A specific transcription factor, nuclear factor kappa B 
(NFκB), has been implicated in a number of inflammatory pathways, including the 
MAPK pathway (Kim, Lee et al. 2006) and is thought to play a central role in the 
pathogenesis of VILI.  The more recent discovery of the PI3kinase/Akt pathway has 
highlighted the complexity of the intracellular signalling networks.  The counterpart 
to activation of the components of the various signalling pathways, which typically 
occurs as a result of phosphorylation, is dephosphorylation (Charbonneau and Tonks 
1992; Clarke 1994).  This is clearly a key process in halting signalling, but is somewhat 
outside the scope of this literature review.  In this section I will briefly discuss each of 
the above pathways, particularly in reference to their involvement in the 
biosynthesis of various inflammatory mediators known to be involved in VILI and 
their response to stretch.   
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Nuclear factor-kappa B  
NFκB is a generic term for transcription factors formed by dimerisation of proteins 
from the Rel family (Lawrence, Gilroy et al. 2001).  NFκB is usually associated with an 
endogenous inhibitor of NFκB (IκB), which holds NFκB in the cytoplasm in an inactive 
state. In order for NFκB pathways to be activated, interactions with IκB must be 
severed, which IκB kinase (IKK2) does by phosphorylating Iκb, and thus tagging IΚB as 
a target for degradation leaving NFκB free to translocate to the nucleus and exert 
transcriptional activation over a number of genes (Lawrence, Gilroy et al. 2001).  
 NFκB is understood to play a pivotal role in inflammation through regulation 
of a host of genes for cytokines, chemokines and adhesion molecules (Blackwell and 
Christman 1997).  In addition to regulating pro-inflammatory mediators, NFκB has 
also been implicated in anti-inflammatory pathways and in the resolution of 
inflammation. Lawrence and colleagues observed in a rat model of pleurisy that 
there was a biphasic activation of NFκB, with an initial pro-inflammatory phase at 6 
hours followed by later anti-inflammatory effects after 24 hours. Moreover, they 
found that resolution of inflammation was prolonged by inhibiting NFκB at 24 hours, 
which reduced leukocyte clearance. Inhibiting NFκB at the onset of the experiment in 
conjunction with the stimulus (carrageenin) was protective (Lawrence, Gilroy et al. 
2001).  Similar findings of protection were observed by Cheng and colleagues in a LPS 
model (Cheng, Zhang et al. 2002) and by Chiang and colleagues in an in vivo model of 
high stretch ventilation (Chiang, Pai et al. 2008). Chiang et al demonstrated that by 
pre-treating rats with an anti-NFκB antibody they could attenuate the response to 
high stretch ventilation. 
68 
 
 Many stimuli in experimental studies have been shown to activate NFκB and 
a number of NFκB-linked cytokines and chemokines are known to be increased in 
lavage fluid from ARDS patients (e.g. TNF, IL-1 (Lawrence 2009; Park, Goodman et al. 
2001)). In vitro studies stimulating alveolar macrophages, fibroblasts, epithelial cells  
and endothelial cells (Blackwell, Lancaster et al. 1999; Pugin, Dunn et al. 1998; 
Cheng, Zhang et al. 2002; Kisseleva, Song et al. 2006) have demonstrated NFκB 
activation.  In conjunction with the knowledge that they regulate expression of 
various molecules (including pro- and anti-inflammatory cytokines, adhesive 
molecules, growth factors and inducible enzymes (Lawrence 2009), this supports the 
accepted understanding that NFκB is central to the inflammatory processes 
occurring in ALI and VILI.  
 
Akt/PI3 kinase pathway 
Phosphoinositide-3-kinase (PI3K) is a ubiquitous heterodimeric enzyme that 
catalyses the phosphorylation of inositol lipids and mediates membrane changes 
that facilitate the docking of kinase molecules such as Akt, and as a consequence 
activates various intracellular signaling cascades.  Once Akt (protein kinase B) is 
recruited to the membrane it is activated by dual phosphorylation of its serine and 
threonine residues (Guha and Mackman 2002; Miyahara, Hamanaka et al. 2007).  PI3 
kinases have been shown to play an important role in the production of pro-
inflammatory cytokines and can modulate NFκB activation (Kane, Shapiro et al. 1999; 
Ozes, Mayo et al. 1999; Bone and Williams 2001; Madrid, Mayo et al. 2001; Yang, 
Murti et al. 2001).  Uhlig and colleagues demonstrated that NFκB activation and 
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production of the pro-inflammatory cytokines IL-6 and MIP-2α could be attenuated 
by inhibition of PI3K in an ex vivo model of VILI (Uhlig, Fehrenbach et al. 2004).  Ozes 
and colleagues showed that in vitro TNF-mediated activation of NFκB required Akt 
(Ozes, Mayo et al. 1999).  Activation of Akt has been shown to induce endothelial 
nitric oxide production in response to in vitro (Dimmeler, Fleming et al. 1999; Go, 
Boo et al. 2001) and ex vivo (Kuebler, Uhlig et al. 2003; Miyahara, Hamanaka et al. 
2007) mechanical stretch.  Nitric oxide synthesis can also be induced in neutrophils 
and type II epithelial cells (Kumar, Jyoti et al. 2010; Sunil, Connor et al. 2002) and 
therefore, in addition to its established role in the endothelium, it seems likely that 
Akt plays a role as a signaling molecule in other pulmonary cells.  Li and colleagues 
provided some evidence for an extravascular role of Akt, by demonstrating an 
augmentation of eNOS phosphorylation in bronchial epithelial cells in Akt chimera 
mice compared to wildtype animals (Li, Liao et al. 2007).   
 The mechanism of signaling via PI3K and/or Akt, in terms of how the cell 
determines which molecules to activate, is not completely clear as these kinases 
mediate both pro- and anti-inflammatory effects.  Depending on a variety of factors, 
including the type of stimulus, cell type and activation state, Akt may positively or 
negatively regulate NFκB activity (Henning, Azad et al. 2008).  Peng and colleagues 
used an in vivo VILI model and showed that mechanical ventilation decreased 
PI3K/Akt activation and expression of endothelial nitric oxide synthase (eNOS).  
Injury was augmented through inhibition of Akt phosphorylation, whereas restored 
activation of Akt improved lung oedema (Peng, Damarla et al.), providing further 
evidence that Akt has an important role in mediating vascular permeability (Six, 
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Kureishi et al. 2002).   There is also evidence of cross-talk between the PI3K/Akt and 
p38 MAPK signalling pathways (Peng, Damarla et al.).  A number of studies indicate 
that these two pathways work in opposition (Gratton, Morales-Ruiz et al. 2001; Lv, 
Chen et al. 2008; Rane, Song et al.). 
 
MAP kinase signalling 
The MAP kinases are a family of proline-targeted serine-threonine kinases that 
mediate transmission of an extracellular signal to the nucleus, via a three-tiered 
system of sequential phosphorylation/activation of a series of kinases, ultimately 
resulting in the activation of transcription factors that alter the expression of specific 
genes (Seger and Krebs 1995).  Four groups of MAP kinases have been identified in 
mammals: p38, ERK (extracellular-signal related kinase)-1/2, ERK-5 and JNK (c-Jun 
amino-terminal kinase or stress-activated protein kinase, SAPK)-1/-2/-3 (Chang and 
Karin 2001).  Each of these groups follow the same general pathway, but the 
isoforms within the pathways differ (Seger and Krebs 1995).  Despite the distinct 
routes that have been identified for different MAP kinases, the pathways are not 
isolated (See Figure 1.2).  An extracellular stimulus has the potential to activate more 
than one pathway (Chang and Karin 2001), upstream signals to MAP kinases may 
even be MAPKK-independent (Ge, Gram et al. 2002), and communication between 
intracellular signalling pathways is commonplace (Zarubin and Han 2005).  Whilst my 
focus is mainly on the pro-inflammatory downstream effects of the MAP kinase 
pathways, they are known to play a vital physiological role in cell growth, 
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development, differentiation and controlled cell death (apoptosis) (Boutros, Chevet 
et al. 2008).   
 As outlined in Figure 1.2, activation of a receptor will trigger the sequential 
phosphorylation (ie. activation) of a MAP kinase kinase kinase, followed by a MAP 
kinase kinase and subsequently a specific MAP kinase (e.g. p38, ERK, JNK).  Once 
activated the MAP kinase can translocate into the nucleus and can activate various 
transcription factors, facilitating the expression of specific genes.  The pathway 
components are attached to the actin cytoskeleton and as such a signal, through a 
receptor or via changes in the extracellular matrix stiffness, can result in 
rearrangement of the actin cytoskeleton, bringing together components of the MAP 
kinase pathway and thus facilitating intracellular signalling (Chen, Kinch et al. 1994).     
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Figure 1.2:  MAP kinase signalling pathway overview.  Each of the MAP kinase 
pathways follow a similar sequence of activation involving different 
molecules/effects, some of which are listed as examples. (Adapted from 
(www.cellsignal.com ; Seger and Krebs 1995)) 
  
ExamplesStage of pathway
Inflammation
Apoptosis
Growth 
Differentiation
Biological effect
p53
c-Fos
Stat1/3
Pax6  
Transcription factor
p38 
JNK 
ERK 
MAPK
MEK1/2 
MKK3-7
MAPKK
MEKK1-4 
ASK1
TAK
c-Raf
MAPKKK
Inflammatory cytokines
Stress
Growth factors
Stimulus
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p38 
The most sensitive of the MAP kinases is thought to be the p38 pathway, with 
studies demonstrating its rapid activation (within minutes), as well as a return to 
baseline levels over a similarly short timeframe (Marin, Farnarier et al. 2001).  Four 
different splice variants of p38 have been identified: p38α (usually just referred to as 
p38), p38β, p38γ (also known as ERK6 or SAPK3) and p38δ (also called SAPK4) (Jiang, 
Chen et al. 1996; Lechner, Zahalka et al. 1996; Li, Jiang et al. 1996; Jiang, Gram et al. 
1997).  Of these, p38α and β are ubiquitous whilst p38γ and δ have a more limited 
expression.  The biosynthesis of pro-inflammatory markers such as IL-1 and TNF has 
been shown to be mediated by p38 (Lee, Laydon et al. 1994), both of which have 
also have the capacity to stimulate p38 activation in addition to growth factors and 
stresses (Freshney, Rawlinson et al. 1994; Han, Lee et al. 1994; Foltz, Lee et al. 1997; 
Pietersma, Tilly et al. 1997; Hu, Wang et al. 1999).  Other molecules p38 has been 
implicated in the expression of include IFN-γ, IL-1β, IL-6, IL-8, COX and iNOS (Shapiro 
and Dinarello 1995; Beyaert, Cuenda et al. 1996; Nick, Avdi et al. 1996; Guan, Baier 
et al. 1997; Ridley, Sarsfield et al. 1997; Chen, Chen et al. 1999; Warny, Keates et al. 
2000; Zhang and Kaplan 2000; Iwaki, Ito et al. 2009).  In terms of p38-mediated 
regulation of TNF secretion, this has been identified as occurring at the translational 
level and is thought to be mediated by a downstream target of p38 called MK2 (or 
MAP kinase-activated protein kinase 2, MAPKAPK2), which was the first p38α 
substrate to be identified (Freshney, Rawlinson et al. 1994; Rouse, Cohen et al. 
1994).  Kontoyiannis and colleagues demonstrated that use of MK2 knockout mice 
caused an attenuation of TNF synthesis, while mRNA levels of TNF remained 
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unchanged (Kontoyiannis, Pasparakis et al. 1999; Kontoyiannis, Kotlyarov et al. 
2001).  Additionally, manipulation of an untranslated portion of the TNF gene caused 
an overproduction of TNF and unresponsiveness to p38 inhibitors (Sweeney and 
Firestein 2004), suggesting that p38 acts through MK2 to trigger translation of the 
TNF gene.  
  
JNK 
Three genes for JNK have been identified: JNK1 and JNK2 are ubiquitous, while JNK3 
is limited to the brain, heart and testis (Ip and Davis 1998).  The alternative name for 
the JNK, stress-activated protein kinase, provides a clue as to one of the stimuli for 
this pathway.  In addition to environmental stress the JNK pathway is also stimulated 
by pro-inflammatory cytokines, including TNF (Song, Regnier et al. 1997) and IL-1 
(Saklatvala, Dean et al. 1999).  
  
ERK 
The ERK pathway was in fact the first MAP kinase cascade to be elucidated.  ERK1 
and ERK2 are 44-kDa and 42-kDa respectively and are very similar, sharing about 
90% of the same sequence in mammals (Boulton, Nye et al. 1991).  ERK5 (also known 
as big MAP kinase 1, BMK1) is twice the size of ERK1/2 and the other MAP kinases 
(Lee, Ulevitch et al. 1995; Zhou, Bao et al. 1995).  There are a number of similarities 
between ERK5 and ERK1/2, however the majority of the literature on ERK signaling 
focuses on ERK1/2, probably due to ERK5 not being one of the ‘classical’ MAP kinases 
(Nishimoto and Nishida 2006).  An alternatively spliced version of ERK1, the 46kDa 
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ERK1b, has more recently been identified which appears to be expressed in a more 
selective fashion than ERK1/2, signals slight differently and is primarily found within 
the nucleus rather than the cytoplasm (Yung, Yao et al. 2000).    
 
There appears to be a certain degree of overlap in terms of the stimuli and biological 
outcomes of different signalling pathways.  In addition, for each signalling pathway 
there is an array of transcription factors which potentially could be activated.  For 
example, genes upregulated by the p38 pathway are involved in inflammatory 
processes, apoptosis, growth and the differentiation of cells.  But how the cell 
‘decides’ which transcription factors to activate is not yet completely clear.  Marshall 
suggested that the strength and duration of ERK activation may determine the 
biological response, based on in vitro experiments showing that sustained activation 
triggered cell differentiation whereas shorter, transient activation stimulated cell 
proliferation (Marshall 1995).  
 MAPK activation as a result of in vitro mechanical stretch has been 
demonstrated in both primary (Correa-Meyer, Pesce et al. 2002; Copland and Post 
2007; Cohen, Gray Lawrence et al.) and cell-line derived lung epithelial cells (Quinn, 
Tager et al. 1999; Chess, Toia et al. 2000; Oudin and Pugin 2002; Desai, White et al. 
2009), and alveolar macrophages  (Ding, Xiao et al. 2009), in addition to other cell 
types within the lung.  Cohen and colleagues mechanically stretched rat alveolar 
epithelial cells in vitro and detected phosphorylation of p38, ERK and JNK (Cohen, 
Gray Lawrence et al.).  Li and colleagues performed a similar study, cyclically 
stretching A549 cells (human type II-like alveolar epithelial cells), and they 
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demonstrated phosphorylation of p38, ERK and JNK, although p38 and ERK1/2 
activation was transient.  They also determined that JNK inhibition could block IL-8 
production and mRNA expression (Li, Ouyang et al. 2003). Correa-Meyer and 
colleagues also demonstrated rapid activation of the ERK pathway after alveolar 
epithelial cells activation by in vitro cyclic stretch (Correa-Meyer, Pesce et al. 2002).  
In vivo studies have shed further light on the effects of high stretch ventilation upon 
intracellular signalling pathways (Kotani, Kotani et al. 2004; Uhlig, Fehrenbach et al. 
2004; Li, Liao et al. 2007; Dolinay, Wu et al. 2008; Damarla, Hasan et al. 2009).  
Damarla and colleagues investigated the effect of 4 hours of high stretch (20ml/kg) 
ventilation compared to low stretch (7ml/kg) on wild type and MK2 knockout mice.  
They demonstrated that high stretch ventilation activated MK2 and triggered actin 
polymerisation which was inhibited in MK2-/- mice, which were protected from injury 
(Damarla, Hasan et al. 2009).  This data suggests that p38 activation may regulate 
remodelling of the actin cytoskeleton and therefore may also play a role in 
facilitating signalling via other pathways.  Li et al demonstrated an upregulation of 
p38, ERK and JNK within the lungs, using an rat model of VILI (Li, Liao et al. 2007). 
Uhlig and colleagues also demonstrated activation of MAP kinases in vivo, comparing 
rats ventilated with high stretch (45cmH2O PIP, 10cmH2O positive end-expiratory 
pressure, PEEP) to low stretch (13cmH2O PIP, 3cmH2O PEEP) for 30 or 60 mins, and 
using immunohistochemistry they identified activation of MAP kinases (including 
ERK1/2 and JNK) in alveolar type II-like cells (Uhlig 2002).  However, there is little 
quantitative data on MAPK activation within specific pulmonary cell populations in 
vivo.  Immunohistochemistry is not a very quantitative technique and with Western 
77 
 
blotting there is no indication which pulmonary cells are responsible for changes 
observed, which could be important in designing therapeutics. 
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Figure 1.3:  A simplified outline of the NFκB, JNK, p38 and ERK1/2 pathways. 
Dotted lines represent translocation, whilst solid arrows represent direct 
simulation/modification. Molecules in boxes are kinases (with the exception of NFκB, 
which is a transcription factor), and molecules in circles are either GTPases (Rac, Ras, 
TRAF-6) or adaptor molecules that facilitate activation. (MEK1/2 is also known as 
MKK1/2; TNFR, TNF receptor; ECM, extracellular matrix) (Adapted from 
(www.cellsignal.com)) 
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1.7  Hypothesis and Aims  
We hypothesise that alveolar macrophages play a crucial role in the initiation of 
ventilator-induced lung injury, through detection of stretch (directly or indirectly), 
triggering of the inflammatory cascade and propagation of inflammation in a process 
whereby their interaction with the alveolar epithelium is important.   
 
The principal aim of this project was to investigate the importance of alveolar 
macrophages in VILI and to elucidate the mechanisms by which ventilation activates 
alveolar macrophages.  A secondary aim was to investigate the possible involvement 
of monocytes and neutrophils in propagating systemic inflammation via effects on 
extrapulmonary organs.  Chapters three, four and five concern our principal aim and 
chapter six addresses the secondary aim.  
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CHAPTER TWO 
 
Materials and Methods 
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2.1  Animals 
All protocols were approved by the United Kingdom Home Office in accordance with 
the Animals (Scientific Procedures) Act 1986, United Kingdom.  Wild type CD57BL6 
mice (Charles River Laboratories, Margate, UK) aged 9-13 weeks (20-30g) were used.  
Animals had free access to food and water.  
 
 
2.2 In vivo mouse model of VILI 
The in vivo model of VILI used by our group has been previously described (Wilson, 
Choudhury et al. 2003; Choudhury, Wilson et al. 2004; Wilson, O'Dea et al. 2009).  
Various aspects of this model are however adjustable, which facilitates manipulation 
of injury depending on the molecules or mechanisms being investigated.  Within the 
work presented here, variations of this in vivo model of VILI have been used.  The 
overview of the ventilation protocol is outlined here but precise details will be 
outlined in the respective chapters.   
   
Ventilation apparatus  
A custom-made jet ventilator was utilised for ventilation experiments, as described 
previously.  A cylinder supplies the gas of choice to the system via a regulator to 
control the flow rate, and electronically controlled solenoid valves control the influx 
and outflow of air.  Opening of the inspiratory solenoid permits gas to enter the 
lungs.  This vaIve then closes preventing further gas influx, and opening of the 
expiratory solenoid allows gas to leave the lungs passively due to elastic recoil of the 
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lungs and chest wall.  In this fashion the respiratory cycle can be electronically 
controlled and repeated.  The inspiratory to expiratory ratio within this ventilator 
system is fixed at 1:2.  The rate of respiration can be controlled by adjusting the 
frequency of solenoid activity and thus in combination with flow rate control, the 
volume of gas used to ventilate, the tidal volume (VT) can be adjusted.  Positive end-
expiratory pressure can be applied to the system by submergence of the tubing 
carrying expired gas under a column of water.     
 
Animal preparation 
Mice were anaesthetised by intraperitoneal (i.p.) injection of ketamine (80mg/kg) 
and xylazine (8mg/kg), and maintained via an intraperitoneal line throughout 
ventilation experiments.  Body temperature was maintained at 36-37˚C using a 
heated bed and was monitored using a rectal probe.  Once anaesthetised, a 
tracheostomy was performed and an endotracheal tube inserted.  Mice were 
ventilated using a low stretch ventilation strategy with a VT of 9-10ml/kg, a positive 
end-expiratory pressure (PEEP) of 3cmH2O and a respiratory rate of 120 breaths per 
minute (bpm), using 100% oxygen.  The left carotid artery was cannulated to 
facilitate continual measurement of arterial blood pressure, through use of a 
pressure transducer, and to permit periodic blood gas analysis.  The arterial line was 
also used to infuse normal saline with 10units/ml heparin at 0.4ml/hour to maintain 
fluid balance and compensate for fluid losses due to expiration and dry gas 
ventilation, and to prevent clotting at the tip of the cannula.  As mouse lungs are 
highly susceptible to derecruitment / collapse following induction of anaesthesia, 
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sustained inflations (35cmH2O for 5 seconds) were carried out to standardise the 
volume history of the lungs.  Baseline measurements were then taken to ensure that 
animals were comparable before the commencement of the experimental protocols, 
the precise details of which will be outlined in the relevant sections. At the end of 
the ventilation protocol, mice received an intraarterial overdose of anaesthetic 
before blood sampling, exsanguination and tissue retrieval. 
 
Measurement of respiratory mechanics and physiological changes 
Pressure transducers within the ventilation system facilitated the measurement of 
airway pressure and airway flow (via a differential pressure transducer connected to 
a miniature pneumotach).  Transducer outputs were recorded by connection to a 
PowerLab data acquisition system (AD Instruments, Charlgrove, UK).  In addition to 
direct measurements from these transducers, end-inflation occlusion procedures 
(Ewart, Levitt et al. 1995) were used to calculate the tidal volume and respiratory 
mechanics, including the compliance of the respiratory system.  The end-inflation 
occlusion technique (also referred to experimentally as an ‘inspiratory pause’) is 
comparable to making the animal hold its breath briefly just after taking a breath, as 
both inspiratory and expiratory valves are closed post-inspiration.  The ratio of the 
volume of air within the lungs to the resultant pressure change, when the lungs are 
ventilated at a constant flow rate, is understood to be dependent on the elasticity of 
the lungs (Bates, Ludwig et al. 1988).  End-inflation occlusion is an ‘interrupter 
technique’ which is currently the gold standard for measuring respiratory mechanics.  
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However new techniques are being developed which don’t require ventilation to be 
interrupted (Perchiazzi, Giuliani et al. 2003).  
Blood gas measurements were taken after placement of the arterial line, 
then after 60 mins, 120 mins and at the end of the experiment.  A blood sample of 
70µl was removed and replaced with a bolus of normal saline to prevent 
hypovolaemia.     
 
 
2.3 Intratracheal instillation  
For experiments requiring intratracheal instillation of agents (LPS, TNF, clodronate 
liposomes), I utilised a previously described protocol (Wilson, O'Dea et al.).  
Following induction of anaesthesia (by i.p. injection of 60mg/kg ketamine / 6mg/kg 
xylazine), animals were suspended by their front teeth at about 20˚ from the vertical.  
The tongue was retracted and forceps used to allow and maintain visualisation of the 
vocal cords, which were illuminated transcutaneously using a flexible light source.  A 
fine catheter was then advanced through the vocal cords to permit administration of 
a bolus directly into the trachea with use of a microscope.  The catheter was then 
promptly removed and mice were monitored whilst recovering from anaesthesia in a 
heated environment.  Typically, animals regained full consciousness after about 60 
mins and were then returned to individually ventilated cages.  A small number (<5%) 
of animals died without recovering from anaesthesia, presumably as a result of 
respiratory distress following fluid instillation, combined with the depressive effects 
of anaesthesia.  Once recovered no animals died, irrespective of the agents instilled.  
This protocol was followed in experiments where a soluble agent was instilled into 
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the alveolar space as the single insult to animals or on a separate occasion to their 
ventilation.  In chapter five, intratracheal instillation of various agents was conducted 
after the commencement of ventilation.  The details of this and the necessary 
adjustments to the ventilation protocol will be discussed in that chapter.    
 
 
2.4 In vivo sampling 
Blood sampling was achieved by cardiac puncture, following administration of 
terminal anaesthesia.  If the sample was taken from a non-ventilated mouse, a 
heparinised needle and syringe was used in order to prevent clotting.  As mentioned, 
heparin was included in the saline infusion during ventilation experiments, so this 
measure was not necessary for blood sampling from ventilated animals.   Blood 
samples were centrifuged at 4000rpm for 5 mins at 4˚C.  The plasma supernatant 
was removed and stored at -80˚C.  For experiments where blood was analysed by 
flow cytometry, an aliquot of the sample was taken before centrifugation and stored 
on ice.  
 
Bronchoalveolar lavage (BAL) was performed using 750µl of sterile normal saline, 
which was instilled with a syringe via the endotracheal tube.  400µl was withdrawn 
and re-instilled twice, before removing as much fluid as possible, to facilitate 
representative sampling of the intraalveolar contents.  BAL samples were centrifuged 
at 1500rpm for 5 mins at 4˚C.  Supernatants were removed and stored at -80˚C.  Cell 
pellets were resuspended in 300µl of normal saline for analysis by flow cytometry or 
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using differential cytology, whereby cells (neutrophils, macrophages) were visualised 
under the microscope using Diff-Quik staining (Medion Diagnostics AG, Duedingen, 
Switzerland).    
 
Lung retrieval.  Following blood sampling, the inferior vena cava was transected to 
aid the draining of blood from the pulmonary vasculature.  Lungs were then excised, 
placed in FACS wash buffer (FWB; consisting of PBS, 2% fetal calf serum (FCS), 5mM 
EDTA, 0.1% Na azide) and disrupted using a GentleMACS tissue dissociator (Miltenyi 
Biotec Ltd, Bisley, UK) to create a cell suspension.  Samples were then placed on ice 
before further processing for flow cytometric analysis.    
 
 
2.5 Flow cytometry 
Flow cytometry is a quantitative and qualitative method of analysis whereby a single 
stream of particles is interrogated by a laser beam and the scattering of light and/or 
fluorescence from that particle can be detected, providing information about the 
properties of each particle. This technique is commonly used for cultured cells or 
blood cells in suspension, however work with our group has developed and validated 
techniques for conducting flow cytometric analysis on single cell suspensions 
produced from solid organs, particularly the lung.  In the analysis of lung tissue, a 
single cell suspension is initially created by homogenising and filtering the tissue.  
Cells are labelled with fluorophore conjugated antibodies to facilitate the 
identification of cells expressing specific antigens.  When the sample is then exposed 
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to a laser of specific wavelength as it passes through the flow cytometer, the 
scattering of light is detected by lenses and provides information on the size and 
granularity of cells.  Light scattered in the forward direction (at about a 20˚ angle 
from the laser beam) is collected in the forward scatter channel, and relates to the 
size of the cell/particle, also facilitating the distinction between cells and debris.  
Light scattered at 90˚ to the laser beam is known as side scatter and reflects the 
granularity of the cell’s cytoplasm. Additionally, the light energy from the laser 
excites the antibody/antigen-linked fluorochromes causing them to fluoresce at 
different wavelengths, according to the emission range of the fluorochrome.  This 
light is detected and is converted into a current.  The stronger the degree of 
fluorescence the greater the electrical signal generated.  And thus, in addition to 
being able to identify and quantify different cell types, the expression of various 
molecules can also be measured (Rahman 2006).  As very few epitopes are specific 
for individual cell types, the presence or absence of multiple markers on the cell 
surface allows us to identify cells with a certain degree of certainty.   
 
The work conducted in chapters three and six was carried out using a four-channel 
FACSCaliburTM flow cytometer (Becton Dickinson Biosciences, Oxford, UK), whilst 
experiments described in chapter four and five were analysed using a CyanTM ADP 
Analyser flow cytometer (Beckman Coulter, High Wycombe, UK), which was a new 
addition to the laboratory during the course of the experiments described.  The 
fluorochromes that relate to these channels are listed in Table 2.1.  Use of the 
CyanTM flow cytometer allows the staining of up to seven antigens thus facilitating 
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the simultaneous measurement of more epitopes than the FACSCaliburTM could 
accommodate.  Flow cytometry data was analysed following acquisition with 
CellQuestTM (version 3.1, Becton Dickinson Biosciences) or FlowJo software (version 
7.2.5, Tree Star, Ashland, Oregon, US). 
 
   
Fluorescence channel 
Fluorochromes / dyes 
FACSCaliburTM CyanTM 
1 1 FITC (fluorescein isothiocyanate) 
2 2 PE (phycoerythrin) 
- 3 PE-Texas Red 
3 4 PerCP (peridirin-chlorophyll-protein complex) 
- 5 PE-Cy7 
4 6 APC (allophycocyanin) 
- 7 APC-Cy7 / Alexafluor 780 
 
 
Table 2.1:  Fluorochromes associated with fluorescence channels on FACSCaliburTM 
and CyanTM flow cytometers.  FITC, PE, PerCP and APC are considered single dyes, 
whilst PE-Texas Red, PE-Cy7 and APC-Cy7 are referred to as tandem dyes.  Tandem 
dyes contain two dyes, the second of which is activated and fluoresces in response to 
the excitatory emissions of the first (Rahman 2006).   
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Preparation of tissue for flow cytometric analysis 
Lung cell suspensions produced by the GentleMACs dissociator were filtered through 
a 40μm cell strainer (Becton Dickinson, Oxford, UK), before centrifugation at 
1500rpm for 7min at 4°C.  Supernatants were discarded and cell pellets were 
resuspended in 900µl FWB.  A sample from this single cell suspension was then 
stained in the dark for 30 mins at 4°C with antibodies to facilitate the identification 
of specific pulmonary cell populations and the measurement of various molecules.  
Samples were finally washed with FWB, to remove any excess of antibodies that 
remained unbound, and resuspended in a known volume ready for analysis.  Blood 
and BAL samples were not subjected to the initial washing steps outlined for lung cell 
suspensions but were directly incubated with antibodies for 30 mins at 4°C in the 
dark, after which samples were centrifuged and washed with FWB.  Blood samples 
received an additional wash after the lysis of red blood cells.  Where necessary, 
microsphere beads (Caltag Medsystems, Buckingham, UK) were added in order to 
calculate the number of cells present within the sample.  
  Any adjustments made to the protocol outlined above will be detailed in the 
respective chapters.  
 
Antibodies 
All antibodies used for flow cytometry were fluorophore conjugated, with exception 
to anti-pro-surfactant C which was unconjugated and for which a secondary 
(fluorophore-linked) antibody was used to facilitate its identification.  Relevant 
isotype controls were used according to recommendations from the manufacturers.  
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Details of antibodies used to identify cells are outlined in Table 2.2, and antibodies 
used to measure expression of various molecules are detailed in Table 2.3. 
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Table 2.2:  Antibodies used for cell identification by flow cytometry.  Combinations 
of these antibodies were used to stain tissue in order to identify specific cell 
populations within the lung, bronchoalveolar lavage fluid or blood.  Pro-SPC is an 
unconjugated antibody and thus a secondary antibody was used to label the 
antibody with a fluorochrome to facilitate its detection and analysis by flow 
cytometry.  
  
Antigen Fluorophore Expressed on Company 
CD11b  
APC 
Leukocytes 
Becton Dickinson 
Ax780 eBioscience 
CD11c 
APC Macrophages 
(high), monocytes 
(low) 
Biolegend 
Ax780 eBioscience 
CD45 
PE-Cy7 
Leukocytes 
eBioscience 
PerCP Biolegend 
CD74 FITC 
Alveolar 
macrophages,  
Type II epithelial 
cells  
Serotec 
E-cadherin PE Epithelial cells R&D systems 
EpCAM  
FITC 
Epithelial cells 
Santa Cruz 
Biotechnology 
APC eBioscience 
F4/80 FITC 
Bone-marrow 
derived cells 
AbD Serotec 
Gr-1 PerCP Leukocytes Becton Dickinson 
PECAM -1 PerCP Endothelial cells AbD Serotec 
Pro-SPC 
(2˚antibody) 
(unconjugated) 
PE 
Type II alveolar 
epithelial cells 
Millipore 
Abcam 
T1α 
(podoplanin) 
FITC 
Type I alveolar 
epithelial cells 
eBioscience 
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Antigen Fluorophore Company 
Membrane-bound    
L-selectin PE eBioscience 
CD11b  APC Becton Dickinson 
ICAM-1 FITC / PE Becton Dickinson 
TNF APC eBioscience 
   
Intracellular    
Phospho-Akt APC Cell Signaling 
Phospho-ERK APC Cell Signaling 
Phospho-MK2 APC Cell Signaling 
Phospho-p38 APC Cell Signaling 
 
 
Table 2.3:  Antibodies used to measure activation markers expressed by cells using 
flow cytometry, either expressed on the cell surface or intracellularly.  
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Cell identification 
Leukocytes 
We used a similar method of leukocyte identification as previously described by our 
group (O'Dea, Wilson et al. 2009).  After excluding cell debris based on low forward 
scatter, CD11b+ cells were selected and their F4/80 and Gr-1 expression analysed.  
Neutrophils were identified based on their F4/80–Gr-1high expression.  Both Gr-1high 
and Gr-1low subset monocytes express F4/80, and the subsets were distinguished 
based on their high or low expression of Gr-1.  
 
Alveolar macrophages 
Alveolar macrophages are known to be F4/80+CD45+CD11blowautofluorescencehigh 
CD11chigh cells.  When using the four-channel FACSCaliburTM, we identified alveolar 
macrophages using F4/80 and CD11c, having validated this population as being 
highly autofluorescent and low expressors of CD11b.  We identified this population 
in BAL samples before identifying the same population within the lung single cell 
suspension (Figure 2.1).  Using the CyanTM we identified macrophages using their 
high CD45 and CD11c expression, due to the combination of other channels being 
used.   
Dendritic cells are known to have a similar phenotype to alveolar 
macrophages (Vermaelen and Pauwels 2004) and it is possible that we may have 
included dendritic cells in our macrophage gate in lung samples.  However we think 
this is unlikely, as the population identified within lung samples has a fairly 
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homogenous phenotype that is similar to that of alveolar macrophages found in BAL 
where dendritic cells are absent.  
 
Epithelial cells 
Epithelial cells were labelled using a pan-epithelial marker, EpCAM. When using the 
FACSCalibur we identified epithelial cells by their CD45-EpCAM+ expression and in 
order to draw an accurate gate around this population, an isotype control for EpCAM 
was used.  Using the CyanTM, a preliminary step of excluding PECAM+ events 
(endothelial cells) was included and ICAM-1 expression was easily measured, which 
brought to our attention two populations within the EpCAM positive gate.  Further 
characterisation of the pulmonary epithelial cells will be described in detail in 
chapter 4.  
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Figure 2.1:  Identification of alveolar macrophages in bronchoalveolar lavage (A) 
and lung single cell suspension (B) by flow cytometry.  Representative dot plots 
showing identification of alveolar macrophages based on their F4/80+CD11c+ 
phenotype. 
F4/80
CD11c
A.
F4/80
CD11c
B.
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2.6 Protein assay 
Total protein levels were measured in BAL samples using a standard Bradford assay 
(Bio-Rad Laboratories, Hemel Hempstead, UK).  In this assay, a Coomassie Brilliant 
Blue dye is used to bind to proteins and thus a change in the intensity of colour is 
proportional to the quantity of protein within the sample (Bradford 1976).   Samples 
were compared to a set of BSA (bovine serum albumin) standards with known 
protein concentrations and both were analysed in triplicate using a colorimetric 
plate reader.  Protein concentrations were predicted and samples diluted prior to 
assay as necessary, in order for measured concentrations to fall within the limits of 
the standard curve.   
 
 
2.7 KC/MIP-2 ELISAs 
In-house colorimetric sandwich Enzyme-Linked Immunosorbent Assay (ELISA) kits 
were used to quantify levels of KC (keratinocyte-derived chemokine) and MIP-2 
(macrophage inflammatory protein-2) in BAL supernatants.  The antibodies and 
reagents used were purchased from R&D systems.  Overnight incubation of 100µl of 
monoclonal anti-mouse KC or MIP-2 capture antibodies in 96 Immuno MicroWell 
plates (NUNC, Denmark) was conducted to coat the plates. After which plates were 
washed four times with wash buffer (0.05% Tween 20 in DPBS) and blocked for one 
hour with 300µl blocking buffer (1%BSA, 5% sucrose, 0.05% azide in DPBS) per well. 
After washing the plate again, standards (using recombinant mouse KC/MIP-2) and 
samples were plated in duplicate (following pre-dilution if necessary based on 
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predicted concentrations).  After 2 hours incubation, the plate was washed and 
100µl of 50ng/ml biotinylated KC or MIP-2 detection antibody was added. After a 
further 2 hours incubation and subsequent washing, 100µl streptavidin-HRP solution 
diluted in PBS with 1% BSA using a ratio of 1:200 was added to each well for 20 mins.  
Following a final washing step, 100µl of substrate solution was added and plates 
were kept in the dark for 30 mins. The reaction was stopped with 2N sulphuric acid 
(Sigma) and a colorimetric reader (MRX II absorbance reader, Dynex Technologies, 
Magellan Biosciences, Worthing, UK) was used to analyse the samples in comparison 
to the standard controls.  All stages of this process took place at room temperature. 
 
 
2.8  Model validation  
Ventilation strategy parameter validation 
Although our group has published many papers using in vivo mouse models of VILI, I 
first validated that in my own hands high stretch ventilation reproducibly induced 
substantial physiological and inflammatory changes compared to non-injurious, low 
stretch ventilation.   High stretch ventilation utilised a VT of 37-46ml/kg, 3cmH2O 
PEEP and a respiratory rate of 90 breaths per minute (bpm) using 4% CO2/oxygen gas 
mix, while low stretch ventilation involved continuation of the parameters used 
during surgical instrumentation (described above), with sustained inflations 
(35cmH2O for 5 seconds) every 30 mins to prevent the development of atelectasis.  
Supplemental CO2 was used during high stretch ventilation to prevent the 
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development of hypocapnia.  Mice were ventilated for either 3 hours, or until blood 
pressure dropped below 40mmHg, whichever occurred first.   
During low stretch ventilation, peak inspiratory pressure (PIP) showed 
minimal change throughout the experiment.  In contrast, after initiation of high 
stretch ventilation, PIP showed an initial decrease and plateau, followed by a steep 
increase towards the end of the experiment.  The early decrease in PIP is likely to 
represent ongoing recruitment of alveolar units, while the late increase in PIP is 
thought to represent the increase in fluid within the airways (see Figure 2.2A).  We 
measured protein levels within the BAL fluid as an additional indicator of the degree 
of pulmonary oedema, and found a significant increase as compared to low stretch 
ventilation (see Figure 2.2B).  We measured intra-alveolar levels of the cytokines KC 
and MIP-2 and found a significant increase with high stretch ventilation (Figure 2.3).   
In terms of leukocyte margination to the lung, we found no change in Gr-1low 
margination compared to low stretch (see Figure 2.4), as was expected as Gr-1low are 
the resident subset in comparison to their Gr-1high expressing ‘inflammatory’ 
counterparts (discussed in chapter 1).  We also observed an increase in neutrophil 
and Gr-1high monocyte margination with high stretch ventilation, which although not 
as clear an increase as we had seen previously still followed a similar trend (Wilson, 
O'Dea et al. 2009).  These data show that this model of high stretch ventilation 
induces substantial changes in respiratory physiology and alveolar epithelial 
permeability (BAL protein) and inflammation (BAL cytokines).  As such, this model or 
adaptations of it were used for the experiments described within this thesis.   
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A.  Peak inspiratory pressure (PIP) 
 
B. Protein in BAL 
 
 
Figure 2.2: Physiological changes within the lung due to high stretch ventilation.  In 
order to validate the adjustments made to the model of VILI used previously by our 
group, we assessed changes in peak inspiratory pressure (A) and BAL protein (B) 
comparing our high stretch ventilation to low stretch. (# indicates the start of high 
stretch ventilation after surgery and stabilisation. N=4-5 ** P<0.01) 
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Figure 2.3: Chemokines in bronchoalveolar lavage are upregulated by high stretch 
ventilation.  Levels of KC and MIP-2 were measured in BAL samples from low and 
high stretch animals in addition to non-ventilated controls and were analysed by 
ELISA.  (NVC: non-ventilated control. N=3, *P<0.05, ***P<0.001)  
 
 
 
Figure 2.4:  Leukocyte recruitment to the lung with high stretch ventilation.  As part 
of the model validation we examined the number of leukocytes marginating to the 
lung after either high or low stretch ventilation and found that high stretch 
ventilation resulted in the margination of neutrophils and the inflammatory subset 
of monocytes (Gr-1high) to the lung but not the resident Gr-1low subset.  (*P<0.05, 
**P<0.01, ***P<0.001) 
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Model Justification and Relevance 
In vivo and ex vivo models of VILI have proven fundamental in elucidating the 
pathophysiology underlying ARDS, providing a more physiological environment than 
in vitro conditions can offer, without the complexity of co-morbidities and inter-
patient variations existent in the clinical setting.  There are two main groups of 
experimental models of VILI: one-hit models, which use pure mechanical ventilation 
strategies; and two-hit models, which use a primary ‘hit’ (e.g. endotoxin/LPS 
administered via intratracheal or intravenous routes; or acid instillation) before 
ventilation, which acts as a second ‘hit’.  Stimulating the lungs with LPS or acid prior 
to ventilation can represent the clinical scenario to some degree due to the 
heterogeneity of the underlying causes of ARDS, where systemic LPS can mimic the 
presence of sepsis and acid instillation models imitate the aspiration of acidic 
stomach contents.  In addition to two-hit models being somewhat more 
physiological, their major advantage is that animals are sensitised by the first hit and 
as such the inflammatory response subsequently observed following ventilation is 
enhanced in comparison to ventilation alone.  For example, Ricard and colleagues 
report that they could not detect TNF in the bronchoalveolar lavage of ventilated 
rats unless they were given a prior endotoxin challenge (Ricard, Dreyfuss et al. 2001).  
Although two-hit models have been shown to be more susceptible to injury, one of 
the major downsides of these models of VILI is the difficulty in dissecting out the 
effects of ventilation in relation to the other ‘hit’.  Gajic and colleagues highlighted 
the worthiness of investigating VILI as a single hit by assessing the incidence of ALI in 
patients who were ALI-free prior to ventilation and reported an association between 
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a high initial tidal volume and the development of ALI (Gajic, Dara et al. 2004).  The 
same group also showed in an observational study that ARDS occurred in about 6% 
of mechanically ventilated patients and was associated with high tidal volumes/peak 
airway pressures used in initial ventilation settings (Gajic, Frutos-Vivar et al. 2005).  
The vast majority of ICU patients receive ventilation and regardless of any possible 
difference in response to ventilation as a result of underlying injury, the use of a one-
hit model facilitates clear delineation of the effects of ventilation per se.  This 
knowledge may facilitate the development of appropriate therapies, and as such VILI 
remains very amenable to therapy, particularly in light of its entirely iatrogenic 
nature.  
 An argument commonly made is that animal models of VILI are not clinically 
relevant.  Tidal volumes in animal studies are indeed often higher than those applied 
clinically.  However, it is important to note that although the aim is to keep 
parameters of experimental models as representative of those present in the clinical 
setting as possible, animal models are primarily modelling the injury achieved in 
humans rather than precisely imitating the mechanism of injury.  For example, by 
applying a tidal volume of 35ml/kg to ventilated mice our group (Wilson, Choudhury 
et al. 2003) were able to cause an injury that is similar to that observed in humans 
(Ware and Matthay 2000), whereas Gajic and colleagues reported that ALI occurred 
in patients ventilated with a tidal volume of 10.4-11.4ml/kg, which is considered a 
high stretch-type tidal volume within the clinical setting (ARDSNet 2000).  An 
important factor to consider is the length of time over which ventilation is occurring.  
Within the clinical setting VILI develops over the course of days, whereas in the 
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experience of our group it is difficult to keep mice stable under anaesthesia for 
longer than six hours.  Therefore, in order to model the injury caused in humans, it is 
necessary for the parameters we use in the experimental setting to be more extreme 
in order to induce a similar level of injury in a much shorter time frame.  Nonetheless 
the ‘baby lung phenomenon’ suggests that the tidal volumes applied in our VILI 
model are not so far removed from the effective tidal volumes in ARDS patients 
(Gattinoni and Pesenti 2005).  Due to the pulmonary oedema, consolidation and 
atelectasis that affect the lungs of ARDS patients, the modest tidal volumes applied 
actually produce a much higher effective VT due to the small proportion of aerated 
lung available.  The physiological differences between mice and humans also cannot 
be overlooked.  The murine chest wall is considerably more elastic than in humans, 
where the rib cage constricts inflation.  Soutiere and Mitzner demonstrated that the 
murine lung continually expands up to 80cmH2O without causing irreversible 
damage to the lung (Soutiere and Mitzner 2004).  Lastly, the VT applied in our high 
stretch group is similar to those employed by other groups in previous animal studies 
that have made notable contributions to our understanding of the mechanisms of 
VILI (Dreyfuss and Saumon 1998).  Unpublished data from our group further 
supports the school of thought that experimental high stretch tidal volumes cannot 
match values used in the clinical setting for human lungs.  And as such, we consider 
our one-hit in vivo model of VILI appropriate for the purposes of our experiments.  
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2.9 Statistics 
Data are reported as mean ± standard deviation.  Statistical analysis was carried out 
using Prism software (version 4.0, GraphPad, La Jolla, USA), by t-tests or ANOVA with 
post-hoc Bonferroni for multi-comparison analysis where appropriate. A P value of < 
0.05 was considered significant.    
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CHAPTER THREE 
 
Alveolar macrophages play an important role in 
ventilator-induced lung injury 
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Ventilator-induced lung injury can cause injury that is histologically identical to ARDS, 
but the mechanisms underlying the detection of overstretch and its translation into 
characteristic inflammatory sequelae are currently unknown.  Alveolar macrophages 
are considered key players in the pathogenesis of lung injury due to their role as a 
major source of cytokines within the alveolar space.  However, there is still 
contention over whether they are necessary for the initiation and development of 
injury, with some studies reporting that macrophage depletion attenuates acute lung 
injury, and others reporting exacerbation of injury.  This chapter reports experiments 
designed to clarify whether alveolar macrophages do indeed play an important role 
in mouse models of ventilator-induced lung injury, and whether there is any 
evidence that their role may involve interactions with other cell types. 
 Depletion of alveolar macrophages using clodronate liposomes caused an 
attenuation of injury following high stretch ventilation, highlighting the importance 
of alveolar macrophages in the development of VILI.  This included reductions in 
both physiological and inflammatory markers of injury.  High stretch also caused a 
significant decrease in macrophage recoverability which we speculate may be 
explained by enhanced adhesive interactions, suggesting that such processes may be 
important during VILI.   
 Based on these findings, I proposed the ‘starfish hypothesis’ in which I 
postulate that continual macrophage-epithelial communication via ICAM-1 facilitates 
the detection of stretch through interaction with beta-2 integrins, which have the 
capacity to signal in an outside-in direction, activate intracellular signalling pathways 
and trigger inflammatory responses such as cytokine production.  
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3.1  Background  
There is a wealth of information about the inflammatory sequelae that occur in ARDS 
and more specifically as a result of VILI.  However, relatively little is known about the 
very early stages of the injury, nor specifically which cell/cells are responsible for 
detecting the overstretch that occurs and subsequently triggers the characteristic 
inflammatory cascade.  The two most likely candidate cells are alveolar macrophages 
and epithelial cells.  There is increasing evidence that epithelial cells, rather than 
merely acting as a structural and immunological barrier, play a much more active 
role in the pathogenesis of lung injury than previously credited, including 
responsibility for the production of a variety of inflammatory mediators (Demling, 
Ehrhardt et al. 2006; Su, Hodnett et al. 2007).  Additionally, their position within the 
alveolar unit means that epithelial cells (particularly type I, but also type II cells) are 
ideally placed to sense mechanical deformation.  Meanwhile, alveolar macrophages 
are already considered key players in the pathogenesis of VILI due to their major role 
in cytokine production.  Studies have demonstrated the activation of alveolar 
macrophages in in vitro models of high stretch (Pugin, Dunn et al. 1998; Dunn and 
Pugin 1999; Pugin 2003; Frank, Wray et al. 2006; Lang, Barnett et al. 2006).  Alveolar 
macrophages are thought to be closely associated with but not adherent to the 
alveolar epithelium (Fujii, Hayashi et al. 2002).  As such, it remains unclear as to 
whether alveolar macrophages are in fact stretched in vivo, and whether the 
inflammatory responses observed in vitro actually occur in the more complex in vivo 
milieu.  In particular, the removal of alveolar macrophages from the negative 
108 
 
regulatory factors described previously makes it very hard to extrapolate from the in 
vitro to the in vivo situation. 
Within the literature, there are only two studies that consider the importance 
of alveolar macrophages in VILI in vivo, as indicated by their depletion.  Eyal and 
colleagues treated rats with either clodronate-loaded liposomes or PBS-filled 
liposomes via intratracheal instillation.  After 48 hours they went on to compare rats 
ventilated with high stretch settings (45cmH2O PIP, zero PEEP, 40ml/kg VT) for 15 
mins to animals ventilated with high stretch for a similar length of time, followed by 
low stretch ventilation (10ml/kg VT) for up to 120 mins.  They found that at both time 
points, physiological outcomes were better in macrophage-depleted animals (Eyal, 
Hamm et al. 2007).  Interestingly however, there was no difference (if anything an 
increase) in the levels of macrophage derived cytokines, TNF or macrophage 
inflammatory protein-2 (MIP-2), following macrophage depletion in high stretch 
ventilated rats.  Frank and colleagues had a similar method of macrophage depletion 
but a different ventilation model.  They pre-treated rats with either clodronate-filled 
or empty liposomes and subsequently ventilated them for 4 hours using high stretch 
settings (30ml/kg VT, zero PEEP).  They also showed that the development of 
pulmonary oedema and increased permeability was attenuated following high 
stretch ventilation in alveolar macrophage-depleted animals (Frank, Wray et al. 
2006), as well as the production of the neutrophil chemoattractant keratinocyte-
derived chemokine (KC).  However, a couple of studies have demonstrated that 
alveolar macrophage depletion worsened outcome, in mouse models of acute lung 
injury.  In a study by Bem and colleagues, mice were pre-treated with an 
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intratracheal instillation of clodronate- or PBS-filled liposomes.  After 24 hours, 
either a Fas receptor activating antibody or isotype control was instilled via the same 
route.   They found that macrophage depletion had no effect on neutrophil 
margination to the lung, the production of various inflammatory cytokines which 
were measured in lung homogenate, nor the development of histological signs of 
pulmonary injury (Bem, Farnand et al. 2008).  Similarly, Elder and colleagues used an 
endotoxin model of acute lung injury and after pre-treating mice with clodronate or 
PBS liposomes, treated animals with either LPS or saline as a control.  They reported 
that macrophage-depleted animals treated with LPS had significantly higher levels of 
soluble inflammatory mediators and a greater degree of neutrophil infiltration within 
the alveolar space compared to mice treated with saline-filled liposomes (Elder, 
Johnston et al. 2005).   
In view of the studies described, it remains a point of contention as to 
whether alveolar macrophages are an essential component in the pathogenesis of 
ALI.  Whether the discrepancies in the above studies reflect suboptimal experimental 
technique, differential involvement of alveolar macrophages in different aetiologies 
of ALI, or even species differences (with alveolar macrophages being less relevant in 
mice than rats) remains unclear.  Therefore my first area of investigation was to 
clarify whether alveolar macrophages play an important role in the pathophysiology 
of VILI in mice. 
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3.2  Aim 
The main aim of this chapter was to clarify the importance of alveolar macrophages 
in the development of ventilator-induced lung injury, starting with their depletion 
using clodronate liposomes.  
 
 
3.3 Protocols  
Clodronate depletion of alveolar macrophages 
In order to deplete alveolar macrophages, mice were anaesthetised and treated with 
an intratracheal bolus instillation of 50µl clodronate liposomes (gift from Roche 
Diagnostics GmbH, Mannheim, Germany), following the intratracheal instillation 
protocol outlined in chapter 2.  After 48 hours incubation, mice were then 
anaesthetised and surgically instrumented for ventilation. 
 
In vivo model of VILI 
We adapted an existing in vivo model of VILI previously developed within our group 
(Wilson, Choudhury et al. 2003), as detailed in chapter 2.  The following parameters 
were applied to the two groups of mice following surgery and stabilisation: 
Low stretch ventilation: 
 VT: 9-10ml/kg 
 PEEP: 3cmH2O 
 respiratory rate: 120 breaths per minute (bpm) 
 gas: 100 % O2  
 with recruitment manoeuvres (35cm H2O for 5 seconds) every 30 mins 
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High stretch ventilation: 
 VT: ~40ml/kg 
 PEEP: 3cmH2O 
 respiratory rate: 90 bpm 
 gas: O2 with 5% CO2 
 without recruitment manoeuvres 
The experiment was terminated after a 30% increase in peak inspiratory pressure, a 
fall in blood pressure below 40mmHg or after 180 mins of high stretch, depending on 
whichever occurred first.  Low stretch experiments were terminated after 180 mins, 
whereas high stretch experiments lasted 160 mins on average before one of the 
above criteria were reached.  A saline bronchoalveolar lavage was then performed 
and after centrifugation and removal of the supernatant, resuspended samples were 
stored on ice for analysis by flow cytometry or were used for differential cytology.  
The lungs were then removed and homogenised using a GentleMACS tissue 
dissociator before washing and staining with antibodies for flow cytometric analysis, 
as outlined in Chapter 2.     
 
3.4  Results  
Alveolar macrophage depletion is protective 
We depleted alveolar macrophages using clodronate liposomes, administered 
intratracheally 48 hours prior to ventilation.  We achieved a 70-80% reduction of 
alveolar macrophages in this time frame (Figure 3.1), consistent with other studies 
(Frank, Wray et al. 2006).  After 180 minutes of high stretch ventilation, we observed 
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that clodronate treated animals showed an attenuation of injury as indicated by 
various physiological measurements, including PIP and lung compliance (Figure 3.2), 
thus showing that alveolar macrophage-depleted animals were protected from VILI.  
Protein levels in bronchoalveolar lavage were also reduced, indicating that the 
development of pulmonary oedema was attenuated in macrophage depleted 
animals (Figure 3.2C).  These data confirm that alveolar macrophages are important 
in the development of physiological signs of VILI.  Furthermore, pro-inflammatory 
cytokines KC and MIP-2 were attenuated following macrophage depletion (KC 
showed a trend towards attenuation, p=0.051, whilst the difference between non-
pretreated and macrophage-depleted animals was significant. See Figure 3.3), 
suggesting that alveolar macrophages are activated to produce and release 
inflammatory mediators during VILI.  We measured the percentage change in 
compliance of the respiratory system (an indicator of lung stiffness) comparing the 
start of high stretch ventilation to baseline levels following surgery and stabilisation: 
the change in compliance in the high stretch only group was -35.6% ± 3.0%  whilst in 
the clodronate pre-treated group, -32.8% ± 2.6%.  There was no significant 
difference between the groups, suggesting that pre-treatment with clodronate did 
not influence respiratory mechanics and the difference observed between the two 
groups upon ventilation was due to stretch.  
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Figure 3.1: Alveolar macrophage depletion 48 hours after intratracheal clodronate 
lipsome instillation. Comparison of lung cell suspensions from a non-ventilated 
control (A) and a clodronate pretreated mouse (B) demonstrates a reduction in the 
alveolar macrophage population (circled).  This 70-80% depletion was calculated 
quantitatively using counting beads (not shown).   
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Figure 3.2: Alveolar macrophage depletion attenuated ventilator-induced lung 
injury. Animals treated with clodronate liposomes showed protection from injury as 
demonstrated by the abrogation of an increase in peak inspiratory pressure (A) after 
3 hours of high stretch ventilation as compared to non-pretreated animals ventilated 
with a high stretch protocol.  The improvement in respiratory system compliance (B) 
and protein concentration in BAL (C) also indicate an attenuation of injury. (N=3-4, 
**P<0.01) 
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Figure 3.3:  KC and MIP-2 levels in BAL after high stretch ventilation are lower with 
clodronate depletion. (N=3-4, *P<0.05)   
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Macrophage recoverability  
Whilst conducting these experiments we observed a dramatic reduction in the 
number of macrophages recovered in the bronchoalveolar lavage following high 
stretch experiments, compared to the historical values our group had found in 
unventilated mice.  We therefore investigated macrophage recoverability in high and 
low stretch ventilation experiments, to determine whether high stretch or some 
other aspect of the experiment (e.g. surgery, anaesthesia, etc.) influenced our ability 
to recover macrophages.  Flow cytometric analysis of lavage fluid demonstrated a 
clear decrease in macrophage recoverability with high stretch ventilation (Figure 
3.4), suggesting that macrophages were either more adhesive in this group or had 
undergone apoptosis or other forms of cell destruction.  
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Figure 3.4: Macrophages recovered by bronchoalveolar lavage after ventilation.  
After termination of low or high stretch ventilation (lasting about 180 mins), a saline 
bronchoalveolar lavage (BAL) was performed via the endotracheal tube.  A sample of 
BAL was processed and stained with antibodies to facilitate its analysis by flow 
cytometry.  Counting beads were included in the sample in order to calculate the 
number of macrophages present.  (N=6-9, *** P<0.001) 
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CD11b expression on alveolar macrophages  
To further investigate whether adhesive interactions involving alveolar macrophages 
were likely to occur during VILI, I determined the surface expression of adhesion 
molecules on the surface of both alveolar macrophages and epithelial cells.  Amongst 
the leukointegrins, the integrins with the highest expression on alveolar 
macrophages are CD11c and CD11b. High levels of CD11c expression formed part of 
our flow cytometric identification protocol for alveolar macrophages, and this 
marker is commonly used to identify this cell population.  CD11b expression is often 
used within the literature as a marker of activation and has been shown to increase 
upon macrophage activation (Buhling, Ittenson et al. 2000; Lubick, Radke et al. 
2007).  There was no evidence of a significant change in CD11b expression after 
ventilation with our model (Figure 3.5), but the fact that its expression was retained 
suggests that CD11b-mediated interactions may still occur and be important after 2-
3 hours of injurious mechanical ventilation. 
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Figure 3.5: CD11b expression on alveolar macrophages from bronchoalveolar 
lavage of mice ventilated with low or high stretch protocols.  (MFI: mean 
fluorescence intensity.  N=5-8, not significant) 
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 ICAM-1 expression on EpCAM+ cells 
The primary ligand for beta-2 integrins is ICAM-1, which is constitutively expressed 
on the surface of alveolar epithelial cells (Kang, Crapo et al. 1993).  I therefore 
sought to ascertain whether ICAM-1 could be detected on epithelial cells and if this 
expression was conserved with high stretch ventilation, employing the use of EpCAM 
as an epithelial cell marker, as had previously been established within our group.  I 
demonstrated that ICAM-1 expression on EpCAM+ cells is not only conserved with 
high stretch ventilation, but is upregulated compared to low stretch ventilation 
(Figure 3.6).   
 
Macrophage aggregation 
Decreased macrophage recoverability (in various compartments, including the 
peritoneal cavity) has been reported as being due not only to increased adherence of 
macrophages to the epithelial lining, but also to homotypic aggregation of 
macrophages.  To assess this possibility within the alveolar space during VILI, I also 
inspected the cellular contents of lavage fluid by light microscopy.  Differential 
cytology showed substantial amounts of debris and potentially fibrous material, and 
also evidence of macrophage aggregation in the lavage fluid of high stretch 
ventilated mice (Figure 3.7). 
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Figure 3.6: ICAM-1 expression on EpCAM+ cells increases with high stretch 
ventilation compared to low stretch.  (N=6-7, ** P<0.01) 
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Figure 3.7:  Macrophage aggregation in bronchoalveolar lavage.  The images are 
from differential cytology slides from animals ventilated with low stretch (A) or high 
stretch (B) strategies.  High stretch ventilation caused an increase in macrophage 
aggregation.  (The arrowhead  indicates a cluster/aggregate of macrophages. 
Magnification: x400)  
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ICAM-1 expression on alveolar macrophages  
Finally, because homotypic aggregation of macrophages (as well as macrophage-
epithelium interaction) is thought to be an ICAM-1 mediated process (Nelson and 
Boyden 1963; Barth, Hendrzak et al. 1995), I also analysed ICAM-1 expression on 
alveolar macrophages.  I found a significant increase in ICAM-1 expression on 
macrophages recovered by lavage, and also on those left behind in the lung tissue, 
with high stretch ventilation compared to low stretch (Figure 3.8).  Taken together, 
these data suggest that inter-cellular interactions involving macrophages are likely to 
occur during the development of VILI, and may be important in its pathogenesis.   
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Figure 3.8:  ICAM-1 expression on alveolar macrophages increases with high stretch 
ventilation.  Expression of ICAM-1 was measured on alveolar macrophages 
recovered by bronchoalveolar lavage (BAL) and on macrophages left behind in the 
lung.  Expression of ICAM-1 on alveolar macrophages from mice treated with 
intratracheal LPS (20µg) was investigated as a positive control for ventilation 
experiments and this was compared to untreated (non-ventilated) control animals. 
(LPS and untreated animals were not included in statistical tests.  ***P<0.001)  
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3.5 Discussion  
In this chapter I have confirmed that alveolar macrophages play an important role in 
the development of pulmonary oedema and inflammation in our in vivo mouse 
model of VILI.  Depletion of macrophages prevented both the development of 
physiological signs of injury and pulmonary oedema formation in concurrence with 
existing studies demonstrating a similar attenuation of injury in rat models of VILI 
(Frank, Wray et al. 2006; Eyal, Hamm et al. 2007).  The role of alveolar macrophages 
as the main cytokine factory within the alveolar space is well established, and it is 
possible that interruption of cytokine production is one of the mechanisms 
underlying the protective effect of macrophage-depletion. Indeed, in the current 
study we observed a 70-80% reduction in the levels of the soluble pro-inflammatory 
mediators KC and MIP-2 within the alveolar space.  It remains possible that alveolar 
macrophages regulate the release of these mediators from other cell types such as 
epithelial cells, which have been shown to produce such mediators in response to 
stretch in vitro (Li, Ouyang et al. 2003). It has been suggested that KC in particular is 
primarily a product of epithelial cell activation, although both KC and MIP-2 are 
known to be released by alveolar macrophages (Vaneker, Joosten et al. 2008).  The 
fact that alveolar macrophage numbers in lavage fluid were decreased to almost 
exactly the same extent as cytokine levels (~75%) may be evidence that these cells 
were in fact the main source in our model. However, in the study by Eyal and 
colleagues, animals in one of their treatment groups were ventilated for only 15 
mins and yet worsening of various physiological parameters (PaO2, lung compliance) 
was observed between macrophage-depleted animals and controls (Eyal, Hamm et 
126 
 
al. 2007).  In addition, no attenuation was observed in TNF and MIP-2 levels within 
the alveolar space following macrophage depletion, suggesting that alveolar 
macrophages may have a role to play very early in the initiation of VILI, 
supplementary to their cytokine-producing activity.  The effect of macrophage 
depletion may be more complex than their mere removal. Alveolar macrophages 
play an important role in surfactant metabolism and thus depletion will increase 
surfactant pool sizes and studies have used a similar method of macrophage 
depletion to investigate the effect of an altered surfactant pool on the development 
of injury (Forbes, Pickell et al. 2007).  Thus we cannot be completely certain in our 
model what portion of protection from injury should be attributed to the absence of 
alveolar macrophages or the altered surfactant levels.  Nevertheless, assessing the 
mechanics at the baseline and start of high stretch ventilation can shed some light 
on this, and in our study such assessment indicated that clodronate pretreatment 
did not affect respiratory mechanics, thus suggesting that the protection offered in 
the clodronate treated animals was due to the absence of alveolar macrophages.  
 It is important to note that there is an ongoing discussion as to the best 
control for clodronate liposome treated animals. Van Rooijen et al (Van Rooijen and 
Sanders 1994) advise that the best control for depleted macrophages should be a 
situation where non-activated macrophages are present, however the occasion does 
arise where the use of PBS liposomes or saline instillation may be warranted to 
control for the potential inflammatory aspect of the intratracheal instillation 
procedure, which may act as an additional 'hit' to the model.  Clodronate liposomes 
work by triggering the apoptosis of alveolar macrophages.  As a ‘foreign body’ within 
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the alveolar space, the liposomes are phagocytosed by macrophages after 
intratracheal instillation and are incorporated into lysozymes.  Lysozymes contain 
phospholipases however, which break down the lipid bilayer of which the liposomes 
are composed.  The accumulation of clodronate within the macrophage cytoplasm 
eventually triggers apoptosis (Van Rooijen and Sanders 1994; Van Rooijen, Sanders 
et al. 1996).  However, in the case of PBS liposomes, alveolar macrophages 
phagocytose the liposomes but do not apoptose.  It is therefore possible that these 
macrophages are more activated than macrophages in animals not receiving 
liposomes.  In terms of saline being used as a control, it offers an intratracheal 
procedure as a point of comparison to clodronate instillation, however the length of 
time it takes for alveolar macrophages to completely recover from being activated by 
the instillation is not yet clear.  Therefore it is possible that saline instillation may in 
fact prime macrophages to respond in a more exaggerated fashion than without any 
prior intervention.  Thus I chose to utilise non-pretreated animals as the controls 
within this experiment.  Finally, it is important to note that clodronate may also have 
other ‘non-specific’ consequences, for example due to its role as a broad spectrum 
matrix metalloproteinase inhibitor (Sasanelli, Boccarelli et al. 2007). MMPs have 
been shown to influence VILI both positively and negatively, depending on the 
specific enzyme (Albaiceta, Gutierrez-Fernandez et al. 2008; Albaiceta, Gutierrez-
Fernandez et al. 2010).  However, we believe that our other findings at least strongly 
imply an important role for alveolar macrophages in VILI.  
Increased adherent properties of macrophages from various origins are 
widely accepted to be indicators of activation, and this phenomenon has been 
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observed in in vitro conditions with activated macrophages adhering tightly to the 
plastic in which they are cultured (Hirano, Anuradha et al. 2002; Joshi, Applewhite et 
al. 2005), or with increased homotypic macrophage aggregation occurring, both in 
vitro  (Brown, Dransfield et al. 1993; Grigg, Kukielka et al. 1994; Sasaki, Namioka et 
al. 2001) and in patients (Kotani, Lin et al. 1995; Kotani, Hashimoto et al. 2000).  The 
phenomenon of decreased macrophage recoverability was first described by Nelson 
and Boyden (Nelson and Boyden 1961) who serendipitously observed that 
subcutaneous injection of tuberculin to guinea pigs resulted in the macrophages 
recovered by peritoneal lavage almost completely disappearing within a few hours. 
As such, this phenomenon was labelled the macrophage disappearance reaction. 
Further studies have investigated the macrophage disappearance reaction within the 
peritoneal cavity (Haskill and Becker 1985; Melnicoff, Horan et al. 1989; Barth, 
Hendrzak et al. 1995) a similar occurrence has been detected within the lung in 
experimental studies (Bozinovski, Jones et al. 2004; Frank, Wray et al. 2006) and in 
patients (Kotani, Lin et al. 1995).  The apparent disappearance of macrophages under 
in vivo conditions is thought to be due to increased adherence to the epithelium and 
homotypic aggregation, which was first reported by Nelson and Boyden who noticed 
clumps of alveolar macrophages in peritoneal lavage fluid (Nelson and Boyden 1963). 
These macrophage aggregates are thought to be surrounded by fibrin filaments. But 
the ‘disappearance’ of macrophages was suppressed using heparin or 
monosaccharides, providing further support for increased cell-cell interactions and 
an explanation for the difficulty in recovering macrophages (Baba, Yoshida et al. 
1979; Haskill and Becker 1985). The decline in the number of alveolar macrophages 
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recovered by lavage that I observed with high stretch ventilation is therefore 
consistent with increased macrophage activation under these conditions, and 
supports the likelihood that cellular interactions involving macrophages may be 
important during VILI.   
The mechanism by which putative macrophage cellular interactions most 
likely take place is through ICAM-1 and beta-2 integrins, expression of which I 
therefore determined during VILI.  CD11b is a well known marker of activation of 
neutrophils and monocytes and has previously been identified as a marker of 
alveolar macrophage activation in response to high stretch and other stimuli (Wilson, 
O'Dea et al. 2009; Wilson, O'Dea et al.).  However, a few groups have described that 
the increase in CD11b expression they observed on alveolar macrophages was due to 
monocyte-derived macrophages that had recently migrated to the alveolar space 
(Lensmar, Prieto et al. 1999; Garn, Siese et al. 2006; Guth, Janssen et al. 2009), an 
observation quite elegantly supported by the work of Lundahl et al, who 
demonstrate that cultured monocytes when stimulated increased their expression of 
CD11b, whereas expression on alveolar macrophages did not change (Lundahl, 
Hallden et al. 1996).  In the experience of our lab with the VILI model and in other 
models, as described by Doherty and colleagues, neutrophils migrate into the 
alveolar space in response to an inflammatory stimulus 3-4 hours before monocytes 
enter (Doherty, Downey et al. 1988).  This difference in cell-specific migration timing 
is most probably size-related with monocytes usually being bigger than neutrophils 
(neutrophil diameter: 9-16μm, monocyte diameter: 10-30μm 
(www.wadsworth.org)).  In my experiments I did not detect any change in 
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macrophage CD11b expression following high stretch ventilation, which is somewhat 
at odds with a previous study (the only other study which has looked at this, to the 
best of my knowledge), carried out by Imanaka and colleagues.  The ventilation 
settings used in the study by Imanaka were somewhat harsher than those used in 
our model, and as such their model may have caused greater damage to the epi-
endothelial barrier resulting in more rapid infiltration of leukocytes, and this may 
therefore account for their detection of an increase in macrophage CD11b 
expression (Imanaka, Shimaoka et al. 2001).  My primary aim was however to 
investigate whether integrin levels were maintained during ventilation which could 
allow cellular interactions, and this was indeed the case. 
Finally, we observed an increase in expression of ICAM-1 on both alveolar 
macrophages and EpCAM positive epithelial cells with high stretch ventilation.  
ICAM-1 is constitutively expressed on alveolar macrophages but its upregulation has 
been demonstrated upon stimulation with various pro-inflammatory agents (Beck-
Schimmer, Schimmer et al. 1998; Madjdpour, Oertli et al. 2000; Hubbard, Thibodeau 
et al. 2001; Sasaki, Namioka et al. 2001).  At later stages of lung injury, ICAM-1 on 
alveolar macrophages may facilitate adherence and subsequent clearance of 
infiltrating leukocytes. In the relatively acute stages of VILI, such as studied here, 
macrophage ICAM-1 does not have a clear physiological role, although it is likely to 
be involved in macrophage aggregation, as macrophages express both cell adhesion 
molecules beta-2 integrins and their ligand ICAM-1.  We would speculate that such 
interactions between macrophages may act as a mechanism for the amplification of 
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macrophage activation and subsequent mediator release, which will be revisited 
later. 
 
Starfish hypothesis 
It has been proposed that during physiological conditions ICAM-1 on type I epithelial 
cells acts a scaffold network to which alveolar macrophages can temporarily dock via 
beta-2 integrins and migrate over the alveolar surface, like a starfish moving across 
the sea floor, thus enabling them to patrol the alveoli in their role as immune 
sentinels of the alveolar space.  Paine and colleagues state that there is 
approximately one macrophage per alveolus and reported impairment of 
macrophage migration (Hu, Zhang et al. 2008) over epithelial cells with ICAM-1 
blockade or interference with the cytoskeleton of epithelial cells (Paine, Morris et al. 
2002).  In addition, an upregulation of ICAM-1 on both epithelial cells and alveolar 
macrophages with high stretch has been observed in this study and by other groups 
in either in vitro or in vivo studies (Madjdpour, Oertli et al. 2000; Ning and Wang 
2007; Hu, Zhang et al. 2008).   
As mentioned previously, there is currently no clear hypothesis to explain 
how macrophages are activated by mechanical stretch, be it either directly sensing 
stretch in some way or following the production of a signal from the true 
‘mechanosensor’.  Based on my findings of decreased macrophage recoverability 
along with maintained/increased integrin and adhesion molecule expression 
respectively, I hypothesise that continual macrophage-epithelial communication 
facilitates the detection of stretch via beta-2 integrins, which have the capacity to 
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signal in an outside-in direction.  Consequently, this interaction means that alveolar 
macrophages are able to detect epithelial stretch (via their beta-2 integrin mediated 
interaction with epithelial ICAM-1, and possibly through additional beta-2 integrin-
ECM interactions) and become activated.  The proposed mechanism for activation of 
alveolar macrophages in VILI would rely on the stretch of epithelial cells by high tidal 
volume ventilation either distorting the geometry of ICAM-1 molecules and/or 
stiffening epithelial cells, which would be detected by beta-2 integrins expressed on 
alveolar macrophages.  Signalling via the beta-2 integrin receptor would trigger 
rearrangement of the actin cytoskeleton (Yan and Berton 1998), to which beta-2 
integrins are connected, and as a result intracellular signalling molecules would be 
activated and inflammatory pathways triggered.  I have called this the ‘starfish 
hypothesis’ (outlined in Figure 3.8), which will be further explored within this thesis. 
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Figure 3.9:  The starfish hypothesis.  (Not drawn to scale)    
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CHAPTER FOUR 
 
Development of markers of alveolar macrophage and alveolar 
epithelial cell activation 
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In order to address the involvement of alveolar macrophages during VILI and in 
particular to explore the ‘starfish hypothesis’, I first needed to develop and validate 
techniques to assess activation of alveolar macrophages and epithelial cells. 
Arguably the most commonly used indicator of alveolar macrophage activation is the 
production of soluble inflammatory mediators such as TNF or IL-8.  However there 
have been claims that these cytokines can also be produced by epithelial cells, 
rendering these soluble mediators uninformative as indicators of cell-specific 
activation.  The intracellular signalling molecules mitogen-activated protein (MAP) 
kinases have been implicated in various inflammatory responses and have been 
shown to change within the lung with injurious ventilation.  However, a recent 
methodological advancement has opened up the use of flow cytometry to measure 
MAP kinase changes and detect activation of cell subpopulations, thus facilitating the 
investigation of which pulmonary cells are in fact activated by high stretch.  
 Applying a recently described method of alveolar epithelial cell identification 
and combining this with the flow cytometric technique of MAP kinase measurement, 
I developed a novel flow cytometric technique to detect activation of discrete 
pulmonary cell populations by their levels of intracellular MAP kinase pathway 
phosphorylation.  I was able to demonstrate very rapid activation of alveolar 
macrophages in response to LPS, TNF and high stretch ventilation.  Although type I 
and type II epithelial cells also showed signs of activation, alveolar macrophages 
appeared to be more responsive than their epithelial counterparts.  As such our data 
demonstrates that in vivo high stretch can activate alveolar macrophages very 
rapidly, thus providing evidence to support the starfish hypothesis.     
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4.1  Background  
In order to prove our starfish hypothesis and investigate whether macrophage 
activation by high stretch ventilation is dependent on adhesion molecule mediated 
interactions with the alveolar epithelium, as outlined in the previous chapter, it was 
necessary to first identify reliable markers of alveolar cell activation.  The most 
commonly used markers of alveolar macrophage or epithelial cell activation are 
soluble mediators, with TNF and IL-8 being two of the most well defined soluble 
inflammatory mediators.  Typically, production of soluble TNF is used as a marker of 
alveolar macrophage activation, whereas IL-8 production is commonly used to 
indicate epithelial cell activation.  There is evidence however to suggest that 
pulmonary epithelial cells (primary and cell-line derived) and alveolar macrophages 
can also produce TNF and IL-8 respectively in response to stimulation (Isowa, Xavier 
et al. 1999; Xavier, Isowa et al. 1999; McRitchie, Isowa et al. 2000). Thus the 
multiplicity of their cellular origin renders these soluble mediators uninformative as 
specific markers of either macrophage or epithelial activation in an in vivo model of 
VILI.   
As an alternative to soluble mediators, assessment of membrane-bound 
markers of activation has been used in various models of lung injury to demonstrate 
activation of alveolar cells.  Different cells express a variety of molecules and trying 
to identify which of those molecules change with high stretch requires a ‘fishing 
expedition’.  Markers of macrophage activation that have been used previously 
within the literature include cell adhesion molecules CD11a, CD11b, CD18 and ICAM-
1, major histocompatibility complex (MHC) class II, cell surface receptors HLA-DR and 
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HLA-DQ, and the Fc receptor CD64, amongst others (Viksman, Bochner et al. 2002) 
(Viksman, Liu et al. 1997; Viksman, Liu et al. 1997; Imanaka, Shimaoka et al. 2001).  
Within our group we have previously utilised expression of membrane-bound TNF as 
a marker of monocyte activation during models of pulmonary inflammation (O'Dea, 
Young et al. 2005; O'Dea, Wilson et al. 2009). TNF is produced in a precursor form as 
a cell membrane-bound molecule (26kDa), before being cleaved from the cell 
surface by TACE and released as soluble TNF (sTNF, 17kDa) (Navarro-Gonzalez, 
Mora-Fernandez et al. 2011), and therefore detection of its membrane-bound form 
has the potential for use as a marker of activation on alveolar macrophages.   
Alternatively, intracellular signalling pathways, such as MAP kinases and 
NFκB, are common to all cells and their activation is responsible for a host of 
physiological and pathological functions, including inflammatory responses such as 
cytokine production.  A large number of studies have identified MAP kinase 
activation in response to lung stretch, using in vivo and in vitro cell stretch.  
However, the majority of existing data detecting MAP kinase levels has been 
conducted using Western blotting techniques and examines changes in the whole 
lung as opposed to within specific cell types.  In 2002, Perez and Nolan described a 
new method for MAP kinase detection using flow cytometry, which could facilitate 
the detection and comparison of MAP kinase levels in cell subpopulations within a 
tissue (Perez and Nolan 2002). Application of the Perez & Nolan methodology could 
therefore facilitate mechanistic investigation of when and how specific pulmonary 
cells are activated by high stretch ventilation.   
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4.2   Aims 
The specific aims of this chapter were to:  
 identify markers of activation in alveolar macrophages, and type I and II 
epithelial cells;  
 subsequently elucidate whether alveolar macrophages are activated by 
high stretch ventilation.  
 
The successful completion of these aims required substantial methodological 
refinements, which will be addressed below. 
 
 
4.3  Protocols  
In vivo model of VILI  
Similar ventilation parameters were used after surgery and stabilisation as in chapter 
3, with mice ventilated using a high stretch protocol (VT: 38-42ml/kg, PEEP: 3cmH2O, 
90bpm respiratory rate) or low stretch protocol (VT: 9-10ml/kg, PEEP: 3cmH2O, 
120bpm respiratory rate).  The endpoints and duration were the same as outlined in 
the previous chapter.  
Following termination of the experiment a bronchoalveolar lavage was 
performed with saline + BB94 (batimastat), a hydroxamate-based inhibitor of the 
endogenous membrane-TNF sheddase TACE (TNF- converting enzyme), included to 
prevent the shedding of TNF from the cell surface (O'Dea, Young et al. 2005).  After 
centrifugation and removal of the supernatant, resuspended samples were stored on 
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ice for analysis by flow cytometry.  The lungs were then removed and chopped 
manually before washing and staining with antibodies for flow cytometric analysis, 
as outlined in Chapter 2.     
 
Comparison of isoflurane to ketamine/xylazine 
During the studies to investigate MAP kinase signalling, it became apparent that 
different types of agents used to induce anaesthesia may have an impact.  To 
investigate this possibility, I conducted experiments to compare the effect of 
isoflurane and ketamine/xylazine on MAP kinase levels in otherwise untreated 
animals.  Mice exposed to isoflurane received an inhalational overdose for one 
minute, followed by cervical dislocation.  Mice receiving ketamine/xylazine were left 
for 10 mins after intraperitoneal injection of the anaesthetic before cervical 
dislocation.  The lungs were then removed and processed for flow cytometric 
staining.  
 
LPS / TNF instillations 
 Anaesthetised mice (ketamine/xylazine) were dosed with an intratracheal 50μl bolus 
of 20μg LPS or 20ng TNF, following the intratracheal instillation procedure outlined 
in chapter 2.  After 5, 15, 30 or 60 minutes mice were terminated by cervical 
dislocation, and lungs were removed and treated as outlined below.  
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MAP kinase detection: mechanical ventilation protocol 
Anaesthetised mice were tracheostomised and an endotracheal tube was inserted.  
As these experiments were designed to be very short (based on the findings from 
LPS and TNF stimulation, we anticipated that MAP kinase activation would occur very 
rapidly during high stretch ventilation), the carotid artery was not cannulated.  
Animals were then ventilated with either low stretch (VT: 9-10ml/kg, PEEP: 3cmH2O, 
respiratory rate: 120bpm) or high stretch settings (VT: 38-42ml/kg, PEEP: 3cmH2O, 
90bpm respiratory rate) for either five or 60 minutes.  
 
MAP kinase detection:  tissue processing protocol  
For MAP kinase detection, a modification of our standard protocol was required, 
because i) MAP kinase staining requires permeabilisation of cells to allow antibodies 
access to the intracellular compartments, and ii) MAP kinases are very rapidly 
deactivated by phosphatases.  Once lungs were removed from treated or control 
mice, they were immediately immersed in a formaldehyde-containing fixative 
solution (BD Cytoperm/Cytofix (BD Biosciences, San Diego, US) or IC fixation buffer 
(eBioscience, San Diego, US)) and disrupted using a GentleMACS tissue dissociator.  
The cell suspension was then incubated for 5 mins at 37˚C, after which fixation was 
halted by the addition of a BSA-containing buffer solution (PBS with 0.5% BSA, 0.1% 
Na Azide).  The tissue was then strained (using a 40μm filter), washed twice, using 
buffer solution with 0.2% saponin added to permeabilise the cells, with 
centrifugation (2000rpm, 5 mins, 20˚C).  A sample of the single cell suspension was 
then incubated with antibodies at room temperature for 30 mins, and subsequently 
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washed and resuspended, ready for analysis by flow cytometry.  In samples where 
the unconjugated antibody against ProSPC was used, following washing of the 
sample an additional incubation step was conducted with a fluorophore-conjugated 
secondary antibody to facilitate detection of ProSPC by the flow cytometer, followed 
by a further wash and resuspension.   
 
 
4.4  Results  
Membrane-bound TNF was not a useful marker of alveolar macrophage activation 
during VILI 
Previous work has demonstrated increased TNF production by macrophages as a 
result of high stretch in vitro and in vivo (Takata, Abe et al. 1997; Dunn and Pugin 
1999) and raised levels of membrane-bound TNF (mTNF) following stimulation.  We 
therefore started by examining expression of mTNF on macrophages recovered by 
bronchoalveolar lavage.  BB94 (Batimastat), a broad-spectrum metalloproteinase 
inhibitor, was included in the wash used to lavage the lungs in order to block TACE-
mediated shedding of mTNF.  However, we did not detect a difference in mTNF 
expression on alveolar macrophages recovered from BAL after 150 mins of high or 
low stretch ventilation (see Figure 4.1).     
We considered that the macrophages recovered by the lavage procedure 
might not be representative of the whole alveolar macrophage population and so 
looked at expression of mTNF on macrophages left behind in the lung after lavage. 
However, the changes echoed those seen on macrophages recovered by lavage, with 
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no detectable change in mTNF expression, providing us with no evidence to suggest 
we were preferentially removing a less activated subpopulation of alveolar 
macrophages.  LPS is commonly used to activate cells and trigger an inflammatory 
response, so as a positive control I gave a large intratracheal dose of LPS (20μg) to a 
number of mice and after 2 hours detected an increase in mTNF both on alveolar 
macrophages recovered by BAL and left behind in the lung (Figure 4.1), suggesting 
that the inability to detect a change in TNF with high stretch ventilation was not 
merely a methodological problem.  
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Figure 4.1:  Membrane-bound TNF expression on alveolar macrophages recovered 
by bronchoalveolar lavage (BAL) or within the lung single cell suspension.  Despite 
seeing no change in expression with an injurious (high stretch) compared to a 
protective (low stretch) ventilation strategy, we were able to detect a change in TNF 
with 20µg LPS compared to untreated mice, suggesting that the flow cytometric 
technique was sensitive enough to detect a change.  (LPS and untreated groups (n=2) 
were not included in statistical tests.  Low/high stretch groups: N=3-6, not 
significant)  
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MAP kinase development 
As measurement of surface TNF expression was not able to detect activation of 
alveolar macrophages, I turned instead to consider MAP kinases as activation 
markers.  One of the advantages of using MAP kinase activation is that this is a 
relatively ubiquitous system, and therefore able (theoretically at least) to detect not 
only macrophage activation, but also that of epithelial cells, an important 
consideration in terms of testing the starfish hypothesis.  Although studies have used 
MAP kinase phosphorylation to assess activation of epithelial cells and macrophages 
previously, the majority of the data specific to these cells is from in vitro studies.  
With the exception of one study which used immunohistochemistry (Uhlig, Haitsma 
et al. 2002), the majority of in vivo studies use Western blotting to measure MAP 
kinase levels within the whole lung.  As far as we are aware, flow cytometry has been 
not previously been used to measure in vivo MAP kinase activation within the lungs. I 
therefore set out to develop a novel methodology to measure MAP kinase 
phosphorylation in specific pulmonary cell populations.  
 In order to develop the model we used LPS, which is a known pro-
inflammatory stimulus that has been shown to trigger activation of various 
intracellular signalling cascades including MAP kinases within alveolar macrophages 
and epithelial cells previously (Thrane, Schwarze et al. 2001).  We then tested 
whether an endogenous (non-bacterial) stimulus could cause activation of alveolar 
cells, using TNF to mimic an inflamed alveolar state.  After testing and developing 
our model using these two pro-inflammatory stimuli, we then attempted to detect 
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activation of alveolar macrophages and/or epithelial cells with high stretch 
ventilation.  
 However, before I could begin this aspect of my study, it was necessary to 
develop a new protocol for the identification of epithelial cells.  
 
Epithelial cell identification validation 
The alveolar macrophage phenotype, CD11c+CD45-autofluorescencehigh, is well 
reported within the literature (Bhatia, Fei et al. 2011).  However, the identification of 
pulmonary epithelial cells is less well defined and EpCAM, the pan-epithelial marker 
we used in chapter 3, although traditionally used within our group for pulmonary 
epithelial identification, has not been validated as a marker of alveolar epithelium.  
In order to test my starfish hypothesis and gain mechanistic insights into the nature 
of cellular activation during VILI, it was necessary to clearly validate the staining for 
alveolar epithelial populations.  
 Fortunately, half-way through my PhD studies a paper was published by 
Marsh and colleagues reporting a flow cytometric procedure for identification of 
type I and type II alveolar cells (Marsh, Cakarova et al. 2009).  Utilising their 
procedure, I was able to identify alveolar epithelial cells with the use of specific 
antibodies: T1α (podoplanin) and pro-surfactant protein C (ProSPC) expressed on 
type I and type II pneumocytes respectively.  Similarly to Marsh, I identified both 
type I and type II pneumocytes but also a smaller third population of cells expressing 
both T1α and ProSPC, likely to be cells transdifferentiating into type I cells from type 
II pneumocytes (Uhal 1997) (Figure 4.2). 
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 I then decided to compare the new epithelial identification to our old 
strategy using EpCAM, and using back gating techniques was able to characterise the 
expression of ICAM-1, CD74 (type II cell marker) and E-cadherin (pan-epithelial 
marker), in addition to examining expression of the specific alveolar markers.  Four 
sub-populations of epithelial cells were identified within the lung and we were able 
to deduce that cells staining positive for either specific alveolar epithelial marker 
(T1α or ProSPC) did not express high levels of EpCAM (See Figure 4.3).  McQualter 
and colleagues identified EpCAMhigh cells as bronchial epithelial cells, which is likely 
to describe the population we found of a similar phenotype, supported by the lack of 
alveolar-specific epithelial markers on these cells (McQualter, Yuen et al. 2010).   
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Figure 4.2:  Alveolar epithelial cell identification by flow cytometry.  Initially, CD45 
negative events were gated to exclude leukocytes, then PECAM-1 negative events 
were selected so as to exclude endothelial cells.  Finally, type I and type II epithelial 
cells were positively identified based on their respective T1α or ProSPC expression. 
In addition, a third population expressing both markers was identified. Placement of 
the gates for the alveolar epithelial populations was aided by a sample unstained for 
ProSPC and T1α.   
 
 
PECAM-1
0 
200 
400 
600 
800 
1000 
Side
Scatter
10 0 10 1 10 2 10 3 10 4 
CD45
0 
200 
400 
600 
800 
1000 
Side 
Scatter
10 0 10 1 10 2 10 3 10 4 
T1α
0 
200 
400 
600 
800 
1000 
Pro-SPC
10 0 10 1 10 2 10 3 10 4 
Type II
Type I
Dual phenotype
(no T1α)
(no Pro-SPC)
148 
 
 
 
Population EpCAM ICAM-1 T1a ProSPC E-Cadherin CD74 Cell type 
1 - - - + - + Type II 
2 - + + - - - Type I 
3 + + + + + + Dual phenotype 
4 ++ - - - ++ - Bronchial 
 
 
Figure 4.3: Four pulmonary epithelial sub-populations identified by flow cytometry. 
Combining both old and new epithelial identification strategies we observed four 
epithelial phenotypes based on expression of EpCAM and E-cadherin, pan epithelial 
markers; T1α, a type I pneumocyte-specific marker; ProSPC, a specific type II 
pneumocyte marker; CD74, a MHC molecule expressed on type II pneumocytes; and 
ICAM-1, the cell adhesion molecule constitutively expressed on type I pneumocytes.  
Using these phenotypes (identified on the dot plot and described in the table) we 
were able to identify type I and II alveolar epithelial cells, a dual phenotype 
population and bronchial epithelial cells.   
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To confirm that EpCAM was expressed on bronchial epithelial cells, we carefully 
removed the edge of the lung with a scalpel, where due to the hierarchical structure 
of the lung airways only alveoli should be present, then processed and stained this 
tissue.  We found that our EpCAMhigh population of cells were not present (Figure 
4.4) in this sample of tissue, thus confirming that our old epithelial staining is likely to 
have mainly identified a combination of dual phenotype and bronchial epithelial 
cells.  
 
 
 
 
 
 
 
 
Figure 4.4:  EpCAMhigh cells are not present in alveoli. Analysis of lung tissue taken 
from the extreme periphery of the lung, where bronchial epithelium should not be 
present, was stained for EpCAM and CD45.  Compared to analysis of the whole lung, 
there was a marked reduction in EpCAMhigh cells at the lung periphery, indicating 
that EpCAMhigh expressers within the lung are bronchial epithelial cells.    
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The best control? Isoflurane vs ketamine/xylazine 
Once I had optimised the staining procedures to identify the various cell types of 
interest, experiments were carried out using LPS and TNF to clarify the responses to 
these inflammatory agents (and to validate whether the flow cytometric staining 
methodology would be able to detect cellular activation).  During the development 
of the methodology, I observed that after 5 mins of LPS treatment the levels of 
phosphorylated MAP kinases were consistently lower than levels in untreated 
animals.  This unexpected result drew our attention to an important difference 
between our treated and control animals: the untreated animals were receiving an 
inhalational overdose of isoflurane with cervical dislocation, whereas treated 
animals were anaesthetised with intraperitoneal ketamine/xylazine prior to 
intratracheal instillation, followed by cervical dislocation at the end of the 
experiment.  Reports have been made in the literature about a potential protective 
effect of ketamine/xylazine (Song, Li et al. 2004). We considered that this might 
provide an explanation and compared MAP kinase levels in untreated animals 
receiving an overdose of isoflurane with those receiving 10 mins of 
ketamine/xylazine before cervical dislocation.  In animals receiving 
ketamine/xylazine we found significantly lower levels of phospho-ERK in alveolar 
macrophages and type I and II epithelial cells along with lower levels of phospho-p38 
in type I and II epithelial cells, compared to animals receiving isoflurane, suggesting 
that ketamine/xylazine does in indeed infer a protective effect (Figure 4.5).  As all of 
the treatment groups require ketamine/xylazine for anaesthetic induction, for the 
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remainder of this chapter untreated data are from animals sacrificed 10 mins after 
ketamine/xylazine, unless otherwise stated. 
  
152 
 
 
 
 
 
 
 
 
Figure 4.5:  Ketamine/xylazine lowers MAP kinase levels in alveolar macrophages 
and type II and type I alveolar epithelial cells of untreated animals. Mice 
underwent cervical dislocation after either inhalational overdose of isoflurane for 1 
min or 10 mins post intraperitoneal injection of ketamine/xylazine. Alveolar 
macrophages and type I and II alveolar epithelial cells (AEC) were analysed for levels 
of intracellular ERK, p38 and MK2. (N=4, *P<0.05, **P<0.01) 
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Having determined the appropriate controls for my experimental groups, I carried 
out experiments utilising LPS or TNF administration.  Following intratracheal 
instillation of 20µg LPS or 20ng TNF, anaesthetised mice were sacrificed after 5, 15, 
30 or 60 minutes. Their lungs were removed and homogenised within a solution to 
fix and permeabilise the cells in order to facilitate the measurement of the 
intracellular MAP kinase molecules.  We measured levels of phosphorylated p38, 
MK2 and ERK.  Assessment of the histograms comparing MAP kinase levels to those 
measured in control animals indicate that the responses seen in alveolar 
macrophages are believable (representative histograms are shown in Figure 4.6 for 
the alveolar macrophage response to 5 mins of LPS).  
 
Phosphorylated MAP kinase levels following LPS instillation 
In response to intratracheal LPS, alveolar macrophages demonstrated very rapid 
activation, as demonstrated by significant increases in phosphorylated ERK, p38 and 
MK2 compared to untreated animals.  Peak levels of MAP kinase activation were 
seen at the five minute time point and decreased subsequently (Figure 4.7A).   
Epithelial cells showed substantially smaller responses than alveolar 
macrophages.  Phosphorylated ERK levels were significantly raised at 5 mins in type II 
cells and by 30 mins in type I cells and remained high for the duration of the time 
course for both epithelial subpopulations.  There is some suggestion of an increase in 
phosphorylated p38 levels. However, the mean fluorescence intensity (MFI) values 
were very low, thus calling into question the validity of this signal. Additionally, no 
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change in phospho-MK2, a MAP kinase molecule that lies directly downstream of 
p38, was detected in either cell type (Figure 4.7B and C)  
 
 
 
 
Figure 4.6:  Representative histograms showing alveolar macrophage activation in 
response to intratracheal LPS.  Histograms demonstrate increased levels of 
phosphorylated ERK (A), p38 (B) and MK2 (C) in response to 5 mins exposure to 20µg 
LPS as compared to untreated control (filled histogram).  
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Figure 4.7:  Time course of alveolar macrophage and epithelial MAP kinase 
responses to intratracheal LPS.  Expression of phosphorylated intracellular MAP 
kinases ERK, p38 and MK2 in alveolar macrophages, type II and type I alveolar 
epithelial cells (AEC) were measured 5, 15, 30 and 60 minutes after intratracheal 
instillation of 20µg LPS.  (N=3-4, * P<0.05, **P<0.01, ***P<0.001) 
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MAP kinase levels following TNF instillation 
In response to TNF, alveolar macrophages were again very rapidly activated, showing 
highest levels of phosphorylated ERK, p38 and MK2 at 5 mins compared to untreated 
animals (Figure 4.8A).  The MFI values for epithelial cells were again much lower than 
for alveolar macrophages.  Further echoing the pattern seen with LPS, type II cells 
appeared more sensitive than type I cells, demonstrating more rapid activation of 
ERK (5 mins vs 15 mins, respectively).  The changes seen with p38 for both type I and 
II cells are statistically significant to untreated animals, but again the MFI values are 
very low and therefore not robust nor supported by changes in MK2 levels, which 
remained static and were not different to those in untreated animals (Figure 4.8B 
and C).    
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Figure 4.8:  Time course of MAP kinase response to intratracheal TNF in alveolar 
macrophages and epithelial cells.  Expression of intracellular MAP kinases ERK, p38 
and MK2 in alveolar macrophages, type II and type I alveolar epithelial cells (AEC) 
were measured 5, 15, 30 and 60 minutes after intratracheal instillation of 20µg LPS. 
(N=3-4, * p<0.05, **p<0.01, ***p<0.001) 
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MAP kinase levels following high stretch ventilation  
Having elicited activation of MAPK pathways within alveolar macrophages and 
epithelial cells using LPS and TNF, I then applied this novel methodology to the 
ventilation model. The largest MAPK response was observed 5 mins after 
administration of both LPS and TNF, so we used this time point in investigating the 
response of alveolar macrophages and epithelial cells to high stretch ventilation.  
 Alveolar macrophages showed raised levels of phosphorylated ERK, p38 and 
MK2 compared to low stretch ventilation (Figure 4.9A).  This increase, though 
significant, was smaller than in response to LPS or TNF.  Epithelial cells showed a 
different pattern of activation compared to LPS/TNF: type II cells appeared 
unresponsive to high stretch ventilation (Figure 4.9B), whereas type I pneumocytes 
demonstrated activation via ERK and perhaps p38, although the signal again is 
extremely small (and probably beyond the sensitivity of the measurements), with a 
trend towards MK2 activation (Figure 4.9C)    
 We went on to compare 60 mins of low stretch to high stretch ventilation but 
found no difference between the groups (data not shown) and therefore decided not 
to look at further time points in between (due to the large number of animals that 
would be required for a full low stretch and high stretch time course). 
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Figure 4.9: MAP kinase levels in alveolar macrophages, type II and type I alveolar 
epithelial cells (AEC) after ventilation.  Changes in phosphorylated levels of ERK, p38 
and MK2 following five minutes of high or low stretch ventilation. (N=3-4, *P<0.05, 
***P<0.001) 
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4.5  Discussion  
The development of appropriate methodologies to identify discrete cell populations 
and to evaluate activation of these cells during mechanical ventilation was a 
fundamental part of my PhD studies and required a significant amount of time.  In 
the end, I was successful in developing a novel method to investigate the activation 
of individual cells within the lung, using flow cytometry to measure increased levels 
of intracellular MAP kinase phosphorylation as an indicator of activation.  My data 
clearly demonstrate for the first time in vivo that alveolar macrophages are very 
rapidly activated upon stimulation by high stretch ventilation.  A number of studies 
have looked at activation of MAP kinase pathway components, but due to the heavy 
reliance on Western blotting and semi-quantitative immunohistochemistry, there is 
a paucity of information available about intracellular activation of specific cell types 
in in vivo models of lung injury.  
I began this study by attempting to detect a change in mTNF expression on 
alveolar macrophages with high stretch ventilation.  In the experience of our group, 
TNF is very easily shed from the cell surface, hence the precautions applied by 
keeping lavage samples on ice and addition of the metalloproteinase inhibitor BB94 
for lavage of the lungs, with the intention to block the actions of TACE and prevent 
shedding during post-experimental tissue processing.  Additionally, for these 
experiments manual chopping was used to mince the lung, as the electronic 
GentleMACS tissue dissociator was felt likely to be too harsh and could increase the 
chances of shedding.  Studies have demonstrated that LPS can trigger an 
upregulation of mTNF (Nii, Sone et al. 1993; Chaudhri 1997; Tsao, Lin et al. 2004) 
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but, to the best of our knowledge, there are no reports within the literature of mTNF 
expression in models of VILI.  The mechanism of activation and subsequent TNF 
upregulation in response to LPS (known to signal via TLR4) and high stretch is likely 
to be different, and as such it is possible that mTNF is shed more quickly with high 
stretch or is simply expressed at much lower levels than after stimulation by LPS.  
Additionally it is important to consider the kinetics of TNF upregulation during VILI.  
Until about 5 years ago the involvement of TNF in VILI remained controversial, partly 
because not all research groups were able to consistently detect TNF in the alveolar 
space in their models (Verbrugge, Uhlig et al. 1999; Dreyfuss, Ricard et al. 2003).  Our 
group at least partly addressed this issue by demonstrating that soluble TNF 
increased early in the progression of VILI (after about 2 hours), after which it 
declined (Wilson, Choudhury et al. 2003).  The mechanism behind this decrease is 
unclear, although we would postulate that rapid influx of TNF receptors from the 
plasma may sequester soluble TNF and prevent its detection (Dorr, Wilson et al. 
2011).  Thus it is possible that the failure to detect mTNF upregulation in our 
experiments may also have resulted from measuring levels at the wrong time (and 
we currently are still unaware of what the right time would be) and/or quenching of 
membrane-bound TNF by soluble receptors following an increase in alveolar barrier 
permeability.  
 The enhanced epithelial identification I was able to implement in this section 
of my investigation was facilitated firstly by a publication by Marsh and colleagues in 
2009, outlining a new and clear method of type I and II alveolar epithelial cell 
identification by flow cytometry (Marsh, Cakarova et al. 2009); and secondly by the 
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acquisition of a seven-channel flow cytometer by our lab group, permitting a more 
thorough characterisation of the pulmonary epithelial subpopulations than could be 
achieved with the preceding four-channel flow cytometer.  In addition to 
identification of the two alveolar epithelial cell types identified by Marsh, we were 
able to identify a third population with a dual T1α+ProSPC+ phenotype.  It seems 
likely that this is a transdifferentiating population. Type II cells are the pneumocyte 
responsible for regulating the alveolar epithelium and can transdifferentiate into 
terminally differentiated type I pneumocytes in response to damage inflicted upon 
the epithelium, but also during homeostasis, with a ~4% turnover of cells per day in 
the adult rat lung  (Tanswell, Byrne et al. 1991).    
 In this study we did not use isotype controls for the MAP kinases we 
measured.  During the development of the technique we tested commercial isotype 
controls but found that the background staining was higher than the signal from 
some of the MAP kinase antibodies.  In view of their questionable validity, we 
omitted the controls, instead comparing basal levels in normal lungs with treated 
levels.  In terms of the very low expression of phosphorylated levels of p38 and ERK 
in epithelial cells it would be useful to optimise the method further and validate the 
levels achieved using inhibitors.  However, the magnitude of MAP kinase signal 
detected in alveolar macrophages was significantly greater than in epithelial cells, 
indicating that this methodology works and suggesting that macrophage activation 
may be more relevant.  We chose to investigate p38, MK2 and ERK due to their wide 
usage within the literature.  Having validated the model, it should be easy to assess 
levels of other intracellular signalling molecules such as NFκB, JNK and Akt (we did 
163 
 
assess changes in Akt with ventilation although the data is not shown here).  We also 
did not measure the level of unphosphorylated MAP kinases, which is a common 
practice with Western blotting.  In the shorter experiments (<30 mins) in the LPS and 
TNF time courses total MAP kinase expression was unlikely to change and although it 
could change in the longer experiments, we were interested in detecting an increase 
in MAP kinase activity per se, irrespective of any increase in expression.  In addition, 
by using flow cytometry we were able to measure the level of phosphorylated MAP 
kinase per cell, and thus the signal was intrinsically normalised.  
A dampened MAP kinase response was observed with non-ventilated control 
animals treated with ketamine/xylazine compared to isoflurane.  Studies have 
previously demonstrated that ketamine offers a protective effect (Mazar, Rogachev 
et al. 2005; Wang, Lu et al. 2007; Yang, Chen et al. 2011) with animals showing 
attenuation of lung injury.  Incidentally, isoflurane has also been reported to offer 
protective effects, particularly when used as a preconditioning agent (de Rossi, Horn 
et al. 2002; Li, Zhu et al. 2009; Zhang, Luo et al. 2010).  However any anti-
inflammatory effects are unlikely to be witnessed within the very short period (1min) 
that untreated animals were exposed to isoflurane, in comparison to 
ketamine/xylazine (10 mins).  This observation served to highlight the sensitivity of 
our model in detecting MAP kinases and, in conjunction with the rapid changes in 
MAP kinases observed in the alveolar cells, how sensitive MAP kinases are as 
markers of activation.  Identification of this effect of different anaesthetic regimes 
was vital for my experiments, as without this, it is probably unlikely that I would have 
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been able to detect activation of epithelial cells in particular, as they showed a 
relatively small upregulation of all MAP kinases studied, regardless of the stimulus. 
The MAP kinase response of alveolar cells to intratracheal LPS or TNF in this 
study was remarkably similar. It has been well documented that LPS signals via Toll-
like receptor 4. However, although TNF is arguably the best-defined pro-
inflammatory cytokine, the multiplicity of its effects and the existence of two TNF 
receptors (p55 and p75) with apparently opposing effects, mean that the exact 
mechanisms triggered by TNF have yet to be clearly elucidated (Wilson, Goddard et 
al. 2007).  We used TNF as a sterile insult (in contrast to LPS which is a bacterial 
product) to simulate an alveolar environment where macrophages were already 
activated, as activated macrophages in vitro are known to release TNF and various 
models of ALI and VILI have been shown to increase intra-alveolar levels of TNF 
(Takata, Abe et al. 1997; Halbertsma, Vaneker et al. 2005).  TNF is understood to be 
an alveolar macrophage autocrine signalling molecule (Skerrett and Martin 1996) 
that can also trigger macrophage aggregation (Barnes, Abrams et al. 1993).  As such, 
the rapid increase of MAP kinases in response to TNF was not wholly surprising.   
It was interesting to note that type II cells were apparently more responsive 
to both LPS and TNF than type I pneumocytes.  Type I cells showed a delayed 
response to stimulation, for which there could be two possible explanations: a 1) 
type I cells are less responsive to LPS/TNF than their type II counterparts; or 2) the 
activation observed was in response to a secondary signal either from alveolar 
macrophages or type II cells.  If option two were to be true, such activation of type I 
cells (represented by the increase in MAP kinase levels) would need to occur and 
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start returning to normal within the space of five minutes.  Although possible, this 
seems somewhat unlikely, as although alveolar macrophages showed a peak signal 
at 5 mins followed by a marked decline in MAP kinase levels, it took a long time for 
levels to return to baseline, still remaining higher than untreated levels at the 60 
mins time point.  Thus it seems most likely that type I cells are less responsive to 
LPS/TNF than type II pneumocytes.  The difference in response between alveolar 
epithelial cells may be due to differential expression of TNF receptors and/or TLR4, 
and the in vivo characterisation of expression of these receptors on alveolar 
epithelial cells has yet to be conducted.  
 The response to high stretch ventilation was noticeably different to the LPS or 
TNF responses.  Firstly, type I cells were more responsive to high stretch than type II 
cells.  This seems a logical finding as type I cells cover 95% of the alveolar surface and 
are thus much more likely to be physically stretched than cuboidal type II 
pneumocytes.  Secondly, the MFI values for all cell types were substantially smaller 
with ventilation. There is the possibility that ventilation is simply not as great an 
inflammatory stimulus as LPS/TNF.  But an alternative explanation could be due to a 
recently described phenomenon resulting from vagal nerve stimulation which will be 
discussed further in chapter seven.  The very rapid and substantial MAP kinase 
response detected in alveolar macrophages compared to epithelial cells with high 
stretch ventilation could indicate that:  
a)  activation of alveolar macrophages is more biologically significant than 
epithelial cell activation. Rather, epithelial cells serve to aid macrophage 
activation, in line with our 'starfish hypothesis'; or 
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b)  activation of alveolar macrophages occurs as a result of very rapid 
epithelial activation that occurs before the five minute time point we 
investigated.  The very short time frame makes this seem unlikely, but rapid 
release of prostaglandins for instance has been detected within a similar time 
frame (Coker, Hughes et al. 1983); or  
c) another signalling pathway is involved (e.g. Akt, JNK) in epithelial activation 
and/or may not involve MAP kinase signalling at all.  However, this seems 
unlikely as many other studies have shown stretch-induced activation of 
epithelial cells through ERK and p38.  
The rapid response in MAP kinase activation that I observed has in fact been 
reported in other models (Thrane, Schwarze et al. 2001; Cohen, Gray Lawrence et 
al.).  In addition, a difficulty in detecting p38 within pulmonary epithelial cells, which 
I observed was independent of the stimulus, was also reported by Thorley and 
colleagues (Thorley, Ford et al. 2007).       
 
In summary, I have developed a novel method for the flow cytometric detection of 
phosphorylated levels of MAP kinases, for use as intracellular markers of activation 
in specific pulmonary cell subpopulations.  I demonstrated that in vivo high stretch 
activates alveolar macrophages very rapidly.  There are also signs of increased MAP 
kinase levels in type I epithelial cell activation, although the physiological significance 
of this is unclear.  As the data gathered in this study supported my starfish 
hypothesis, the final step was to test it.   
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CHAPTER FIVE 
 
Blockade of intra-alveolar integrin-mediated cellular interactions 
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In the previous chapters I demonstrated the importance of alveolar macrophages in the 
development of ventilator-induced lung injury and showed evidence to suggest increased 
interactions between alveolar macrophages and epithelial cells (as well as macrophage-
macrophage interactions).  I proposed the starfish hypothesis, which postulates that 
heterotypic interactions between alveolar macrophages and epithelial cells are likely to be 
mediated by ICAM-1/beta-2 integrins, and went on to detect very early activation of alveolar 
macrophages by stretch using intracellular phosphorylated MAP kinase levels as an indicator 
of activation.  I believe that the rapidity of alveolar macrophage activation, and apparent 
relative lack of epithelial activation, supports my hypothesis that macrophages are most 
likely directly responsive to stretch or deformation, rather than secondary signals produced 
by epithelial cells.  The hypothesis further implicates integrin-mediated interactions as the 
mechanism behind which alveolar macrophages sense deformation of the lungs.  
I therefore used an anti-CD18 antibody in order to inhibit interactions between beta-
2 integrins and their ligand ICAM-1.  Animals were allocated to three different groups and 
dosed with intratracheal anti-CD18 or an isotype control overnight, with the exception of 
group 2 in which animals received antibodies after connection to the ventilator.  Mice in 
group 1 were subjected to 180 mins of high stretch ventilation; group 2 received one hour of 
low stretch followed by 5 mins of high stretch; and group 3 received 5 mins of high stretch 
ventilation.  Physiological changes were observed in group 1, whilst MAP kinase levels were 
measured in groups 2 and 3.  We did not detect any significant effect on the progression of 
injury nor the activation of alveolar cells using anti-CD18 compared to an isotype control.   
Whilst we were unable to demonstrate a protective effect using anti-CD18 in this 
study, existing data suggests that blockade of the ICAM-1/beta-2 integrin interaction within 
the alveolar space can offer protection in ALI and thus future experiments using alternative 
methods of blockade should be able to demonstrate such an attenuation of injury and thus 
provide evidence for our starfish hypothesis.    
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5.1  Background  
An attenuation of injury has been demonstrated in models of ALI when ICAM-1 
mediated interactions have been blocked (Lundberg, Fukatsu et al. 2001; Beck-
Schimmer, Madjdpour et al. 2002; Basit, Reutershan et al. 2006). In chapter 3 we 
outlined our starfish hypothesis in which we proposed that ICAM-1 mediates the 
activation of alveolar macrophages during high stretch ventilation, by facilitating 
their detection of epithelial stretch.  Having demonstrated very early activation of 
alveolar macrophages by high stretch ventilation, using MAP kinases as intracellular 
markers of activation (chapter 4), we wanted to further test our hypothesis to obtain 
some more definitive evidence that ICAM-1 mediates alveolar macrophage 
activation. We have observed the protective effect of macrophage depletion 
(chapter 3), and so we considered that blocking interactions between macrophages 
and the alveolar epithelium could have a similar effect.  The next step was therefore 
to block ICAM-1 or its ligands.  
 Various studies have tried blocking ICAM-1 or beta-2 integrins in models of 
acute lung injury, with most groups administering blocking antibodies via the 
intravascular (i.v.) route. Folkesson and colleagues blocked CD18 and CD11b 
(separately) in a rabbit acid instillation model and found a significant improvement in 
endothelial permeability, pulmonary oedema formation and blood gases (pO2, pH) 
with both antibodies (Folkesson and Matthay 1997).  Mulligan and colleagues have 
published a couple of studies where they demonstrate an attenuation of lung injury 
using blocking antibodies.  In 1992 they reported 63% protection from injury using 
i.v. anti-CD11b and 74% with anti-CD18 in animals subjected to cobra venom factor-
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induced lung injury, as indicated by improvements in vascular permeability and 
haemorrhage, which were used as their markers of injury (Mulligan, Varani et al. 
1992).  In 1995 they published another study in which they compared the effects of 
blocking antibodies against CD11a, CD11b, ICAM-1 and L-selectin, which were 
administered intravenously or intratracheally,  in an IgG immune complex model of 
ALI (Mulligan, Vaporciyan et al. 1995).  Their indicators of injury were increased 
levels of BAL TNF, upregulation in vascular ICAM-1 and an increase in lung 
myeloperoxidase (which is a marker of neutrophil influx).  They found an attenuation 
of injury with i.t. anti-CD11b and anti-ICAM-1 (whereas anti-CD11a and anti-L-
selectin offered no protection in this compartment) and protection from injury using 
i.v. administered anti-CD11a, anti-ICAM-1 or anti-L-selectin (whilst i.v. anti-CD11b 
had no effect).  As described in chapter one, CD18 is the common beta chain of the 
beta-2 integrins and as such an antibody against CD18 has the capacity to prevent 
the binding of beta-2 integrins with ICAM-1, theoretically at least.  As such, it is not 
surprising that blockade of individual alpha chains has been reported to not be quite 
as successful at preventing injury as when CD18 blockade is used, as reflected in the 
studies by Mulligan and Folkesson (Mulligan, Varani et al. 1992; Folkesson and 
Matthay 1997).   
 
 
5.2  Aims  
The aim of this chapter was to interfere with the ICAM-1/beta-2 integrin interaction 
between alveolar macrophages and the alveolar epithelium (and/or in homotypic 
macrophage interactions), with the goal of preventing alveolar macrophage 
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activation, as detected by MAP kinase activation or improved physiological outcomes 
following high stretch ventilation.  
 
 
5.3  Protocols  
CD18 blockade – MAP kinase measurements  
In this set of experiments I instilled 1mg/ml of anti-CD18 antibody (Becton Dickinson) 
or an isotype control intratracheally and measured MAP kinase levels after a short 
period of ventilation.  There were two groups of mice: 
In group 1, anaesthetised mice had an endotracheal tube inserted and were 
ventilated with low stretch settings (VT: 10ml/kg).  Following stabilisation, either 
anti-CD18 or an isotype control antibody was instilled via the endotracheal tube.  A 
series of four recruitment manoeuvres were performed to assist distribution of fluid 
throughout the lung.  Low stretch ventilation was then continued for one hour, with 
recruitment manoeuvres at 20min interval. High stretch settings (mean VT : 37ml/kg 
±2ml/kg, 3cmH2O PEEP) were subsequently applied.  After five minutes of high 
stretch ventilation animals were sacrificed, and the lungs removed and processed for 
MAP kinase analysis by flow cytometry, as described previously (chapter four).  This 
model of antibody instillation after connecting the mouse to the ventilator has been 
developed within our group and facilitates the instillation of fluid immediately prior 
to high stretch ventilation, whilst allowing some standardisation of ventilation 
parameters, which vary between animals due to fluid within the conducting airways.   
172 
 
In group 2, mice received their dose of intratracheal anti-CD18 or isotype control the 
day before ventilation (instilled using the technique described previously).  Following 
surgery and stabilisation, animals were ventilated with high stretch for 5 mins (VT: 
37ml/kg ±2ml/kg, 3cmH2O PEEP), after which animals were sacrificed and lungs 
processed to measure MAP kinase levels.  
 
CD18 blockade – physiological measurements  
An additional third group of mice were given an intratracheal dose of anti-CD18 or 
isotype control antibody the day before ventilation. Similar ventilation settings were 
used as for alveolar macrophage depletion experiments (outlined in chapter 3).  As 
such, mice were ventilated with high stretch settings using a VT of 39-41ml/kg, 
3cmH2O PEEP and a respiratory rate of 90bpm using 4% CO2 in oxygen.   The end 
points for experiments were 180 mins of high stretch, a fall in blood pressure below 
40mmHg or an increase in PIP of 20%, whichever occurred first.  We assessed 
respiratory mechanics and other physiological measures (including blood gases) 
during the experiment, and the level of protein and cytokines in bronchoalveolar 
lavage was measured after the experiment, in addition to lung wet/dry ratios and 
differential cytology.  The right lung was tied off and resected for wet/dry weight and 
the left lung was lavaged.   
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5.4  Results  
Group 1: 5 mins high stretch, 1 hour after antibody instillation 
Applying the new MAP kinase methodology (as described in chapter four), we 
attempted to interfere with the interaction between macrophages and the 
epithelium by blocking the beta subunit of beta-integrins using an anti-CD18 
antibody.  After instillation of either the anti-CD18 antibody or an isotype control 
and a subsequent 60 mins of low stretch ventilation, high stretch settings were 
applied for five minutes (the time point where the greatest alveolar macrophage 
activation was detected in our MAP kinase time course) and MAP kinase levels were 
measured.  Upon analysis of phosphorylated levels of ERK, p38 and MK2 in alveolar 
macrophages we found that there was no difference between animals treated with 
anti-CD18 or isotype control treated animals (Figure 5.1).  
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Figure 5.1:  Alveolar macrophage MAP kinase levels following 5 mins high stretch 
ventilation following CD18 blockade and 60 mins low stretch.  Animals were 
connected to the ventilator and after stabilisation were dosed with anti-CD18 or the 
isotype control.  Following a further 60 mins of low stretch ventilation, a high stretch 
protocol was applied for 5 mins, after which the experiment was terminated.  We 
observed no significant change in phosphorylated levels of ERK, p38 nor MK2 
comparing animals treated with intratracheal anti-CD18 to those dosed with an 
isotype control antibody.  (N=4-5, not significant) 
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Group 2: overnight antibody incubation + 5 mins high stretch  
We considered that the instillation procedure or the initial 60 mins of low stretch 
ventilation could have triggered activation of the MAP kinase pathways, in which 
case by the time we switched to high stretch we would have missed the peak 
activation that we observed after 5 mins of high stretch in the MAP kinase study 
described in chapter four.  Alternatively, it might take longer than one hour for the 
antibody to interfere with alveolar macrophage-epithelial interaction as the 
instillation procedure would not necessarily detach macrophages from the 
epithelium and permit antibody binding.  As such, we adjusted the model and dosed 
the animals with either anti-CD18 or isotype control antibodies the day before 
ventilating.  Animals were then subjected to 5 mins of high stretch ventilation and 
the lungs were processed for flow cytometric analysis of MAP kinase levels.  
However, again we found that there was no significant difference between anti-
CD18 and isotype control treated animals in terms of ERK, p38 and MK2 levels in 
alveolar macrophages (Figure 5.2).  
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Figure 5.2:  MAP kinase levels following overnight CD18 blockade and 5 mins high 
stretch ventilation.  We observed no change in phosphorylated levels of ERK, p38 
nor MK2 comparing animals treated with intratracheal anti-CD18 to those dosed 
with an isotype control antibody.  (N=3-4) 
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Physiological changes with CD18 blockade  
As I was unable to detect a difference between control and CD18 blockade treated 
animals, I speculated that the inflammatory nature of the instillation procedure may 
have affected the sensitivity of the MAP kinases to further activation by high stretch.   
As it was clear from chapter 3 that macrophage depletion reduced both 
inflammatory and physiological consequences of high stretch ventilation, I 
considered that such changes following a longer period of high stretch ventilation 
may provide a clearer idea of whether CD18 blockade offers a protective effect.  
Therefore animals were treated with anti-CD18 or isotype control the day before 
ventilation, and were subjected to a 3 hour ventilation protocol.  We did not see a 
significant difference in physiological measurements between the groups (see Table 
5.1 for respiratory mechanics and blood gas data).  I looked at the lung wet/dry wet 
ratios and BAL protein as indicators of alveolar-epithelial permeability.  Although the 
difference was not significant due to the large amount of variability between 
animals, it is possible that with additional experiments a level of significance could 
be achieved as there appears to be a trend towards an attenuation of injury with 
CD18 blockade (Figure 5.3).  The levels of MIP-2 and KC mirrored this trend towards 
attenuation, with decreased levels of both chemokines with CD18 blockade, 
although these changes were not significant (Figure 5.4).  However, differential cell 
cytology of BAL indicated a greater degree of alveolar macrophage clumping and a 
lower number of alveolar macrophages in mice treated with isotype + 180 mins high 
stretch compared to animals pre-treated with anti-CD18 (Figure 5.5). 
 
 
178 
 
 
 
 
 
Physiological 
parameters 
Isotype control + high stretch Anti-CD18 + high stretch 
start end start end 
PIP (cmH2O) 43.8 ± 4.6 49.8 ± 6.3 39.2 ± 2.6 44.3 ± 10.9 
Respiratory system 
compliance change (%) 
-7.6 ± 3.7 -11.08 ± 16.9 
pCO2 (mmHg)* 39.3 ± 0.8 44.5 ± 3.4 37.3 ± 0.7 44.0 ± 5.5 
pO2 (mmHg)* 491.1 ± 49.6 237.7 ± 168.2 480.6 ± 40.6 264.8 ± 202.5 
 
 
 
Table 5.1:  Physiological changes during high stretch ventilation in animals treated 
with anti-CD18.  Changes in respiratory mechanics and blood gas measurements are 
shown, comparing the start of high stretch to the end of the experiment.  *The start 
value for pCO2 and pO2 was taken from a blood gas measurement 15 mins after the 
start of high stretch.  (Data is displayed as mean ± standard deviation. N=3)   
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Figure 5.3: Lung wet/dry ratio (A) and bronchoalveolar lavage protein 
concentration (B) following high stretch ventilation in anti-CD18 treated animals.  
Mice were treated with an intratracheal dose of anti-CD18 or isotype control and the 
following day were ventilated with high stretch settings for up to 180 mins.  (N=3, 
not significant) 
 
 
 
Figure 5.4:  MIP-2 and KC levels in bronchoalveolar lavage from ventilated animals 
following anti-CD18 antibody pre-treatment.  Concentrations of murine IL-8 
homologues KC (A) and MIP-2 (B) show a trend towards lower levels with CD18 
blockade compared to the isotype control. (N=3, not significant)  
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Figure 5.5:  Differential cell cytology from lavage of isotype (A) and anti-CD18 (B) 
treated animals subjected to 180 mins of high stretch ventilation.  (Magnification: 
x100.  Arrowheads  indicate macrophage aggregates)  
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5.4  Discussion  
Our initial attempts at blocking interactions between alveolar macrophages and the 
epithelium using anti-CD18 have so far been unfruitful.  The intention in this study 
was to block the ICAM-1/β2 integrin-mediated interactions between alveolar 
macrophages and epithelial cells using an anti-CD18 antibody and, based on our 
starfish hypothesis (chapter three), we aimed in this way to prevent the detection of 
high stretch by alveolar macrophages and consequentially block the signal to trigger 
the inflammatory cascades of VILI.  With the longer CD18 blockade experiments 
(group 3) we were hoping to achieve a degree of protection from injury, following 
through with the logic that we had already demonstrated protection with 
macrophage depletion (chapter three) and thus by blocking communication between 
alveolar macrophages and the epithelium we might demonstrate the importance of 
this interaction in another fashion.   
 Anti-ICAM-1 has been used previously to block the ICAM-1/β2 integrin 
interaction (Mulligan, Wilson et al. 1993) but there are a number of issues which 
might make use of such an approach complicated.  Firstly, ICAM-1 is a ubiquitious 
molecule within the alveolar space, expressed on epithelial cells, macrophages and 
also present in its soluble form, following cleavage of the membrane-bound form of 
ICAM-1 from the cell membrane by TACE or alternative transcription (Mendez, 
Monroy et al. 2011), and thus complete blockade of ICAM-1 may prove difficult to 
achieve.  Additionally, Mulligan and colleagues reported that their attempts to block 
interactions in vivo using anti-ICAM-1 in its form as a whole IgG molecule were only 
successful after fragmentation of the antibody to remove the unspecific Fc portion 
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(Mulligan, Wilson et al. 1993).  However, fragmented ICAM-1 is not currently 
available on the market and initial attempts using an antibody fragmentation kit 
within our lab to obtain F(ab’)2 portions from whole antibodies have yielded 
insufficient quantities of antibody by the end of the fragmentation process to be of 
any use.  I felt that, in contrast, CD18 provided a more focused target than the 
ubiquitous ICAM-1, due to its limited localisation on alveolar macrophages within the 
non-inflamed alveolar space.  Studies have also used antibodies against specific beta-
2 integrin alpha chains, CD11a and CD11b (Mulligan, Vaporciyan et al. 1995; Maus, 
von Grote et al. 2002; Moreland, Fuhrman et al. 2002).  However, simultaneous 
blockade of CD11a and CD11b or either alpha chain in combination with anti-CD18 
has been shown to be a more effective method of blockade than individual use of 
these blocking agents (Mulligan, Vaporciyan et al. 1995).  As outlined in chapter 1, 
beta-2-integrins CD18/CD11a, -b and -c are capable of binding to ICAM-1 and 
therefore this report that alpha-chain blockade is not as effective as blocking the 
common beta-chain CD18 is unsurprising.   
Initially, I attempted to determine whether blockade of macrophage-
epithelial interactions would influence macrophage activation in terms of MAP 
kinase phosphorylation. Unfortunately, these experiments did not detect any 
influence of the antibody treatment.  As these experiments were unsuccessful I 
finally tried to determine whether any of the later physiological and/or inflammatory 
consequences of VILI may be influenced by this treatment, as they were by 
macrophage depletion as shown in chapter 3.  While there was no clear effect of 
anti-CD18 antibody on respiratory mechanics or blood gases, there were trends 
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towards decreased alveolar epithelial cell permeability and cytokine release in 
addition to a decrease in macrophage aggregation as observed with cytology.  There 
are a number of possible reasons why anti-CD18 treated animals did not 
demonstrate a clear attenuation of VILI.   
Firstly, model design. Instillation of fluid into the alveolar space is widely 
accepted to be an ‘inflammatory’ procedure, which is why isotype antibody or saline 
instillations are often used as controls, in order to account for changes that occur 
due to the instillation procedure itself.   As such, it is possible that instillation of an 
antibody into the alveolar space acted as an initial insult and it is unclear as to the 
length of time it takes in order for inflammation within the lungs to subside following 
a procedure such as intratracheal instillation.  Furthermore, the instillation of any 
fluid into the airspaces of mice has a major impact on respiratory mechanics.  As my 
high stretch experiments were standardised based on respiratory mechanics (airway 
pressure), any heterogeneity in the responses would have introduced a large amount 
of noise that could have prevented the detection of clear changes.  I did determine 
compliance of the lungs at the start of high stretch ventilation, which showed that 
there was no obvious difference between groups.  This issue was one reason why I 
investigated the consequences of overnight antibody incubation.   
Secondly, antibody instillation.  We used an intact antibody in our 
experiments, as opposed to just instilling the functional F(ab)2 portion.  As there are 
no leukointegrins (Gonzalez, Hards et al. 1996) nor Fc receptors (Rojanasakul, Wang 
et al. 1994) expressed on epithelial cells, cross-linking between macrophages and the 
epithelium is unlikely to have occurred.  However, as both beta-2 integrins and Fc 
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receptors are present on macrophages, homotypic aggregation may have been 
facilitated with the instillation of this antibody.  This would appear to be unlikely 
however, as I did not observe a substantial enhancement of macrophage clumping in 
lavage fluid from these animals.   
 
Overall, my attempts to interfere with the interaction between alveolar 
macrophages and epithelial cells by blocking the ICAM-1/beta-2 integrin ligand 
indicated no impact on alveolar macrophage activation (by MAP kinases), but 
perhaps a trend towards decreased inflammation and alveolar-epithelial 
permeability.  The interpretation of these experiments must remain tentative, but 
may suggest that integrin-mediated homotypic interactions between macrophages 
may be important for the amplification of macrophage chemokine production 
(although the cytokines measured are not specific for macrophages, it is generally 
accepted that these cells are the primary producers). We plan to carry out further 
experiments using alternative approaches to interfere with ICAM-1/beta-2 integrin 
interactions, by using siRNA or chimeric mice to knock down pulmonary epithelial 
ICAM-1 expression.    
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CHAPTER SIX 
 
The recruitment of activated leukocytes to extra-pulmonary organs 
with high stretch ventilation 
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Multiple system organ failure is a major cause of death amongst ARDS patients.  The 
leading theory to explain the systemic expansion of an inflammatory response that is 
initially localised to the lung is the biotrauma theory which proposes that overstretch by 
ventilation stimulates production of soluble mediators which decompartmentalise due 
to the breakdown of the epithelial and endothelial barriers.  The increase of systemic 
cytokines has been identified as the cause of extrapulmonary organ failure.  However 
some studies have indicated that leukocytes may also have a role to play, although this 
role has yet to be thoroughly investigated.  
 In order to assess the involvement of neutrophils, Gr-1high and Gr-1low monocytes 
in extrapulmonary organ injury, we examined the number of each of these leukocyte 
subpopulations in the liver, kidney, spleen, heart, brain and blood of mice following in 
vivo high or low stretch ventilation.  We also measured expression of cell surface 
markers of activation, CD11b and L-selectin, as an indicator of whether marginated cells 
were more activated following high stretch.   
 We demonstrated a significant increase in neutrophils and Gr-1high monocytes in 
the liver and an increase in neutrophils in the blood.  We also observed a trend towards 
leukocyte increase in the kidney.  No change was observed in the heart or brain, nor in 
Gr-1low monocyte levels which remained static.  Additionally, neutrophils in the liver 
were significantly activated, as indicated by raised CD11b expression.  
 These results indicate organ-specific margination of activated leukocytes with 
high stretch ventilation.  The increase in leukocytes we observed is likely to be due to 
bone marrow mobilisation of cells.  The recruitment of Gr-1high but not Gr-1low 
monocytes also fits with the reported inflammatory characteristics of Gr-1high expressing 
monocytes.  
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6.1  Background  
The majority of ARDS patient mortality is not due to respiratory failure but rather the 
malfunction of other organs eventually leading to multiple system organ failure 
(MSOF) (Slutsky and Tremblay 1998; Imai, Parodo et al. 2003; Pinhu, Whitehead et 
al. 2003; Del Sorbo and Slutsky 2011).  As outlined earlier, the most prominent 
hypothesis in the literature offering an explanation for this propagation of a lung-
limited inflammation to the systemic scale, is the biotrauma theory (Slutsky and 
Tremblay 1998).  This theory proposes that high tidal volume ventilation 
overstretches the lung, damaging the epithelial and endothelial barriers and 
prompting production of soluble inflammatory mediators.  These mediators then 
leak out of the lung, called 'decompartmentalisation', seep into the circulation and 
travel to other organs in the body to propagate the inflammatory message from the 
lung.  There is evidence to support this theory as a number of studies have 
demonstrated increased systemic levels of cytokines in models of ALI (Imai, Parodo 
et al. 2003; Dhanireddy, Altemeier et al. 2006), VILI (Chiumello, Pristine et al. 1999; 
Haitsma, Uhlig et al. 2000) and in patient studies (Bauer, Monton et al. 2000; Sheng, 
Chiang et al. 2005).  
 An alternative theory is that the inflammatory ‘message’ is carried to 
extrapulmonary organs by leukocytes rather than soluble factors, infiltration of 
leukocytes into organs being a characteristic sign of inflammation and tissue damage 
(Spitzer, Zhang et al. 1994).  However, surprisingly little work has been conducted to 
investigate this alternative theory.  It has been suggested that leukocytes 
marginating within the kidney play a role in kidney dysfunction during acid-
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aspiration-induced ALI (Goldman, Welbourn et al. 1990).  However, prior to the work 
presented in this chapter, such a role for leukocytes in mediating extrapulmonary 
organ dysfunction had not previously been considered in VILI.  In addition, the 
involvement of different leukocyte subsets in this type of extrapulmonary injury had 
not been thoroughly investigated in any type of ALI, with studies focusing on 
neutrophils.   
 The importance of neutrophils in the pathogenesis of acute lung injury is well 
established and studies of different aetiologies, including VILI, have shown that 
injury can be attenuated by depleting or otherwise interfering with neutrophils.  
However with the fairly recent discovery of two subsets of monocytes, it has become 
apparent that many of the methods used in those neutrophil studies were not in fact 
specific to that single cell type and may have also affected the monocyte population.  
As discussed in the introduction, there are two subpopulations of monocytes: Gr-
1high monocytes which have been identified as the inflammatory subset, and Gr-1low 
monocytes which are considered the resident or non-inflammatory subset.  There is 
evidence to suggest that there is a maturation bias in Gr-1 expression, with older 
cells losing their Gr-1 expression while monocytes recently released from the bone 
marrow have a more inflammatory phenotype (Sunderkotter, Nikolic et al. 2004).  
 
6.2  Aims 
 To investigate recruitment of both monocyte subsets and neutrophils to 
extrapulmonary organs with high stretch ventilation 
 To assess activation of marginated cells using cell surface markers of activation. 
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6.3  Protocols  
In vivo model of VILI 
The following parameters were applied to the two groups of mice after surgery and 
stabilisation: 
Low stretch ventilation: 
VT: 9-10ml/kg 
PEEP: 3cmH2O 
respiratory rate: 120 bpm 
gas: 100 % O2  
with recruitment manoeuvres every 30 minutes 
High stretch ventilation: 
 Initial plateau pressure: ~38cmH2O, VT: 37-46ml/kg 
 PEEP: 3cmH2O 
 respiratory rate: 90 bpm 
 gas: O2 with 5% CO2 
 without recruitment procedures 
 
The experiment was continued until the blood pressure fell to 45mmHg or fluid 
could be seen in the endotracheal tube.  High stretch experiments lasted 160 mins 
on average, and as such low stretch experiments were terminated at 180 mins.  After 
overdose of anaesthesia, the mouse was exsanguinated via cardiac puncture which 
permitted blood sampling.  The lungs, liver, kidney, spleen and heart were then 
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removed and chopped manually.  After being washed, tissues were stained with 
antibodies for flow cytometric analysis, and counting beads were added.    
 
 
6.4  Results  
Monocytes in extrapulmonary organ dysfunction during VILI 
To begin testing our hypothesis of cell-mediated propagation of pulmonary 
inflammation to the systemic scale, we investigated the number of leukocytes 
marginating to extrapulmonary organs with low and high stretch ventilation.  High 
stretch ventilation caused a significant increase in the number of neutrophils and Gr-
1high monocytes present in the liver (Figure 6.1A).  There was no evidence of 
leukocyte infiltration to the heart (Figure 6.1D) nor the brain (data not shown).  
However, an increase in neutrophil margination to the spleen (Figure 6.1B) and 
kidney (Figure 6.1C), and an increase in Gr-1high monocytes in the kidney were 
observed, although these findings were not significant.  We also counted the number 
of monocytes and neutrophils present in the blood to get an indication of whether 
the increase in leukocyte numbers in extrapulmonary organs was merely due to 
'compartmentalisation' of circulating leukocytes, in which case we would expect to 
see a generalised leukopenia.  However, we detected a significant increase in 
neutrophils in the blood with high stretch ventilation (Figure 6.1E).  This global 
increase in leukocytes in both the circulation and organs points towards high stretch 
ventilation triggering mobilisation of leukocytes from the bone marrow. 
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Figure 6.1: Leukocyte numbers in the liver (A), spleen (B) kidney (C), heart (D) and 
blood (E) from high stretch and low stretch ventilated mice.  Use of counting beads 
allowed us to identify the number of leukocytes in each sample of tissue analysed by 
flow cytometry.  Using that as a representative sample of the total organ, we were 
then able to calculate the number of cells in the whole organ, as the weight or 
volumes used in processing the tissue were recorded and standardised. (N=4-7,  
*p<0.05, **p<0.01) 
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Leukocyte activation status 
Having demonstrated leukocyte margination to extrapulmonary organs, we went on 
to examine the cell surface expression of activation markers L-selectin and CD11b on 
these leukocytes.  We measured CD11b expression as a marker of activation only on 
neutrophils, as we used it to identify the monocyte populations (and therefore we 
could not use it to assess activation), whereas L-selectin expression was studied on 
both neutrophils and monocytes.  L-selectin is normally shed from activated cells, 
whereas CD11b expression increases with cell activation (Van Eeden, Bicknell et al. 
1997).  We found an increase of CD11b on neutrophils in the liver and a similar trend 
on neutrophils in the blood with high stretch compared to low stretch ventilation 
(Figure 6.2).  There were no significant changes in L-selectin expression on either Gr-
1high monocytes or neutrophils, although we did see trends towards L-selectin 
shedding within the kidney, spleen and particularly the blood when comparing high 
stretch to low stretch ventilation (Figure 6.3).  We did not investigate activation 
markers on Gr-1low monocytes as their numbers in the organs and blood did not 
change with ventilation, and thus it seems they are not actively involved in this 
inflammatory process.  Nevertheless we cannot entirely exclude the possibility that 
Gr-1low monocytes play some role in patrolling blood vessels for instance (Auffray, 
Fogg et al. 2007).  
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Figure 6.2: CD11b expression on neutrophils in the liver, kidney, spleen and blood 
of low and high stretch ventilated mice.  CD11b expression increases with cell 
activation.  As such, neutrophils in the liver were more activated following high 
stretch ventilation.  An increase was noticed in the kidney and blood but this was not 
significant.  (N=4–6, *P<0.05)  
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Figure 6.3: L-selectin expression on neutrophils (A) and Gr-1high monocytes (B) in 
the liver, kidney, spleen and blood of low and high stretch ventilated mice.  L-
selectin is shed upon activation.  The decrease in L-selectin observed on neutrophils 
and Gr-1high monocytes with high stretch ventilation was not significant.  (N=4-6, not 
significant.)   
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Liver and kidney wet/dry weight ratios 
As mentioned in chapter one, inflamed tissues become oedematous and as such 
wet/dry weight ratios can be an indicator of injury.  We assessed the wet/dry weight 
ratios for the liver and kidney in our low stretch and high stretch groups but found 
that there was no increase in organ weight with high stretch (Figure 6.4).  This data 
indicates that in the model of ventilation used, high stretch did not cause injury to 
extrapulmonary organs despite evidence of leukocytosis and leukocyte margination 
to the liver.    
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Figure 6.4:  Wet/dry ratios of kidney (A) and liver (B) following high stretch 
ventilation do not show signs of extrapulmonary organ injury.  There is no 
significant difference in the liver nor kidney wet/dry ratios comparing low and high 
stretch groups. (N=4, not significant) 
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6.5  Discussion  
We demonstrated for the first time the margination of neutrophils and Gr-1high 
monocytes to the liver with high stretch mechanical ventilation and activation of 
marginated neutrophils within the liver, as indicated by CD11b expression (Waite, 
Wilson et al. 2008), suggesting that leukocytes are at least in a position to play a role 
in extrapulmonary organ dysfunction.  
 The vast majority of studies investigating leukocyte involvement in VILI have 
focused on their role in pulmonary dysfunction.  A small number of studies have, 
however, postulated that leukocytes can cause extrapulmonary damage in other 
models of ALI.  For example, in a rat model of acid aspiration it was demonstrated 
that induction of lung injury led to oedema formation in the kidney and heart 
(Goldman, Welbourn et al. 1990).  This was attenuated by leukocyte depletion, 
which was assumed to be predominantly neutrophils, but the methods used would 
have depleted monocytes also.  In the current study we, for the first time, 
investigated leukocyte margination to extrapulmonary organs in a model of pure 
VILI.  We did not find significant changes in leukocytes in any other organs (ie no 
leukocyte margination to the heart nor the brain though there was a trend towards 
increased numbers in the spleen) suggesting that organ-specific leukocyte 
margination is taking place.  Interestingly, damage to the liver and kidney in 
particular has been reported in both clinical studies (Ranieri, Suter et al. 1999; 
Dhanireddy, Altemeier et al. 2006) and animal models of ALI (Choi, Quinn et al. 2003; 
Gurkan, O'Donnell et al. 2003; Imai, Parodo et al. 2003), which support our theory 
that leukocytes marginating within these organs play some role.  Since this work 
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presented in this chapter was conducted, Hegeman and colleagues have published a 
very similar study to ours, investigating neutrophil recruitment to the liver, kidney 
and brain in response to high or low stretch ventilation.  They demonstrated a similar 
increase in neutrophil margination to the liver, with no detectable neutrophils in the 
brain.  Hegeman et al additionally measured expression of cell adhesion molecules 
(VCAM-1, ICAM-1, E-selectin) and soluble markers of inflammation (TNF, KC, IL-1β) in 
the tissues and found peak expression largely after 4 hours of high stretch ventilation 
(Hegeman, Hennus et al. 2009).  
 Currently we do not understand the mechanisms by which leukocytes are 
recruited to these organs.  It is interesting that on examination of the blood, we 
found a significant increase in neutrophils and maintenance of monocyte numbers.  
This combined increase in leukocyte numbers in the organs plus the blood suggests 
that high stretch ventilation is triggering mobilisation of cells from the bone marrow. 
(Without a mechanism of replenishing leukocytes we may have anticipated finding a 
generalised leukopenia.)  This is known to occur following systemic administration of 
endotoxin (O'Dea, Young et al. 2005), but had not previously been observed with 
injurious mechanical ventilation. 
 In addition to increased leukocyte numbers, we also observed a trend 
towards activation of leukocytes within extrapulmonary organs.  The markers of 
activation we used were L-selectin, which is normally shed from activated cells, and 
CD11b, which increases with activation.  Although not significant, there was a trend 
towards loss of L-selectin expression on leukocytes within most organs with high 
stretch ventilation compared to the low stretch group, consistent with increased 
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activation.  There was also an increase in neutrophil CD11b expression, which was 
significant in the liver.  However, looking at the kidney and liver wet/dry weight 
ratios, which did not show signs of injury despite leukocyte margination with high 
stretch, it appears that other markers of injury and/or organ dysfunction are needed. 
Possible techniques for this route of investigation include the use of dye 
extravasation as an indicator of an inflamed ‘leaky’ epithelium or the identification of 
apoptotic cells using TUNEL or annexin V/propidium iodide staining (Ranieri, 2003; 
Imai 2001). 
 
In summary, these data, showing margination of activated leukocytes within 
extrapulmonary organs, act as initial evidence to support our hypothesis of cell-
mediated propagation of pulmonary inflammation to the systemic scale, as an 
alternative or in addition to the cytokine-mediated progression proposed in the 
biotrauma theory (Slutsky and Tremblay 1998).  The mechanisms by which 
monocytes that have marginated within the lungs can induce injury (which they are 
known to do from our group’s previous work (Wilson, O'Dea et al. 2009)) and the 
pathophysiological consequences of our findings, regarding leukocyte margination 
and activation within extrapulmonary organs, are not yet known and thus lie within 
the scope of future work. 
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CHAPTER SEVEN 
 
Final Discussion 
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The main focus of this study has been the earliest phase of ventilator-induced lung 
injury.  Descriptions of the pathophysiology of VILI usually start with a description of 
the inflammatory phase, the breakdown of the endothelial-epithelial barrier leading 
to the influx of oedema and neutrophils into the alveolar space where activated 
macrophages are present.  A whole section of the inflammatory process is 
overlooked in this fashion and this is reflected by the paucity of literature focusing 
on exactly how alveolar macrophages are activated and on what triggers the 
inflammatory responses that have been otherwise well characterised.  
 Work that investigates this ‘activatory phase’ of VILI has largely been based 
on in vitro study - the assumption is largely made that this is representative of what 
occurs in vivo.   However, in view of the complex and carefully balanced pulmonary 
environment, highly specialised to prevent trivial triggering of inflammatory 
processes, this is quite a leap of faith.  We have thus investigated interactions 
between alveolar macrophages and the epithelium during the early activatory and 
inflammatory stages of VILI and have developed a novel flow cytometric method to 
detect intracellular activation.  
 Although we have not completely answered all the questions we set out with, 
we have provided evidence to suggest that alveolar macrophages are key to the 
triggering of inflammatory cascades and the development of VILI, and our data hints 
towards an interaction with the epithelium being important for such detection of 
stretch. We have also conducted a proof of concept study into the margination and 
potential role of leukocytes in the development of extrapulmonary organ injury.  
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7.1  Summary of Findings 
In this work I have primarily explored the role of alveolar macrophages within the 
context of the early phases of ventilator-induced lung injury.  In chapter three I 
highlighted the crucial role alveolar macrophages play in VILI by showing an 
attenuation of injury in response to high stretch following macrophage depletion and 
was thus able to confirm existing data within the literature (Frank, Wray et al. 2006).  
I also observed a decrease in the recovery of alveolar macrophages by 
bronchoalveolar lavage, matched by an upregulation of cell adhesion molecule 
(ICAM-1) expression on epithelial cells, suggesting an enhancement of cell adhesive 
contact.  I went on to propose the starfish hypothesis and postulated that continual 
interaction of alveolar macrophages with epithelial cells via the ICAM-1/beta-2 
integrin interaction is necessary for the detection of stretch by macrophages and for 
their subsequent activation.   
In order to explore this idea, I identified MAP kinases as sensitive markers of 
activation in chapter four and developed a flow cytometric method to measure their 
intracellular phosphorylation.  In order to do this we combined two new techniques 
that were available within the literature, namely the flow cytometric measurement 
of MAP kinases outlined by Nolan and colleagues (Perez and Nolan 2002; Krutzik and 
Nolan 2003) and the identification method of alveolar type I and type II epithelial 
cells described by Marsh and colleagues (Marsh, Cakarova et al. 2009).  I went on to 
validate this methodology using intratracheal doses of LPS or TNF and observing the 
response of alveolar macrophages and epithelial cells over a one hour time course.  
Having observed the maximal macrophage response at five minutes, I then exposed 
203 
 
mice to 5 mins of high stretch ventilation and measured the level of phosphorylated 
MAP kinases p38, ERK, MK2 and Akt in similar cells.  I found that alveolar 
macrophages were rapidly activated by high stretch ventilation.  Type I epithelial 
cells showed some signs of activation but the response was much lower than that of 
alveolar macrophages and, as such, the biological significance of such an increase is 
unclear.   
 Having identified rapid activation of alveolar macrophages with high stretch, 
in chapter five I went on to try and interrupt the proposed interaction between 
alveolar macrophages and the epithelium.  I attempted a number of experiments 
using anti-CD18 antibody, a blocking antibody against the beta chain of beta-2 
integrins.  Although I was unable to show a significant improvement in outcome (in 
terms of physiological measurements or an inhibition of alveolar macrophage 
activation as detected by levels of phosphorylated intracellular MAP kinases), I did 
observe a trend to suggest that blockade of the beta-2 integrin/ICAM-1 interaction 
may be important in the activation of alveolar macrophages and the development of 
injury in response to high stretch ventilation.   
 In chapter six I described a proof of concept study, conducted in parallel to 
work focusing on the alveolar compartment.  Here I investigated the mononuclear 
phagocytic cells of the vasculature, Gr-1high and Gr-1low monocytes, and their possible 
involvement in extrapulmonary organ injury.  I found that a significantly higher 
number of activated Gr-1high monocytes marginate to the liver with high stretch 
ventilation compared to low stretch, with a similar trend present within the lung.  
This section of work highlighted that monocytes may have a role in the progression 
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of VILI to the extrapulmonary scale, and that their importance may be 
underestimated having been hidden in the shadow of neutrophils, which are known 
to play a central role in the development of injury.  
 
 
7.2  Nervous control of MAP kinase activation 
I observed in my MAP kinase study that the response of alveolar cells to high stretch, 
in terms of the level of phosphorylated MAP kinases, was dampened in comparison 
to animals stimulated with intratracheal LPS or TNF.  There is the possibility that 
ventilation is simply not as great an inflammatory stimulus as LPS/TNF.  An 
alternative explanation could be due a recently discovered phenomenon resulting 
from vagal nerve stimulation.  Dos Santos and colleagues report that stimulation of 
the vagus nerve can dampen an inflammatory response (in organs innervated by the 
vagal nerve) and thus attenuate injury in various models including VILI (dos Santos, 
Shan et al. 2011).  Macrophages and other cytokine-producing cells express 
acetylcholine receptors, and when exposed to acetylcholine (which is released from 
the efferent vagus nerve) the synthesis and release of cytokines is suppressed 
(Wang, Yu et al. 2003).  Vagal nerve stimulation can be from direct stimulation or 
due to detection of cytokine release, the latter being part of what is called the 
inflammatory reflex (Johnston and Webster 2009) (see Figure 7.1).   During the 
surgical preparation of animals undergoing ventilation, when placing the 
endotracheal tube, there is almost certainly a degree of vagal nerve stimulation 
through the overlying tissues.  As such, this may have influenced the apparent 
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activation of alveolar cells, although it remains unclear what magnitude of insult is 
required to induce such responses.    
 
 
 
 
Figure 7.1:  The inflammatory reflex. Stimulation of the afferent vagus nerve by pro-
inflammatory cytokines or direct/electrical stimulation results in release of 
acetylcholine (ACh) from the efferent vagus nerve, which binds with ACh receptors 
on cytokine-secreting cells such as macrophages and inhibits cytokine release.  
(Adapted from (Johnston and Webster 2009)) 
 
Inflammatory reflex
Inflammatory 
insult
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7.3  Negative regulation of the lung 
The lung provides a unique and highly specialised environment where the continual 
exposure to pathogenic material must be managed by appropriate inflammatory 
responses.  There is increasing evidence to support the existence of a negative 
regulatory system that is specific to the alveolar space, providing a threshold below 
which alveolar macrophages will not become activated.  As discussed in chapter one, 
various molecules have been identified that exert control over alveolar macrophages 
(e.g. TGF, CD200, IL-10).  The most prominent hypothesis proposes that alveolar 
macrophages interact with the epithelium via these bonds and in the presence of a 
substantial pro-inflammatory signal these links are severed and the macrophages 
detach from the epithelium in order to facilitate their activation.  There is 
subsequently an upregulation in expression of negative regulatory factors in an 
inflammatory effort to restore homeostasis.  Eventually, alveolar macrophages 
resume their close interaction with the epithelium and negative regulation is 
restored.  However, in chapter three I identified that the number of alveolar 
macrophages recovered by bronchoalveolar lavage with high stretch ventilation was 
lower than with low stretch ventilation.  This, in conjunction with existing data in the 
literature, indicates that activated alveolar macrophages have a more adhesive 
phenotype.  Thus it seems unlikely that alveolar macrophages would physically 
dissociate from the epithelium only to promptly re-adhere.  Hence, whilst the 
identification of negative regulatory molecules is of interest, further investigation is 
needed to understand their influence over the transition between an inactive and 
active macrophage state.   
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7.4  Triggering the inflammatory cascade and the starfish hypothesis 
Epithelial cells and alveolar macrophages are the two most likely candidates for 
being responsible for detection of overstretch in VILI.  I considered that as alveolar 
macrophages are located within the surfactant layer it was somewhat unlikely that 
they would be stretched, whereas epithelial cells are in a much more likely position 
to sense stretch.  On the other hand, alveolar macrophages are known as the major 
cytokine producer within the alveolar space and depletion of alveolar macrophages 
results in an attenuation of injury, as reported by Frank and colleagues (Frank, Wray 
et al. 2006) and confirmed in chapter three.  The combination of high constitutive 
ICAM-1 expression on type I epithelial cells and the evidence of increased adhesive 
interactions we observed in response to high stretch ventilation in chapter three, 
with difficulty recovering macrophages and a corresponding increase in epithelial 
ICAM-1 expression, pointed towards ICAM-1 mediated interactions playing an 
important role in epithelial-macrophage communication.  And as such the starfish 
theory was formed to encompass an apparent partnership between alveolar 
macrophages and the epithelium.  The results from my MAP kinase experiments, 
described in chapters four and five, suggest that alveolar macrophages are able to 
rapidly detect high stretch and are activated as a result and that beta-2 integrins are 
likely to be involved, although the results of our blockade experiments were 
inconclusive.   
 The differences between alveolar macrophage and epithelial cell responses 
to stimulation are worthy of note.  Irrespective of the stimulus we used (LPS, TNF, 
high stretch ventilation), alveolar macrophages were very rapidly activated.  
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Epithelial cells on the other hand, showed dampened levels of activation in 
comparison and the biological implications, if any, of such small changes in 
phosphorylated MAP kinase levels remain unclear.  From this observation we could 
draw the conclusion that high stretch ventilation does not activate epithelial cells 
very much in vivo compared to the substantially activated alveolar macrophages.  
This in turn suggests that results from in vitro assessment of epithelial responses to 
stretch, for example, could be misleading and irrelevant when extrapolated to the in 
vivo setting, and that any assumption of equivalence in response within both 
environments should be made with care.  It could be argued that epithelial cells are 
activated but that we are looking at the wrong molecules.  However, MAP kinases 
are commonly assessed in epithelial cells and therefore this might lead us to 
investigate later time points at which a change might be detected.  Alternatively, it is 
possible that the process of creating a lung single cell suspension in preparation for 
flow cytometry could adversely affect cells, thus influencing the measurement of our 
molecules of interest.  However, in terms of being able to identify specific cell types 
within the lung the only real alternative to flow cytometry is immunohistochemistry, 
which is not really a quantitative method and is quite heavily dependent on the user 
and their expertise in cell identification.  So, whilst there may be room for improving 
the tissue and cell recovery protocol, flow cytometry still offers the best option for 
measurement of intracellular markers of activation.  It could be suggested that 
epithelial cells were in fact activated by high stretch in our MAP kinase study, and 
that their release of intracellular stores of cytokines activated alveolar macrophages 
in turn.  This explanation seems highly likely in light of work indicating that ATP 
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release is markedly upregulated in response to high stretch (Rich, Douillet et al. 
2003) and at high concentrations can activate secretion of the inflammatory cytokine 
IL-1β by signalling through the purinergic P2X7 receptor (Solle, Labasi et al. 2001; 
Bianco, Pravettoni et al. 2005).  P2X7 receptors have also been identified on 
macrophages and their activation has been shown to trigger activation of the MAP 
kinase p38 (Pfeiffer, Aga et al. 2004).  This mechanism of stretch-induced activation 
provides a feasible explanation for the absence of a MAP kinase response in alveolar 
epithelial cells despite a clear signal being detected in alveolar macrophages.  
 The starfish hypothesis is evidently a simplistic view of what might take place 
within the alveoli and should probably be expanded to include the very rapid release 
of soluble mediators such as ATP from the alveolar epithelium prior to mechanical 
signalling via adhesion molecules.  As discussed in chapter one, in addition to ICAM-1 
as a beta-2 integrin ligand, extracellular matrix components are also known to signal 
via these receptors and are very likely to play an important role in 
mechanotransduction.  Additionally, there is likely to be some degree of species 
variance.  Whilst VCAM-1 is often reported on human cell-line derived lung epithelial 
cells, it has not been described on murine pulmonary epithelial cells.  In addition, the 
blockade study by Beck-Schimmer and colleagues achieving 100% blockade of 
neutrophil adherence to human epithelial cells using anti-ICAM-1 and anti-VCAM-1 
antibodies in conjunction (Beck-Schimmer, Schimmer et al. 2001), suggests that 
VCAM-1 is likely to be involved in the macrophage detection of stretch in humans.   
The multiple interactions that are thought to exist within the alveolar space between 
macrophages and the epithelium perhaps warrant the use of multiple forms of 
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simultaneous blockade when attempting to interrupt communication between cells 
(bearing in mind the success of Beck-Schimmer and colleagues’ in vitro blockade 
experiment described above). 
 The starfish hypothesis postulates that there is no need to remove alveolar 
macrophages from the lungs in order to offer protection from stretch-induced injury.  
Whilst macrophage depletion attenuated VILI, in both our model and existing data 
(Frank, Wray et al. 2006), it is probably not a good idea within the clinical setting, 
particularly as ARDS patients are likely to have or acquire other illnesses, such as 
pneumonia, and removal of macrophages in a non-sterile setting could render the 
immune system at risk of attack.  An ideal would be if we could interfere with 
macrophage-epithelial interactions and thus prevent the detection of high stretch 
and subsequent activation, whilst maintaining the immune defence role of 
macrophages and allowing a ‘normal’ response to infection.  In the meantime, there 
is a need to further elucidate the interactions between alveolar cells. 
 
 
7.5  Monocyte-endothelial interactions: a mirror of the alveolar macrophage-
epithelial relationship?   
A number of similarities between the mononuclear cells and their interactions within 
their respective vascular and alveolar compartments can be drawn.  As macrophages 
derive from monocytes, their similarity as cells is not so surprising.  However the 
idea that the glycocalyx (the layer of protective fluid lining the vasculature) is 
damaged by high stretch, thus exposing molecules and making them accessible for 
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cells to bind to, highlights a parallel with the alveolar space, where destruction to the 
surfactant layer is likely to facilitate increased interactions between alveolar 
macrophages and the epithelium.  Both monocytes and alveolar macrophages are 
capable of producing TNF, which can activate endothelial cells (Kotovuori, Pessa-
Morikawa et al. 1999).  As such, it seems feasible that monocytes play a role in the 
propagation of injury to the extrapulmonary scale.  In this fashion, both the 
biotrauma theory and the idea of cell-mediated injury could have a role, with local 
production of cytokines by monocytes (and potentially neutrophils) having a larger 
impact than the spillover of pulmonary cytokines into the circulation, where they are 
likely to be diluted and mopped up by erythrocytes (Darbonne, Rice et al. 1991; 
Jaecklin, Otulakowski et al. ; Jaecklin, Engelberts et al.). 
 
 
7.6  Concluding remarks 
The historical focus on neutrophils alone is slowly phasing out, replaced by a shared 
focus that includes mononuclear phagocytes and their importance in VILI, together 
with the increasing realisation that ‘structural’ cells within the lung play an important 
role in the maintenance and restoration of homeostasis.  In this study I have focused 
my attention on the pulmonary detection of overstretch during the often 
overlooked, earliest phase of VILI.  Whilst the roles of alveolar macrophages and 
epithelial cells individually have been investigated, interactions between these two 
cell types in the in vivo setting are likely to be important for the detection of high 
stretch.  The work described here will form the foundation for future work that will 
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aim to develop and validate the starfish hypothesis, and investigate the role and 
importance of mononuclear cells in the development of pulmonary and 
extrapulmonary organ injury.  In addition, the flow cytometric method we have 
described can facilitate the study of many different cell types and their mutual 
interactions, within or external to the lung.  The mortality rates for ARDS patients 
still remain high, despite the amenability of patients to treatment in light of the 
iatrogenic nature of VILI.  With the hailing of inflammation as the most promising 
area for future therapeutic targets, the potential clinical value of this area of 
investigation in identifying specific molecules or cells that can be targeted at the 
commencement of ventilation cannot be overlooked.   
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